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Chapter1: Cauda Equina Syndrome (CES) is an emergency condition that requires 
acute intervention and can lead to permanent neurological deficit in working age 
adults. A Core Outcome Set (COS) is the minimum set of outcomes that should be 
reported in any future research study within a specific disease area. A COS for 
patients with CES will be developed for use in future research studies.  
 
Chapter 2&3: A systematic literature review (SLR) was performed using PRISMA 
guidelines to document the outcomes used in CES studies. A total of 1873 studies 
were identified of which 61 met the inclusion criteria. There were 737 verbatim 
outcome terms reported. There was significant heterogeneity in the outcomes 
reported for studies after surgery for CES patients. The duration from the start of the 
CES to the operation was also analysed in these studies. There was significant 
heterogeneity in the reporting and definition of the timing to intervention in CES. 
 
Chapter 4: The outcomes of importance to patients and the lived experience of CES 
considering its severity was elicited through semi structured qualitative interviews. 
A sampling frame was used, interviews were consented for, audio recorded and 
transcribed for thematic analysis using NVivo. Data saturation was achieved with 22 
participants. Initially, 260 verbatim outcome terms were identified- 43 of which 
were not identified in the SLR. Further in depth analysis revealed 4 themes of 1) 
varying priorities of physical health, 2) a fragmented healthcare service 3) the 
process of adjustment, and 4) anticipatory anxiety and diminished sense of self-
worth.  
 
Chapter 5: Outcomes were combined and condensed from the SLR and from the 
qualitative interviews with CES patients. This resulted in 37 outcomes that were 
rated through two rounds of an international Delphi survey. The Delphi survey 
included 172 participants (104 patients, 68 healthcare professionals) who completed 
both rounds. The results were presented at an international consensus meeting 
attended by 34 key stakeholders (16 patients and 18 healthcare professionals). 
Sixteen outcomes were chosen for inclusion in the COS. They are incontinence of 
urine, urinary retention, sensation of bladder fullness, faecal incontinence, physical 
ability to have sexual intercourse, perineal sensation, sensation in genitals, leg 
muscle strength, pain due to abnormal sensation of non-painful stimulus, 
complications, global quality of life, occupational role functioning, social 
functioning, ability to do daily activities, mobility and walking and low mood and 
depression. 
 
Chapter 6: The COS was obtained by a transparent international consensus process 
involving healthcare professionals and patients with CES as key stakeholders. This 







List of Publications 
 
 
Srikandarajah N, Wilby M, Clark S, Noble A, Williamson P, Marson T. Outcomes 
Reported After Surgery for Cauda Equina Syndrome: A Systematic Literature 
Review. Spine. 2018 Sep 1;43(17):E1005. 
 
 
Srikandarajah N, Noble AJ, Wilby M, Clark S, Williamson PR, Marson AG. 
Protocol for the development of a core outcome set for cauda equina syndrome: 
systematic literature review, qualitative interviews, Delphi survey and consensus 
meeting. BMJ open. 2019 Apr 1;9(4):e024002. 
 
 
Srikandarajah N, Noble A, Wilby M, Clark S, Freeman B, Fehlings M, Williamson 
P, Marson T. Cauda Equina Syndrome Core Outcome Set (CESCOS) An 
international patient and healthcare professional consensus for research studies. 






















List of abbreviations 
A&E Accident & Emergency 
BLB Back or Leg Pain and Bladder Symptoms Study 
BNTRC British neurosurgical trainee research collaborative 
CES Cauda Equina Syndrome 
CESCOS Cauda Equina Syndrome Core Outcome Set 
CESE Cauda Equina Syndrome Early 
CESI Cauda Equina Syndrome Incomplete 
CESR Cauda Equina Syndrome with urinary Retention 
CINAHL  Cumulative index to nursing & allied health literature  
COMET  Core outcome measures in effectiveness trials  
CONSENSUS Squamous Cell CarcinOma of the OropharyNx: Late PhaSE 
CliNical TrialS; Core OUtcomeS study 
CORMAC  Core outcome research measures in anal cancer  
COREQ COnsolidated criteria for REporting Qualitative research 
COS  Core outcome set  
COSMIN  Consensus-based standards for the selection of health 
measurement instruments  
COS-STAD  Core outcome set standards for development  
COS-STAR  Core outcome set standards for reporting  
CRG Cochrane Review Group 
CROWN CoRe Outcomes in Women’s and Newborns health 
EU European Union 
GRADE Grading of Recommendations Assessment, Development and 
Evaluation 
HCP Healthcare professional 
HRA  Health research authority  
HTA Health Technology Assessment 
IPA Interpretative phenomenological analysis 
ISRCTN  International Standard Randomised Controlled Trials Number 
MOMENT Management of Otitis Media with Effusion in Children with 
Cleft Palate 
 vii 
MDT Multidisciplinary team 
MRI Magnetic Resonance Imaging 
NGT  Nominal group technique  
NHS  National health service  
NIHR  National institute of health research  
NRES National Research Ethics 
OMERACT  Outcome measures for rheumatology clinical trials  
PoPPIE Patient Participation, Involvement and Engagement group 
PRISMA  Preferred reporting items for systematic reviews and meta-
analyses  
PROSPERO Prospective Register of Systematic Reviews 
RAND Research and Development 
SCI Spinal Cord Injury 
SLR Systematic literature review 
SPIRIT Standard Protocol Items: Recommendations for Interventional 
Trials 
UK  United Kingdom  
UCES Understanding Cauda Equina Syndrome study 













List of tables 
Table 1. 1 Symptoms relating to CESI and CESR....................................................... 2 
Table 1. 2 Scope of CESCOS ...................................................................................... 5 
 
Table 2. 1 Inclusion criteria for the systematic literature review. ............................. 10 
Table 2. 2 Key search terms used in the scoping search ............................................ 11 
Table 2. 3 Summary characteristics and demographics of included studies.............. 15 
Table 2. 4 Core outcome Domains (in bold) and subdomains ................................... 17 
Table 2. 5 Raw data for each outcome showing how many studies each outcome is 
reported in, the total number of outcomes, the variations for each outcome, if a 
definition is present or not in the reported studies and the number of assessment 
tools for reported outcomes. Outcomes are listed in order of decreasing 
frequency of reported studies. ............................................................................ 20 
Table 2. 6 Assessment tools are listed in alphabetical order for the corresponding 
reported outcomes. ............................................................................................. 22 
 
Table 3. 1 The articles that reported timing, if they were defined, and if there was a 
definition from onset of symptoms. ................................................................... 27 
Table 3. 2 Details regarding the time duration between CES symptoms or admission 
and definition of the symptoms. D: Defined, ND: Not defined, R: Range, M: 
Mean .................................................................................................................. 29 
 
Table 4. 4 Number of verbatim outcome terms condensed to final outcomes. ......... 52 
Table 4. 5 Domain summaries, Ideas and Themes. ................................................... 53 
 
Table 5. 2 Details requested from participants on the registration page of the Delphi 
survey ................................................................................................................. 95 
Table 5. 3 Definitions of a consensus for the Delphi survey ..................................... 98 
Table 5. 4 Sampling frame characteristics for selection of consensus meeting 
participants. ...................................................................................................... 100 
Table 5. 5 Verbatim outcome terms per core domain or subdomain in the systematic 
literature review (SLR) and in the interviews. ................................................. 106 
Table 5. 6 Outcome List for the Delphi survey and their associated plain language 
and clinical descriptions ................................................................................... 108 
Table 5. 7 Stakeholder organisations that agreed and sent out the Delphi survey link 
to its membership. ............................................................................................ 112 
Table 5. 8 Response rate for the Delphi rounds with key stakeholders ................... 112 
Table 5. 9 Demographics of patient Delphi participants who completed both rounds
.......................................................................................................................... 113 
Table 5. 10 Demographics of HCP Delphi participants who completed both rounds
.......................................................................................................................... 114 
Table 5. 11 Percentage of patients and HCPs scoring 7-9 for an outcome in round 1 
and 2. Green were the outcomes that were included and blue were the outcomes 
excluded. .......................................................................................................... 118 
Table 5. 12 Reason for score changes in the stakeholder groups. Percentages are 
given in brackets. ............................................................................................. 120 
 ix 
Table 5. 13 This shows the number of participants who registered an interest in 
round 1 to attend the consensus meeting, the number who completed round 2 
and were eligible to attend, the number invited using the sampling frame and 
the final numbers in attendance. ...................................................................... 121 
Table 5. 14 HCP delegate demographics at the consensus meeting ........................ 122 
Table 5. 15 Patient participant demographics at the consensus meeting ................. 123 
Table 5. 16 Voting on the “no consensus” outcomes for the meeting. .................... 127 
Table 5. 17 Outcomes where the definition was changed during the consensus 
meeting. ............................................................................................................ 127 
Table 5. 18 The 16 outcomes that constitute the Cauda Equina Syndrome Core 
Outcome Set. .................................................................................................... 128 
Table 5. 19 Patient feedback for the consensus meeting. Number of participants are 
displayed with percentage in brackets (%). ..................................................... 129 
Table 5. 20 HCP feedback for the consensus meeting. Number of participants are 
displayed with percentage in brackets (%). ..................................................... 129 
Table 5. 21 Comments on the consensus meeting feedback form from Patients and 





List of figures 
 
Figure 2. 1 PRISMA flowchart for online databases. ................................................ 14 
Figure 2. 2 Stacked bar chart showing total number of articles where the outcome 
was reported and the proportion of those defined (blue) and those not defined 
(red). Also for each outcome the number of articles which have used an 
assessment tool for a reported outcome (green) and the number that have not 
(orange). Outcomes are listed from most to least reported. ............................... 18 
 
Figure 4. 1 Whyte’s six-point directiveness scale ..................................................... 47 
 
Figure 5. 1 Overview of the CESCOS project ........................................................... 86 
Figure 5. 2 Overview of COS development and the final CESCOS. ...................... 105 
Figure 5. 3 Geographical distribution of Delphi participation. ................................ 116 
Figure 5. 4 Bar chart showing average Delphi scores for patients who completed 
both rounds (blue) Vs patients who only completed the first round (orange). 117 
Figure 5. 5 Bar chart showing average Delphi scores for HCPs who completed both 
rounds (blue) Vs HCPs who only completed the first round (orange). ........... 117 
Figure 5. 6 Bar chart showing average Delphi scores for patients who attended the 
consensus meeting (orange) compared to patients who did not attend the 
meeting (blue). ................................................................................................. 124 
Figure 5. 7 Bar chart showing average Delphi scores for HCPs who attended the 
consensus meeting (orange) compared to HCPs who did not attend the meeting 
(blue). ............................................................................................................... 124 
Figure 5. 8 CESCOS international participants with some of the study team at the 


















Table of Contents 
Chapter 1: General Introduction ............................................................................. 1 
1.1 CAUDA EQUINA SYNDROME ...................................................................... 1 
1.2 TIMING OF INTERVENTION AND OUTCOMES ........................................ 2 
1.3 ECONOMIC IMPACT ...................................................................................... 4 
1.4 WHAT IS A CORE OUTCOME SET? ............................................................. 4 
1.5 SCOPE OF THE CAUDA EQUINA SYNDROME CORE OUTCOME SET 
(CESCOS) ................................................................................................................ 5 
1.6 RATIONALE FOR THE DEVELOPMENT OF THE CESCOS ...................... 6 
1.7 HYPOTHESIS ................................................................................................... 7 
1.8 AIMS AND OBJECTIVES ............................................................................... 7 
Chapter 2: Systematic literature review of outcomes reported after surgery for 
cauda equina syndrome ............................................................................................. 9 
2.1 INTRODUCTION ............................................................................................. 9 
2.1.1 Systematic literature reviews in core outcome set development ................ 9 
2.2 METHODS ...................................................................................................... 10 
2.2.1 Search strategy .......................................................................................... 10 
2.2.2 Data Extraction ......................................................................................... 12 
2.2.3 Terminology .............................................................................................. 12 
2.3 RESULTS ........................................................................................................ 13 
2.4 DISCUSSION .................................................................................................. 24 
2.4.1 Limitations ................................................................................................ 26 
2.4.2 Conclusions ............................................................................................... 26 
Chapter 3: Systematic literature review of timing in surgery for Cauda Equina 
Syndrome .................................................................................................................. 27 
3.1 INTRODUCTION ........................................................................................... 27 
3.2 METHODS ...................................................................................................... 27 
3.3 RESULTS ........................................................................................................ 27 
3.4 DISCUSSION .................................................................................................. 33 
Chapter 4: Qualitative Interviews with patients to identify important outcomes 
and themes ................................................................................................................ 35 
4.1 CHAPTER OVERVIEW ................................................................................. 35 
 xii 
4.2 ALIGNING RESEARCH PHILOSOPHY AND METHOD .......................... 35 
4.2.1 Pragmatism and its implications ....................................................................... 35 
4.2.2 Ontological position .......................................................................................... 37 
4.2.3. Epistemological position .................................................................................. 37 
4.3 CONSIDERATION OF THE ROLE OF QUALITATIVE DATA FOR 
EXPLORING CES PATIENT EXPERIENCE AND OUTCOMES ..................... 38 
4.4 METHODOLOGY .......................................................................................... 41 
4.4.1 Design ............................................................................................................... 41 
4.4.2 Patient recruitment ............................................................................................ 42 
4.4.3 Interviews .......................................................................................................... 45 
4.5 RESULTS ........................................................................................................ 50 
4.5.1 Initial Analysis Findings: Outcomes of Importance identified by patients ...... 52 
4.5.2 Detailed Analysis Findings: Themes ................................................................ 53 
4.6 DISCUSSION .................................................................................................. 73 
4.6.1 Main Findings ................................................................................................... 73 
4.6.2 Varying priorities of physical health................................................................. 74 
4.6.3 A fragmented healthcare service ....................................................................... 75 
4.6.4 The process of adjustment ................................................................................ 77 
4.6.5 Anticipatory anxiety and reduced self-worth .................................................... 78 
4.6.6 Reflecting on the qualitative approach ............................................................. 79 
4.6.7 Strengths and weaknesses of the methodology ................................................. 79 
4.6.8 Impact of patient involvement in qualitative research ...................................... 80 
4.6.9 Conclusion ........................................................................................................ 80 
Chapter 5: Cauda equina syndrome core outcome set: the consensus process.. 82 
5.1 INTRODUCTION ........................................................................................... 82 
5.1.1 Including patients in core outcome set development ........................................ 83 
5.1.2 The background to core outcome set development ........................................... 84 
 xiii 
5.1.3 Reaching consensus .......................................................................................... 85 
5.1.4 The CESCOS consensus process ...................................................................... 85 
5.2 METHODS ...................................................................................................... 86 
5.2.1 Overview ........................................................................................................... 86 
5.2.2 “Long to short” list of outcomes ....................................................................... 89 
5.2.3 The Delphi Methods ......................................................................................... 90 
5.2.4 Participants and Inclusion Criteria .................................................................... 92 
5.2.5 Sampling and Recruitment ................................................................................ 92 
5.2.6 Sample Size ....................................................................................................... 94 
5.2.7 Consent ............................................................................................................. 94 
5.2.8 The Delphi survey ............................................................................................. 95 
5.2.9 Cognitive Interviewing ..................................................................................... 96 
5.2.10 Scoring ............................................................................................................ 97 
5.2.11 Analysis ........................................................................................................... 98 
5.2.12 Attrition ........................................................................................................... 99 
5.2.13 The Consensus Meeting Methods ................................................................... 99 
5.2.14 Ethical considerations ................................................................................... 103 
5.2.15 Data Use and Storage .................................................................................... 103 
5.3 RESULTS ...................................................................................................... 104 
5.3.1 Overview ......................................................................................................... 104 
5.3.2 “Long to short” list of outcomes ..................................................................... 105 
5.3.3 Cognitive Interviews ....................................................................................... 111 
5.3.4 The Delphi survey results ............................................................................... 112 
5.3.5 The Consensus Meeting .................................................................................. 120 
5.4 DISCUSSION ................................................................................................ 131 
5.4.1 Main findings .................................................................................................. 131 
5.4.2 “Long to short” list of outcomes ..................................................................... 132 
 xiv 
5.4.3 Delphi survey- number recruited .................................................................... 132 
5.4.4 Delphi Survey- attrition .................................................................................. 133 
5.4.5 Delphi Survey- participants ............................................................................ 134 
5.4.6 Delphi survey- results of the scoring .............................................................. 135 
5.4.7 Consensus Meeting- numbers and participants............................................... 138 
5.4.8 Consensus meeting- voting ............................................................................. 138 
5.4.9 Consensus meeting- the core outcome set ...................................................... 140 
5.4.10 Consensus meeting- feedback ....................................................................... 141 
5.4.11 Impact of patient involvement in the consensus process .............................. 141 
5.4.12 Limitations .................................................................................................... 142 
5.4.13 Summary and Next steps .............................................................................. 143 
Chapter 6: Overall Discussion .............................................................................. 145 
6.1 SUMMARY OF MAIN FINDINGS ............................................................. 145 
6.2 STRENGTHS ................................................................................................ 146 
6.3 LIMITATIONS .............................................................................................. 147 
6.3.1 Participant diversity ........................................................................................ 148 
6.3.2 Pain outcomes ................................................................................................. 150 
6.4 IMPLEMENTATION .................................................................................... 151 
6.4.1 Patient involvement in uptake ......................................................................... 152 
6.5 IMPLICATIONS ........................................................................................... 153 
6.6 APPLICATIONS IN OTHER SETTINGS .................................................... 153 
6.7 FUTURE FURTHER WORK ....................................................................... 154 
6.7.1 Clarification of pain outcomes ........................................................................ 154 
6.7.2 “How” outcomes are measured ....................................................................... 154 
6.7.3 Definition of the time between onset of CES to intervention ......................... 156 
6.7.4 Timing of surgery and relation to outcomes ................................................... 156 
6.8 CONCLUSIONS............................................................................................ 157 
References ............................................................................................................... 158 
 xv 
APPENDICES ........................................................................................................ 176 
Publications ............................................................................................................ 231 
 1 
Chapter 1: General Introduction 
 
1.1 CAUDA EQUINA SYNDROME 
Cauda equina syndrome (CES) was first described in the English literature by Mixter 
and Barr in 1934.
1
 Compression of the lumbosacral nerve roots beneath the conus 
medullaris results in sensory-motor symptomatology of the lower limbs and 
sphincters. Symptoms and signs include low back pain, saddle anaesthesia, unilateral 
or bilateral sciatica, distal motor weakness in the legs, bladder dysfunction, bowel 
dysfunction and sexual dysfunction.
2 3
 However, CES is a clinical-radiological 
diagnosis as clinical signs are not particularly specific to a CES diagnosis.
4 5
 A 
lumbosacral magnetic resonance imaging (MRI) is required for diagnosis. A 
systematic literature review regarding the definition of CES in 105 articles found 17 
different definitions. No single definition of CES within the literature achieved 
consensus but a majority view indicated that there would be bladder and sensory 
disturbance in 74% and 66% of articles respectively.
6
 There were 14 different 
descriptions of bladder involvement, 10 of bowel involvement, 6 of pain, 5 of sexual 
dysfunction, 7 of sensory involvement, 10 of power and 7 of reflex involvement.
6
 
The definition of CES was proposed as:
6
 
1) bladder and/or bowel dysfunction, 
(2) reduced sensation in the saddle area 
(3) sexual dysfunction, with possible neurologic deficit in the lower limb 
(motor/sensory loss, reflex change). 
The annual incidence of CES is 2 per 100,000 in England and it is an indication for 
emergency spinal decompression surgery.
7-9
 Given the low incidence of CES, it may 
only be seen by a general practioner once in their entire career.
10
 The management of 
CES involves many hospital specialties
11
 including Neurosurgery, Orthopaedics, 
Anaesthetics, Emergency medicine, Neurology, Neuro-rehabilitation and Radiology.  
It is estimated that 45% of CES cases are due to a herniated lumbar disc, which is 
the most common cause.
12
 Only 2% of all herniated lumbar discs result in CES.  The 
most common levels involved are L4–L5 and L5–S1. Other less common aetiologies 
include spinal stenosis due to degenerative bone-related changes, spinal tumours, 





1.2 TIMING OF INTERVENTION AND OUTCOMES 
A clinical outcome describes an event that happens because of disease or 
treatment,
13
 which relate to a patient’s symptoms, overall mental state or how the 
patient functions. There is considerable debate regarding appropriate timing of 
surgery for CES to improve outcomes.
14-20
 This is the time between which the 
patient has CES and when they have an operation. A meta-analysis
17
 recommended 
operating within 48 hours of onset of CES symptoms, provided a significant 
improvement in the outcomes of sensory and motor deficits as well as urinary and 
rectal function for patients. This seminal paper by Ahn et al, 2000 is what had 
constituted the widespread recommendation for early surgery. A commentary
21
 had 
re-analysed the raw data from this article and concluded that there was actually a 
significant clinical benefit by operating within 24 hours as opposed to after. 
However, results in certain other studies suggest that delayed surgery may provide 
positive outcomes as well.
22 23
 Other studies have been unable to show a difference 
in outcomes by operating early for CES.
15 24
 Gleave and McFarlane, 2002
8
 stressed 
the importance of categorising CES into CES incomplete (CESI) and CES complete 
with urinary retention (CESR) (Table 1.1). The more severe presentation of CESR 
describes painless urinary retention with overflow incontinence and complete 
perianal sensory loss. When the patient complains of CESI, the symptoms include 
urinary issues of neurogenic origin including loss of desire to void, altered urinary 
sensation, and hesitancy with partial saddle anaesthesia.  
 
Table 1. 1 Symptoms relating to CESI and CESR. 
CESI CESR 
Lumbar +/- leg pain Lumbar +/- leg pain 
Motor or sensory deficit in lower limbs Motor or sensory deficit in lower limbs 
Urinary issues of neurogenic origin 
including loss of desire to void, altered 
urinary sensation, and hesitancy 
Painless urinary retention with overflow 
incontinence 
Partial saddle anaesthesia Complete perianal sensory loss 
Anal sphincter tone reduced Faecal incontinence 
 
 3 
In fact, a meta-analysis of observational studies in CES
23
 highlighted the importance 
of categorising CES into these subtypes and that early surgery did make a clinically 
significant difference in terms of urinary function even in patients with CESR. 
However, several assumptions and judgements were made of the data in order to 
perform statistical analysis and best evidence synthesis, which reflects that the level 
3 evidence regarding CES is difficult to interpret. 
Srikandarajah et al, 2015
18
 showed that operating within 24 hours in patients with 
CESI showed a statistically significant improvement in their bladder function 
compared to CESR where no difference in the outcome of bladder function was seen 
regardless of operating within a certain timeframe. This was a single centre 
retrospective study looking at a single outcome with the inherent limitations of 
retrospective data interpretation and using a local population. More recently a meta-
analysis
25
 of individual patient data in the literature proposed a new category of early 
stage of CES (CESE) to be considered as the early starting point of CES progression. 
CESE symptoms include bilateral sensory motor defects in the lower extremities. In 
a retrospective cohort study of a US nationwide inpatient database, 4,066 inpatients 
with CES from 2005-2011 were analysed.  Complete CES patients (CESR) and 
having interventions beyond 48 hours were seen to have a higher odds for 
unfavourable discharge, prolonged post-surgical length of stay and higher hospital 
charges compared to incomplete CES patients operated within 48 hours.
26
 This data 
relates to health economic costs for US patients, the data is susceptible to biases 
from incorrect coding errors, only short term in-patient stay is analysed and long 
term care is not addressed, and admission to hospital is incorrectly interpreted as the 
onset of CES symptoms. In fact, it is generally accepted within the literature that 
surgical decompression must be done as soon as possible if required. However, 
many of the studies as highlighted previously are of level 3 evidence and have 
inherent flaws.  
 
Questions do arise about the long-term outcomes confronted by CES patients rather 
than in the immediate post-operative recovery period. There is little in the literature 
regarding long term prognosis, which was emphasised by Korse et al, 2013
27
 who 
independently decided to focus on outcomes of micturition, defecation and sexual 
function. Bias in studies, lack of universal definitions and incomplete follow up data 
was seen in this systematic review. This was followed by the same team doing a 
 4 
retrospective study looking at the outcomes of micturition, defecation and sexual 
function without verifying its importance with key stakeholders.
28
 It can be seen 
from our initial scoping searches that different outcomes were being measured in 
different CES studies and there was no uniformity or standard.  
 
1.3 ECONOMIC IMPACT 
As mentioned before, timely decompression within 48 hours for CES secondary to a 
herniated lumbar disc could lead to improved outcomes in patients.
17
 In fact, a delay 
or missed diagnosis of this condition incurs heavy litigation costs to the NHS at 
£336,000 (US $549,427) per case on average
29
 as reported to the Medical Defence 
Union in the UK. According to the NHS Litigation Authority, 293 claims for CES 
occurred between 2010 and 2015. In this time, the total cost for the NHS was 
£25,200,000 including damages, defence and claimant costs (nhsla.com). The 
majority of CES patients will have varying levels of pain and/or residual 
neurological deficits that hinder their return to baseline functionality.
30
 On average, 
20% will require ongoing support with catheterisation, colostomy, sexual function, 
physical rehabilitation and psychosocial issues.
3
 Although a rare condition in the 
population mainly occurring in working age adults, the National Spinal Task Force
31
 
showed that there were 981 operations done in 2010-2011 for CES in the UK. This 
is also only CES where a surgical decompression has been performed so there will 
be more cases where an operation was not performed and the condition was treated 
medically or conservatively. This means that there are possibly over 1000 CES cases 
per year in the UK itself and the economic burden of severe disability is a worrying 
unknown for both patient quality of life and development 
32 33
 of appropriate health 
services.  
 
1.4 WHAT IS A CORE OUTCOME SET? 
A commentary in the Lancet journal stated that up to 85% of research was wasted 
with issues related to low priority questions being addressed, important outcomes 




A core outcome set (COS) is “an agreed, standardised set of outcomes to be 
measured and reported, as a minimum, in all trials in a particular health area.”
35
 The 
aim of a COS is to reduce outcome heterogeneity, reduce outcome reporting bias and 
 5 
include outcomes that matter to key stakeholders, including patients, so research is 
relevant to the audience it is intended to effect.  
The Core Outcome Measures in Effectiveness Trials (COMET) database documents 
ongoing core outcome set studies to minimise duplication and foster health service 
user engagement.
32 33
 There are no existing studies in the literature or on the 
COMET database regarding a core outcome set for CES and there is no transparent 
process where key stakeholders have been brought together to identify what the 
important outcomes are in CES. The World Health Organisation (WHO) recognises 





1.5 SCOPE OF THE CAUDA EQUINA SYNDROME CORE OUTCOME SET 
(CESCOS) 
We intend to develop a core outcome set to address the short and long-term 
outcomes for patients who have cauda equina syndrome. Table 1.2 describes the 
scope in more detail. 
 




All severities of Cauda Equina Syndrome 
Definition Definition of CES into CESI and CESR as proposed by 
Gleave and McFarland 20028 
Population Adult humans 
Geography Apply to any developed country with an established 
healthcare system 
Intervention Surgical or medical management of Cauda Equina Syndrome 
Outcomes Short and long term  
Intended Use For research studies into patients who have CES 
 
The health condition this applies to is called CES, which has been discussed above. 
The population this COS is to be used for, are adults in a country with an established 
healthcare system. The intervention is either surgical or medical management of 
 6 
CES. If there is a compressive lesion it is usually addressed through surgical 
decompression and if the aetiology is non-compressive then medical management 
would be applied. The COS will be developed to encompass all severities of CES 
presentations. 
We are trying to identify “what” outcomes are of concern to key stakeholders in the 
short and long term with transparent methodology but we are not intending to 
validate “how” to measure these outcomes in this study. A core outcome set 
developed for hip fracture trials used a nominal group technique to ascertain “what” 
outcomes to measure and “how” to measure them in the same questionnaire.
37
 The 
CESCOS study team felt that to try and establish the “how” seems premature when 
“what” outcomes are important to key stakeholders have not been decided.  
 
1.6 RATIONALE FOR THE DEVELOPMENT OF THE CESCOS 
Through scoping searches, no randomised controlled trials were identified for this 
condition. Few prospective studies and many retrospective studies for the clinical 
outcomes of patients with CES were identified. There seemed to be variation in the 
outcomes measured and their definitions between CES studies. There is even 
variation in the definition of CES.
6
 This has been seen when developing other core 
outcome sets such as in colorectal cancer and bariatric surgery regarding variations 




In other healthcare areas, such as childhood asthma and oesophageal cancer, 
researchers and clinicians have been guilty of choosing outcomes that suit their 
needs rather than those of most importance to patients and clinicians especially with 
a lack of addressing long term outcomes.
40-43
 In addition, examples are seen where 
patients have identified the outcome as important to them that clinicians would not 
have considered if developing the COS by themselves.
44 45
 Conversely, healthcare 
professionals (HCPs) have identified areas where patients are embarrassed or 




This reduces the amount of data contributable for systematic reviews and meta-
analyses
47
 leading to difficulties interpreting the effects of intervention and making 
evidence based healthcare decisions more difficult. Without evidence based short 
and long term management plans in CES, it makes the decision of follow up and 
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support for these patients under the discretion of the clinician, which can vary on 
their professional experience. In the PARTNERS2 study, physical health or social 
health outcomes were discussed with patients who had a diagnosis of bipolar 
disorder or schizophrenia and HCPs who managed them. These stakeholders talk 
about subtly different outcomes highlighting the importance of involving both 
parties in the consensus decision making process
48
. Other qualitative studies 
previously have witnessed this phenomenon
45 49
 and found that patients may add 
outcomes not previously considered
50
. A national advisory group for public 
involvement in NHS research advocates involvement of patients because “they are 
the participants in trials and ultimately the people for whom research will benefit.”
51
 
There are different consensus techniques available for designing clinical guidelines. 
Methodological decisions may affect the overall quality of the final consensus
52
 
hence decisions are explained regarding methodology in the appropriate sections of 
this thesis.  
 
1.7 HYPOTHESIS  
1. In research studies of CES there is no consensus regarding the most important 
outcomes to report and measure and a lack of definitions of the outcomes.  
2. Outcomes important to CES patients are not being represented in the current 
medical literature 
3. Key stakeholders (e.g. patients and HCPs) in the rare condition of CES can be 
brought together to decide a core outcome set. 
 
1.8 AIMS AND OBJECTIVES  
Current practice is based upon level 3 retrospective evidence and expert consensus 
of HCPs.
53
 Currently there is no defined COS for patients who have CES. This is 
one of the most common conditions for which an emergency spinal operation 
performed.  
The aim of this study is to develop a COS for CES for future research studies with 
involvement of key stakeholders. This would be a novel contribution to the existing 
literature. The long-term aim, which is not within the remit of this study, would be to 
identify the ideal measurement tools for these outcomes
54
 and to conduct a 
prospective multi-centre observational or cluster randomised international study 
looking at patients who have been diagnosed with CES. This would help answer 
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questions such as how timing affects outcomes in CES and if appropriate services 
are available for CES with clear methodology and a stronger evidence base.  
 
The objectives for the CESCOS study will be: 
1} To complete a systematic literature review of outcomes in CES. 
2} Undertake qualitative interviews with CES patients to identify what outcomes are 
important to them and analyse significant themes. 
3}To prioritise the long list of outcomes from the systematic literature review and 
qualitative interviews to a short list of outcomes to be rated in the Delphi survey. 
4} Complete two rounds of an international Delphi survey with key stakeholders. 
5} Undertake an international consensus meeting with key stakeholders to develop 
the core outcome set. 
6} To publish in a high impact journal and present the CESCOS at relevant national 
and international meetings and conferences.  
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Chapter 2: Systematic literature review of 




The previous thesis chapter of the overall introduction explained what Cauda Equina 
Syndrome (CES) is and what a core outcome set (COS) means. It was identified that 
there is no COS for CES, which is to the detriment of patients and health care 
services. The aim of this systematic literature review (SLR) is to inform the future 
development of a COS by identifying all reported outcomes for patients following 
surgery in CES, document if they are defined and to assess what variability there is. 
The SLR is the first step to inform the development of a COS
55
 for patients who 
have undergone surgery for CES to be used in research and in practice.   
 
2.1.1 Systematic literature reviews in core outcome set development 
Systematic literature reviews have previously been used to inform the development 
of core outcome sets.
38 39 41 56-58
 They provide the list of outcomes that have been 
reported in the literature. A systematic review of outcomes in COS studies found 
that
59 60
 57 studies (25%) were seen to conduct a SLR. Outcomes that tend to be 
important for patients are deficient in the literature.
35 61
 A SLR of outcomes used in 
trials of inhaled corticosteroids in childhood asthma showed that the majority of 
studies included outcomes related to short term disease activity while only 16% were 
regarding functional status and 13% measured quality of life.
41
 A SLR of all 
oncology interventional studies between 2007 and 2010 on clinicaltrials.gov showed 
that 25,000 outcomes were identified from 8943 studies, which were only used once 
or twice.
62
 This limits evidence synthesis when trying to combine the data. Outcome 
reporting bias is selectively reporting a part of the measured outcomes based on the 
results obtained. A SLR of the empirical evidence of study publication bias and 
outcome reporting bias showed that 40 to 62% of studies had at least one primary 
outcome that was changed, omitted, or introduced.
63 64
  Another study looking at 
outcome reporting bias in randomised trials showed that 28% of 519 randomised 
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trials demonstrated at least one unreported harm outcome. It was also shown that 
statistically significant outcomes had a higher odds of being fully reported than those 





This study has been registered as 824 on the COMET (Core Outcome Measures in 
Effectiveness Trials) database (http://www.comet-initiative.org/studies/details/824). 
Table 2.1 lists the inclusion criteria applied to the search strategy. 
 
Table 2. 1 Inclusion criteria for the systematic literature review. 
Inclusion criteria 
Diagnosis of Cauda Equina Syndrome 
Patients have undergone surgery for the pathology causing Cauda Equina 
Syndrome 
Randomised controlled trials, non-randomised controlled trials, prospective and 
retrospective cohort studies and case series 
Human studies 
English language 
Five or more patients  
Published between 1990 to 30/9/16 
Adult patients aged 16 and above 
 
2.2.1 Search strategy 
Multiple databases were used to maximise the sensitivity of the search. We searched 
Medline, Embase and CINAHL Plus (Cumulative Index to Nursing and Allied 
Health Literature). Medline and Embase are known to be highly relevant to the 
medical literature and CINAHL Plus was chosen as it is a good source of studies 
conducted by nursing researchers unique from other databases.
66
 Scoping searches 
were performed using the key terms listed below (Table 2.2) including Google 
Scholar to refine the searching criteria into being more specific and relevant but still 
inclusive of other studies.  
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Table 2. 2 Key search terms used in the scoping search 
Disease process Intervention Study design 
Cauda Equina Laminectomy Trial 




 Surgery or surgical Case Series 
 Discectomy or diskectomy  
 
The search strategy for each database is available in Appendix 2.1. Online trial 
registries included Clinical Trials.gov, EU clinical trials registry and ISRCTN 
(International Standard Randomised Controlled Trials Number) registry. The trial 
registries were searched for any completed or on-going trials in surgery for CES. 
The study design was chosen to include observational cohort studies as this where 
most of the evidence for outcomes after surgery in CES exist. Reviews, case reports, 
letters, correspondence, abstracts and conference proceedings were excluded in the 
initial search term due to difficulty with dealing with incomplete information, 
delivering many unnecessary irrelevant studies and collecting rare outcomes that 
were very unlikely to influence clinical practice. Studies with chemotherapy and 
radiotherapy were excluded as the adverse outcomes related to undergoing such 
treatment could overshadow the surgical outcome for CES. Patients who underwent 
repeat surgery for CES would still be included. Studies were restricted to the English 
language due to the resource and financial restrictions of the study.  
 
A review of the past 24 months is recommended
33
 as a minimum to identify relevant 
outcomes for the COS.  It was decided to include studies published after 01/01/1990 
to keep investigation (post MRI era) and surgical management of CES in line with 
current medical practice. Only quantitative studies were included. All age groups 
were considered as if a study contained a majority of adults and a minority of minors 
it would still have been included. The search was limited to all studies except 
animals. It has been seen that studies with humans are not always identified in the 
key terms as “humans,” so are at risk from being undetected when the search criteria 
is limited to humans.
67
 Citations were collated with Endnote X7 referencing 
programme (Thomson Reuters, New York, NY, USA) and duplicates removed.  
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2.2.2 Data Extraction 
Initially publications were reviewed by title and keywords and included if relevant 
or uncertain. Second stage involved reviewing all abstracts of uncertain and included 
studies to see if they were relevant. The full manuscripts of included articles were 
obtained using the University of Liverpool library search facilities. Titles and 
abstracts were screened by one reviewer (NS) using the pre-set inclusion criteria as 
in Table 2.1. Ten percent of included papers were randomly checked for suitability 
by the clinical supervisors (SC, MW, TM) and any discussion regarding uncertainty 
of eligibility criteria applied to the search results was discussed with them. 
Outcomes are recommended to be extracted verbatim from the included studies of 
the SLR.
68
 For example, in a review of outcomes in bariatric surgery there were 41 
verbatim outcome terms for weight loss.
39
 These verbatim outcome terms were all 
condensed to one outcome when using it for the Delphi survey, which will be 
described in Chapter 5. Extraction of the outcome definitions and measurement 
instruments is recommended from the source document to use at the later stage of 
“how” to measure these outcomes.
33
 A Data Extraction form was used to collect data 
on study design and location, patient demographics, timing of operation, definition 
of CES, diagnosis, aetiology, surgical procedure, follow up duration, outcome 
terminology, outcome definition and assessment tool. A Preferred Reporting Items 
for Systematic Reviews and Meta Analyses (PRISMA) flowchart was produced 





Below are the definitions for the main terms used in the analysis of this SLR.  
 
1. Core outcome domain- The overall category to which similar subdomains and 
outcomes are listed under. The outcome domains/ taxonomy that we have used, have 





 and is being piloted for use in Cochrane reviews and within 
the Cochrane linked data project.
72
 These are listed in bold in Table 2.4  
 
2. Subdomain- A subcategory of a core outcome domain to which similar outcomes 
are listed under. These are listed in normal script in Table 2.4 
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3. Outcome- An outcome documented in an article after a patient has had an 
operation for CES. For example, Nervous system (core outcome domain)> Bladder 
function (subdomain)> Urinary incontinence (outcome). 
 
4. Variations- Variations were also documented, which means the number of 
different terms used to define a core outcome domain or subdomain. An example of 
a variation is given in the superscript of Table 2.5 
 
5. Outcome definition- this was categorised as “no definition” or “definition 
present.” If a definition was present it could be subjectively a complete or partial 
definition but was recorded as “definition present”. “No Definition” indicates the 
outcome domain was mentioned with no accompanying definition in the article or 
assessment tool. An example of how an outcome definition was done is given in the 
superscript of Table 2.5 
 
2.3 RESULTS 
A total of 1,873 articles were identified by electronic database searches. 
 
1. Medline (650) 
2. Embase (949) 
3. CINAHL Plus (239) 
4. Registries (35) included Clinical Trials.gov (5), EU clinical trials registry (12) and 
ISRCTN (International Standard Randomised Controlled Trials Number) registry 
(18). 
 
The PRISMA flowchart in Figure 2.1 shows the process during the systematic 
literature review. Following inclusion criteria in Table 2.1 resulted in 1,838 articles 
plus the 35 studies from the online registry search giving a total of 1,873 studies. 
Ten percent of included studies were reviewed by a clinical supervisor (TM, MW or 
SC) to assess if inclusion criteria had been applied adequately and agreement was 
achieved after discussion amongst us.  Uncertainty regarding eligibility of certain 
full text articles for inclusion were discussed with the clinical supervisory team 
(MW, SC, TM) and settled leading to 61 included articles. After the full text was 
 14 
obtained, 34 articles were excluded and the reasons for this were given as in Figure 
2.1 
 































Records identified through 
database searching 
(n = 1838) 
Additional records identified 
through other sources 
(n = 35) 
Records after duplicates removed 
(n = 1633) 
Records screened 




assessed for eligibility 
(n = 95) 
Less than 5 patients operated: 
14 
Unable to retrieve: 9 
Outcomes not after surgery: 8  
Incorrect diagnosis: 1 




Studies included in 
quantitative synthesis  

















Summary details, patient demographics and how many studies they were reported in 
out of the 61 included studies are detailed in Table 2.3 Most studies (90.2%) were 
retrospective. CES was not defined in 20 studies (32.8%). Even in the articles where 
CES is defined there were many differing definitions. The most common definition 
was Cauda Equina Syndrome Incomplete (CESI) and Cauda Equina Syndrome with 




Table 2. 3 Summary characteristics and demographics of included studies 
Characteristic (number of studies reported) Value 
Study design (61)   
Retrospective cohort 55 
Prospective cohort 6 
Location (61)  
Europe 32 
North America 15 
South America 1 
Asia 13 
Single Centre  57 






Mean follow up period post-surgery (54) 8.4 yrs 
Range 1-38 yrs 
Median number of CES patients (61) 14 
Range 5 to 11,207 
Mean age (53) 45.5 
Range 20.5-70 
Median follow up (43) 31 months 
Range post op-29yrs 
CES definition (61)  
Defined 41 
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Not defined 20 




Aetiology (59)  
Disc Herniation 34 
Degenerative 4 




Main Surgical Method (51)  
Laminectomy & Discectomy 15 
Laminectomy 14 




A total of 737 outcomes were reported in the 61 included articles.
18-20 30 73-129
 For 
ease of analysis in this study, these reported outcomes have been categorised to one 
of the 20 core outcome domains (Table 2.4). The nervous system core outcome 
domain had 10 subdomains, and the physical functioning has two subdomains 
(Table 2.4). All different variations in the description of outcomes can be seen in 
Appendix 2.2 linked to the outcome domains.  
 
Figure 2.2 shows the number of articles in which specific outcomes were reported. 
Bladder function, motor, sensation, bowel function, leg pain and lower back pain 
were the most commonly reported in descending order. They are all within the 
Nervous System core outcome domain. Also, for each outcome, the number of 
articles where it is defined and not defined is documented. Figure 2.2 also shows the 





Table 2. 4 Core outcome Domains (in bold) and subdomains 
Mortality Role Functioning 
General Disorders Social Functioning 
Nervous System Outcomes Emotional Functioning 
Bladder Function  Global Quality of Life 
Motor Function Hospital Use 
Sensation Need for Intervention 
General Neurology Adverse Events 
Lower Back Pain  Infection 
Leg Pain Skin and Subcutaneous Tissue 
Bowel Function Vascular 
Perianal sensation Outcomes related to neoplasms 
Perianal Tone Urological and Renal 
Reflexes Cardiac  
Physical Functioning  Blood and Lymphatic 





Figure 2. 2 Stacked bar chart showing total number of articles where the 
outcome was reported and the proportion of those defined (blue) and those not 
defined (red). Also for each outcome the number of articles which have used an 
assessment tool for a reported outcome (green) and the number that have not 
(orange). Outcomes are listed from most to least reported. 
 
 
Table 2.5 shows the raw data for each outcome showing how many studies each 
outcome is reported in, the total number of outcomes, the number of variations in the 
description of the outcome, if a definition is present or not in the reported studies 
0 5 10 15 20 25 30 35 40 45 50
Bladder Function (Nervous System)
Motor Function (Nervous System)
Sensation (Nervous System)
Bowel Function (Nervous System)
Leg Pain (Nervous System)
Lower Back Pain (Nervous System)
General Neurology (Nervous System)
General disorders
Skin and Subcutaneous Tissue
Mortality
Perianal Sensation (Nervous System)
Sexual Function (Physical Functioning)
Walking (Physical Functioning)
Adverse Events
















Definition present Defintion absent Assessment present Assessment absent
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and the number of assessment tools for the reported outcome. Table 2.6 shows the 
various assessment tools used for each outcome. 
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Table 2. 5 Raw data for each outcome showing how many studies each outcome is reported in, the total number of outcomes, the 
variations for each outcome, if a definition is present or not in the reported studies and the number of assessment tools for 
reported outcomes. Outcomes are listed in order of decreasing frequency of reported studies. 







Definition present in 
reported studies (%) 
Assessment tool in 
reported studies (%) 




 13 (30.2) 
Motor Function (Nervous System) 39 (63.9) 62 36 9 (23.1) 16 (41) 
Sensation (Nervous System) 31 (50.8) 53 26 6 (19.4) 6 (19.4) 
Bowel Function (Nervous System) 28 (45.9) 60 47 7 (25) 8 (28.6) 
Leg Pain (Nervous System) 27 (44.3) 32 16 5 (18.5) 7 (25.9) 
Lower Back Pain (Nervous System) 26 (42.6) 31 13 4 (15.4) 9 (34.6) 
General Neurology (Nervous System) 22 (36.1) 31 21 3 (13.6) 8 (36.4) 
Skin and Subcutaneous Tissue 19 (31.1) 22 15 5 (26.3) 0 (0) 
General disorders 19 (31.1) 44 36 6 (31.6) 6 (31.6) 
Mortality 18 (29.5) 25 13 6 (33.3) 0 (0) 
                                                     
1
 An example of analysing the variation of terminology used for Bladder Function outcome domain: “Urinary incontinence” “Bladder dysfunction” and “Urinary retention” are 3 
variations of the way this outcome domain is described. 
 
2
 2 examples of how Bladder Function outcome domain was classified with definition present: 1) Retention of Urine – “the inability to pass urine necessitating urinary 
catheterisation”. This study was retrospective and relied upon adequate documentation in the patients’ clinical notes. Residual urine volumes were only available in 11 patients 
(all greater than 300millilitres) whereas 24 patients were documented to be in urinary retention. Urinary retention at follow-up comprised those patients requiring catheterisation 
to enable them to empty their bladder and also those patients who reported incomplete bladder emptying. (McCarthy et al, 2007). 2) Urine retention diagnosis was clinical (a 
bladder that required catheterisation). (Foruria et al, 2016) 
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Perianal Sensation (Nervous System) 17 (27.9) 23 16 5 (29.4) 0 (0) 
Sexual Function (Physical 
Functioning) 16 (26.2) 46 41 6 (37.5) 6 (37.5) 
Walking (Physical Functioning) 16 (26.2) 28 25 3 (18.8) 5 (31.3) 
Adverse Events 12 (19.7) 16 12 8 (66.7) 0 (0) 
Role Functioning  11 (18) 20 20 3 (27.3) 7 (63.6) 
Perianal Tone (Nervous System) 11 (18) 16 13 2 (18.2) 0 (0) 
Need for Intervention 10 (16.4) 13 13 6 (60) 0 (0) 
Infection 10 (16.4) 11 8 1 (10) 0 (0) 
Vascular 8 (13.1) 13 5 0 (0) 0 (0) 
Hospital Use 5 (8.2) 8 6 0 (0) 0 (0) 
Global Quality of Life 5 (8.2) 8 6 3 (60) 4 (80) 
Reflexes (Nervous System) 4 (6.6) 7 7 0 (0) 0 (0) 
Emotional Functioning  4 (6.6) 7 7 1 (25) 3 (75) 
Respiratory 4 (6.6) 4 5 0 (0) 0 (0) 
Outcomes relating to neoplasms 3 (4.9) 5 3 0 (0) 0 (0) 
Urological and Renal 3 (4.9) 3 3 0 (0) 0 (0) 
Cardiac 3 (4.9) 3 2 0 (0) 0 (0) 
Social Functioning 2 (3.3) 2 2 0 (0) 2 (100) 
Blood and Lymphatic 2 (3.3) 2 2 0 (0) 0 (0) 




Table 2. 6 Assessment tools are listed in alphabetical order for the corresponding reported outcomes. 
OUTCOME 
DOMAIN 
ASSESSMENT TOOLS  
Bladder Function 
(Nervous System) 
25 item questionnaire (Fukui et al, 2011)/ Bristol Female Lower Urinary Tract/ Cystometry/ Functional Independence 
Measurement/ Gibbon’s criteria/ Gleave and McFarland, 1990/ Hannover pelvic scoring system/ International 
Continence Society male questionnaire/ Japanese Orthopaedic Association score / Modified Odom's criteria/ Short 
Form Incontinence Questionnaire/ Urodynamics 
Motor Function 
(Nervous System) 
American Spinal Injury Association Score/ Frankel grading/ Gibbon’s criteria / McCormick scale/ MRC grading/ 
Modified Odom's criteria 
Sensation  
(Nervous System) 
American Spinal Injury Association Score/ Frankel grading/ Gibbon’s criteria / McCormick scale/ Modified Odom’s 




25 item questionnaire (Fukui et al, 2011)/ Chronic idiopathic constipation index / Faecal incontinence questionnaire 
(Jorge et al 1993)/ Functional Independence Measurement/ Hannover pelvic scoring system/ Modified Odom’s criteria/ 
Nanko evaluation system/ Short Form Incontinence Questionnaire/ 
Leg Pain  
(Nervous System) 
Benoist et al 1993/ Japanese Orthopaedic Association score/ Visual Assessment Score 
Lower Back Pain 
(Nervous System) 
Low Back Outcome Score/ Oswestry Disability Index/ Short Form Health Survey 36/ Visual Assessment Score 
General Neurology 
(Nervous System) 
American Spinal Injury Association Score/ Baba et al, 1995 study questionnaire/ Frankel grading/ Gibbon’s criteria/ 
Japanese Orthopaedic Association score/ McCormick's scale 
General disorders 
 
Epstein & Hood/ Nanko evaluation system/ Prolo economic and functional scale/ Short Form Health Survey 36/ 
Spengler classification/ Visual Assessment Score 
Sexual Function International index of erectile function/ Male sexual health inventory/ McCormick scale/ Modified Odom’s criteria/ 
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(Physical Functioning) Nogueira et al. 1990/ Sheffield Female pelvic floor questionnaire/ Japanese Orthopaedic Association score 
Walking  
(Physical Functioning) 
Baba et al 1995/ Functional Independence Measurement/ Japanese Orthopaedic Association score/ McCormick scale/ 
Short Form Health Survey 36 
Role Functioning  
 
Chronic idiopathic constipation index/ Kirkaldy Willis classification/ Nanko evaluation system/ Oswestry Disability 
Index/ Prolo economic and functional scale/ Short Form Incontinence Questionnaire 
Global Quality of Life 25 item questionnaire (Fukui et al, 2011)/ Oswestry Disability Index/ Short Form Health Survey 36 
Emotional 
Functioning  
Functional Independence Measurement/ Kelleher et al 1997 questionnaire/ Short Form Health Survey 36 




This systematic review shows that there is significant heterogeneity in the outcomes 
measured for patients who have undergone surgery for CES with no consensus 
regarding which outcomes should be used or reported.  
 
Most of the evidence regarding outcomes for CES patients after surgery is derived 
from level 4 evidence, namely single centre retrospective cohort review studies. The 
average data collection period was over 8 years with a median number of 14 patients 
per study, which highlights the rare nature of the condition and difficulty in 
collecting meaningful data retrospectively. This feeling is also echoed by Todd and 
Dickson, 2016.
130
  Since 1990 the number of publications analysing outcomes after 
an operation for CES have increased with the most being produced in the last 5-year 
period (43.5%). Median follow up was at 31 months reflecting the deficiency in the 
literature for any long-term outcomes.  
 
The main investigation is MRI, which reflects the SLR focusing on studies from 
1990 onwards. Before this there may have been a reliance on myelography and CT 
to radiologically identify CES compression. The main aetiology is disc herniation. 
There are no studies in the literature documenting the exact distribution of CES 
aetiology but the most common cause is believed to be due to disc herniation.  
 
Poor definition of CES has been previously highlighted in a SLR.
6
 Twenty studies 
(32.8%) did not define CES and of the 41 studies where a definition was present, 
there was significant heterogeneity in the definitions. The most common definition 
for CES in this review was CESI and CESR.
8
 If a study fails to define CES then we 
are unsure of the condition to which the outcomes of the study belong to.   
 
Most common surgical method in studies was a laminectomy and discectomy as 
seen in Table 2.2 but there were other studies that predominantly performed surgery 
via a microdiscectomy. Laminectomy alone, or with instrumentation was also 
mentioned for CES patients. In fact, now there is an increase in the popularity of 
endoscopic lumbar discectomy procedure,
99
 which adds to the range of procedures 
available when dealing with CES secondary to disc herniation. There is no 
consensus in the literature as to a specific decompressive procedure to be used for 
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CES secondary to compressive pathology. This is also another factor that may affect 
outcomes for these patients.  
 
In total, there were 737 outcomes reported verbatim and categorised into 20 core 
outcome domains and 12 subdomains. Instead of the same term being used for each 
outcome there exists 507 variations in terminology (Table 2.5). In addition, most of 
the outcomes in the included articles have no definition. Except for the outcomes of 
bladder function, adverse events, need for intervention and global quality of life, all 
the other outcomes had no definition in the majority of the included articles (Figure 
2.2). This highlights that there is significant heterogeneity in not only the outcome 
terminology used but the level to which it is defined in the literature. Except the 
outcomes of global quality of life, emotional functioning, role functioning and social 
functioning, most outcomes did not have an assessment tool in most of the articles 
(Figure 2.2). Fourteen of the outcome domains/ subdomains we categorised had 
multiple different assessment tools used for each of them as seen in Table 2.6. There 
is a lack of uniformity over which assessment tool is best suited for each outcome in 
the literature. If outcomes are being measured with different scales, scoring systems 
and questionnaires then it would be difficult to synthesise these results for 
meaningful analyses.  
 
There is significant heterogeneity of the outcomes for patients who have undergone 
an operation for CES, how they are defined and measured in the literature. The 
outcomes of bladder function, motor function, sensation, bowel function, leg pain 
and lower back pain are the most reported. They are all physiological core domains, 
which have been prioritised in the literature over the other core domains that relate 
to life impact, mortality, resource use and adverse events. However, there has not 
been consultation with key stakeholders regarding what outcomes are the most 
important to be justifying this practice. Involvement of key stakeholders through an 
iterative process has been employed in Rheumatology through OMERACT 
(Outcome MEasures in Rheumatoid Arthritis Clinical Trials) and in women’s health 
through the CROWN (CoRe Outcomes in Women’s and Newborns health) 
initiative.
131-133
 They have come a long way since developing core outcome sets to 
achieving a level of homogeneity among similar studies to increase the quality and 




The SLR was carried out by the main author (NS). Uncertainties and discrepancies 
were discussed with the research team (PW, TM, MW, SC, AN). Only English 
language articles were included. It would have been beneficial to have another 
independent group conduct the search strategy and data extract independently and to 
compare the results achieved. Due to limitation of resources this was not performed.  
 
2.4.2 Conclusions 
There is significant heterogeneity in outcomes reported for studies after surgery for 
CES patients and the methods by which they are measured. This indicates a clear 
need for the development of a core outcome set and the results of this systematic 
literature will be combined with the results of outcomes sourced from CES patients 
in qualitative interviews. All outcomes will then be prioritised through a Delphi 
process and consensus meeting to develop a core list of outcomes determined to be 
















Chapter 3: Systematic literature review of 
timing in surgery for Cauda Equina Syndrome 
  
3.1 INTRODUCTION 
Although not an outcome of Cauda Equina Syndrome (CES), the time between the 
onset of CES to an operation, to surgically relieve the compression is an important 
issue and of major interest to clinicians and CES patients. There is significant debate 
in the literature whether early surgery improves the outcomes with most studies 
advocating early surgery
14 17 18
 and other studies showing no difference in patient 
outcomes.
108 134
 Seeing that this is an essential question to the management it should 
be reported in all CES studies, which involve surgical intervention so the details of 
surgical timing were further analysed from the included studies in the systematic 





The included studies from the systematic literature review described in Chapter 2 
were analysed to define how timing from the onset of CES to the time of surgery 
were reported. Details collected on the data extraction form included from when the 
timing was started, what the specific symptoms were if the onset of CES was 
recorded and the details of how the timing was categorised. 
 
3.3 RESULTS 







Table 3. 1 The articles that reported timing, if they were defined, and if there 
was a definition from onset of symptoms.  
Timing from (38/61)  
 28 
Onset of symptoms 29 
Admission 3 
Trauma 5 
Not defined 1 
Definition of onset of symptoms (29/61)  
Defined 17 
Not defined 12 
 
Three of these studies categorise CES as starting when the patients are admitted to a 
hospital or when a diagnosis is made by a healthcare professional. Seventeen out of 
the 29 studies where timing was recorded from symptoms defined the symptoms but 
12 did not. Even when there was a definition for the timing, there was heterogeneity 
in the exact symptom used like urinary symptoms or autonomic onset or sphincter 
disturbance (Table 3.2).  
 
Table 3.2 lists all the 29 out of 61 (47.5%) included studies that reported the time 
duration from CES symptom onset. Twelve of these articles did not define the 
symptoms but left a generic remark e.g. timing to operation from symptoms of CES 
onset. The remaining 17 out of 29 articles defined clearly the actual symptoms, 
which were used as the starting point for the timing. However, this was not 
homogenous across the articles as they used different symptoms e.g. sphincter 
disturbance, urinary retention, urinary dysfunction and perianal anaesthesia. When 
timing was reported in 38 studies an average value in days or hours was only given 





Table 3. 2 Details regarding the time duration between CES symptoms or admission and definition of the symptoms. D: 
Defined, ND: Not defined, R: Range, M: Mean 
Timing 
from  
Paper Symptoms defined Details of Timing 
symptoms Aly et al 2014 D sphincter disturbance 1 to 3 months after sphincter disturbance 
symptoms Beculic et al 2016 ND  <2d (9 patients) 2-5d (6pts) 5-10d (5pts) 10-
30d (3pts) >30d (2pts) 
symptoms Bellabarba et al 2006 ND M: 6days R(1-30d) 
symptoms Buchner et al 2002 D onset of urinary dysfunction M: 44hrs R(4hrs-7days) 
symptoms Busseet al 2001 ND M: 6.19days R(1.6-14.3d) 
symptoms Dhattet al 2011 D perianal anaesthesia and disturbances in 
micturition 
M: 12.2 days R(1-35d) 
symptoms Domen et al 2009 D urinary retention or other alarming 
symptoms 
M: 5.8 days since autonomic symptoms and 
24hrs from admission to hospital 
symptoms Foruria et al 2016 D genitourinary symptoms <48hrs (8) >48hrs (10) 
symptoms Fuso et al 2013 ND M: 18 +/- 24 days R(5-115 days) 
symptoms Galasko et al 1991 D complete paraplegia or urinary retention <18hrs from urinary retention 
symptoms Henriques et al 2001 D 2 patients- complete paraplegia, 3 
patients- slight paraparesis, PR numbness, 
loss of tone, urinary incontinence 
24-36hrs in 3, 36-48hrs in 1, 0hr in 1 
symptoms Hussain et al 2003 D PR sensory loss or urinary dysfunction <24 hrs of admission to the unit, median of 1 
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day for urinary symptoms and 6 days for PR 
sensory loss 
symptoms Kennedy et al 1999 ND  M: 14hrs  R(6-24hrs) for good outcome group. 
Mean 30hrs R(6-70hrs) poor outcome group 
symptoms McCarthy et al, 2007 D sphinteric symptoms 5 < 24hrs, 21=24-48 hrs, 16 > 48hrs 
symptoms Ng et al 2004 ND  M: 58hrs (between symptom onset and GP 
contact) 128hrs (from GP to specialist referral) 
67 hrs (from MRI to surgery)  
symptoms Olivero et al 2009 D urinary incontinence/ retention and sacral 
numbness 
<24 hrs (6), 24-48hrs (8), >48hrs (17) R(60hrs 
to 2 weeks) 
symptoms Qureshiet al 2007 D autonomic  M: 131hrs R(6-627hrs) 
symptoms Raj et al 2008 D urinary symptoms acute (27hrs- 6 days) insidious (15d-3m) 
symptoms Schebesch et al 2016 ND <24hrs 
symptoms Sengoz et al 2011 ND  M: 4.2days R(1-10d) 
symptoms Shapiro et al 1993 D urinary symptoms R(<24hrs to more than 30 days)  
symptoms Shapiro et al 2000 D urinary symptoms M: 12.5 hrs R (7-40) for 20 patients and M: 9 
days delay for 24 other patients 
symptoms Shenet al 2014 ND  within 48hrs of CES symptoms 
symptoms Sokolowski et al 2008 D bilateral motor and sensory deficits with 
diminished rectal tone 
R(2-5d of procedure) 
symptoms Srikandarajah et al D urinary symptoms <48hrs, <72hrs >72 hrs 
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2015 
symptoms Szoverfi et al 2014 ND  M: 8.7m R(0-253 months) 
symptoms Tamburrelli et al 2014 ND  <24hrs (2) >24hrs & <36hrs (1) >48hrs (2) 
symptoms Todd et al 2011 D after Cauda Equina Syndrome with 
Retention (CESR) 
16 CESR> 48hrs, 11 CESR 24-48hrs, 7 <24hrs 
after CESR 
symptoms Wostrack et al 2014 ND  M: 24m R(4d-20yrs) 
symptoms Yamanishi et al 2003 D urinary retention M: 42 hrs  
trauma Galvin et al 2014  M: 0.8 days from injury 
trauma Sapkas et al 2008  0-15days after the injury 
trauma Schildhauer et al 2006  M: 6 days R (1-30days) 
trauma Sun et al 2010  M: 4.14d R(3-7d) 
trauma Tan et al 2012  M: 9.5days R(2-42d) 
admission Arrigo et al 2011  <24hrs 76.59% 24-48hrs 12.15% 48hrs 11.26%  
admission Kotil et al 2006  R(24hrs to 10 days), 3 within 48hrs 
admission Shi et al 2010  within 8hrs from CES diagnosis made by 
clinician 
ND Akbar et al 2002   
ND Allegretti et al 2014   
ND Ayoub et al 2012   
ND Baba et al 1995   
ND Bejia et al 2004   
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ND Bozic et al 2003   
ND Crocker et al 2008   
ND Duncan et al 2011   
ND Ea et al 2010   
ND Fukui et al 2011   
ND Gooding et al 2013  <36 hours  
ND Li et al, 2016   
ND Lyons et al 2000   
ND Marascalchi et al 2014   
ND McKinley et al 1998   
ND Morita et al 2012   
ND Okten et al 2015   
ND Podnaret al 2010   
ND Ronen et al 2005   
ND Sakai et al 2009   
ND Smith et al 1990   
ND Takahashi et al 2016   
ND Walker et al 1993   
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3.4 DISCUSSION 
The time between the onset of symptoms of CES and surgery is an important 
confounder for research studies and trials in CES. The results show that most studies 
do not satisfactorily report the time between onset of CES and surgical 
decompression. Less than half of the studies reported the time from onset of 
symptoms. Three papers recorded it from admission and this is incorrect as the 
process of CES has already started with the patient’s symptoms. When the 
symptoms are mentioned, 41% (12 out of 29 studies) did not define them. When the 
onset of symptoms are defined, the symptoms used are different. In addition, the 
time between onset of symptoms and surgery is recorded sometimes as numerical 
data and in other studies as categorical data. If outcomes are being measured from 
potentially different time points then one would not be able to synthesise these for 
meta-analysis of the data. However, this is what is being done in the literature.
16 17 21 
23
 Using the retrospective data which is heterogeneous, guidelines are produced and 
medico-legal arguments are suggested.
130 136 137
 It would be beneficial if an 
agreement can be reached regarding how to define the time between CES research 
studies so this can be standardised for future studies. 
 
For future CES research studies to report the time between CES starting and an 
operation there should be agreement over: 
 
1. Definition of the starting point of CES- is it the symptoms, presentation to 
hospital or confirmation on MRI?  
2. What symptom to record form. It can be contested that back and leg pain although 
innocuous is the start of CES whereas others might argue that it is the autonomic 
symptoms such as bladder, bowel or sexual dysfunction, which are the starting point 
of CES. Another argument maybe that bladder function is the most important 
autonomic function to record from. If it is decided that symptoms are the starting 
point of CES then there needs to be a decision regarding what specific symptom(s) it 
should be.  
3. When the timing stops. This could be when the patient is admitted to theatre, 
when the operation is finished or when the patient is discharged from hospital. 
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4. How the timing is recorded. Is it to be recorded as numerical or categorical data? 
If it is categorical should these categories be agreed on beforehand? And if it is 
numerical data what would be the unit of measurement? 
Further work regarding this concept is important and is highlighted in Chapter 6. 
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Chapter 4: Qualitative Interviews with patients 
to identify important outcomes and themes 
 
4.1 CHAPTER OVERVIEW 
The previous chapter discussed the outcomes of interest for healthcare professionals 
(HCPs) following the conduct of a systematic literature review (SLR) of the medical 
literature in Cauda Equina Syndrome (CES). 
The purpose of this chapter is to describe considerations and decision making around 
choosing the appropriate method; namely semi-structured, face-to-face interviews to 
identify patient-centred outcomes of importance for individuals with CES. .   First, 
the researcher’s philosophical and theoretical influences underpinning this choice 
will be presented. This is followed by consideration of key qualitative literature 
within this field which informed researcher decisions in relation to:  i) the utility and 
appropriateness of using qualitative methods to explore CES patient experience and 
outcomes; and, ii) the appropriateness of semi-structured, face-to-face interviews as 
the chosen method to elicit patient-centred outcomes to inform question 
development for subsequent rounds of the Delphi survey. Finally, detail around data 
collection and analytic techniques will be presented to provide a structured, iterative 
and transparent account of the process(s) undertaken to explore the experiences of 
individuals with CES. 
 
4.2 ALIGNING RESEARCH PHILOSOPHY AND METHOD 
 
4.2.1 Pragmatism and its implications 
To support the development of the philosophical basis of a research project the 
researcher must be aware of their ‘ontological’ and ‘epistemological’ stance. 
Understanding that different research paradigms exist enables the researcher’s own 
perspective and approach to be situated and understood within the context of the 
study. It is important therefore that researchers understand and articulate their beliefs 
about the nature of reality and how this knowledge might be attained. Questions 
around research beliefs need be considered to ensure the right questions are asked to 
explore and explain; otherwise knowledge of that reality could be flawed. 
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Healthcare research in general 
138
 and research in CES 
17 18
 has so far mainly adopted 
the positivistic approach. In the current study, the research paradigm of pragmatism 
139 140
 was adopted.  Pragmatists believe that the process of acquiring knowledge is a 
continuum rather than two opposing and mutually exclusive poles of either 
objectivity or subjectivity.
141
 As such, pragmatism allows for a plurality of views 
and methods to be a part of the overall research plan. In pragmatism dominance is 
given to the research question or, as in the current study, each set of research 
questions.  This means that research which brings together quantitative and 
qualitative approaches is feasible, desirable, and also required to address certain 
research questions or certain combinations of research questions.
142
 As a 
methodological approach to problem solving, pragmatism requires detection of a 
socially situated problem and adequate action to address the problem.  
In adopting this stance, the researcher believes that quantitative analysis alone 
cannot fully capture the patient perspectives. Interviews have been used to good 
effect to collect one off information from patients or carers which is then fed into 
initiatives to improve service provision or quality.
143
 Reflecting on this approach has 
enabled the researcher to consider qualitative data, derived from face-to-face patient 
interviews, as the method most appropriate to address the  research objectives for 
this phase of the study:  
Primary:  
What do patients consider are the most important outcomes in CES and what 




Who patients consider being the key stakeholders in CES? This would help form the 
categories for the stakeholder groups in the Delphi survey. 
What service improvements can be made to improve CES management and 
aftercare? 
Once the patient outcomes are identified from the qualitative data set, they will be 
combined with the HCP outcomes from the SLR to create a “long list” of outcomes 
that will form the basis for the initial round of the Delphi survey. The development 
of the long list is described in Chapter 5.  
 
The central role that the researcher can have in data-collection and analysis within 
qualitative research, means it is important – as per the COREQ guidelines– to 
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outline the ontological and epistemological stance assumed in conducting this phase 
of the research and to articulate the steps taken to ensure data quality.  
 
4.2.2 Ontological position 
Ontology refers to “the nature of our beliefs about reality.”
145
 In the current study, in 
line with pragmatism, the concept of “subtle realism” as described by 
Hammersley,
146
 was adopted. This position accepts that the social world exists 
independently of an individual subjective understanding, but it is only accessible 
through the respondent’s interpretations, which can then be further interpreted by the 
researcher. The respondent’s own interpretations of the relevant research issues are 
emphasised as important. In the context of the current study, adopting a subtle 
realism approach makes possible the examination of CES patients’ views and 
experiences within the context of their day to day concerns and priorities. This 
approach further accepts that the researcher’s representations of reality are from a 
particular point of view and it is not useful to search for a “body of data 
uncontaminated by the researcher.”
147
 This allows for multiple valid explanations of 
the same phenomena.  
 
4.2.3. Epistemological position 
Epistemology refers to “the branch of philosophy that studies the nature of 
knowledge and the process by which knowledge is acquired and validated.”
148
 
Pragmatics “recognise that there are many different ways of interpreting the world 
and undertaking research, that no single point of view can ever give the entire 
picture and that there may be multiple realities.”
149
 In facilitating this position, the 
researcher (NS) strove to be as objective and neutral as possible in the collection, 
interpretation and presentation of the qualitative data. There is of course a need to 
develop a relationship with participants when depth data is sought, which often 
requires acknowledgement of the importance of reciprocity within that 
relationship.
150
  Personal information was not provided as far as possible to 
participants during data collection. For example, the researcher’s background as a 
neurosurgical trainee was not included in the introduction to the participant, as it 
might have biased participant response for fear of their ongoing care being affected. 
However, the researcher was not a practicing clinician at the time of the interviews 
so would not have been involved in the patient’s ongoing care. Reflexivity is an 
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important concept to help progress towards objectivity and neutrality.
151
 Ways in 
which bias can enter the research process were reflected on acknowledging that the 
researcher’s professional and psycho-social background and beliefs could have 
played an important role in this. This is considered in detail in Appendix 4.6, 
“Locating Myself” 
It is important to understand peoples’ perspective in the context of their life 
circumstances and condition(s). As a result, a rich description of participants’ lives 
was aimed for; attempting to understand the phenomenon of interest in terms of the 




. The researcher’s interpretations were also 
important, which is separate to the participants. In developing the interpretations, 
participants’ accounts were closely adhered to but it was realised that deeper insights 
and interpretations in a broader context were obtained by synthesising the accounts 
of several participants.  
 
4.3 CONSIDERATION OF THE ROLE OF QUALITATIVE DATA FOR 
EXPLORING CES PATIENT EXPERIENCE AND OUTCOMES 
 
In line with the researcher’s philosophical and methodological stance, consideration 
was also given to the role and utility of qualitative data in the current literature, in 
exploring CES patient experience and outcomes.  
There are many level 3 or 4 evidence 
154
 CES quantitative studies in the literature 
which have been discussed in the SLR
135
 in Chapter 2. The outcomes elicited from 
this are understood to be representative of what healthcare professionals consider to 
be important to the management of CES.  Little is known though about what 
outcome domains are important to CES patients and it cannot be assumed patients 
would prioritise outcomes similar to HCPs. This has been described further in 
Chapter 1 under “Rationale for development of the CESCOS.” In the context of 
other core outcome sets (COS), qualitative research methods have been successfully 
used 
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 to elicit  outcomes of importance to patients.
156
 Such methods are 
considered ideal as they provide a means of studying and exploring the empirical 
world from the perspective of the subjects who are able to raise what they personally 
regard as important aspects and concerns rather than these being specified in 
advance by the researcher. To date, only 2 qualitative studies have been published 




phenomenological analysis (IPA) was used in one, which involved 11 patients who 
had experienced CES due to a prolapsed lumbar disc.
158
 When patients were asked 
about the challenges and experiences of living with CES, 3 superordinate themes 
emerged from the data-set and captured what patients reported. These centred 
around “dissatisfaction with care”, a “struggle to gain social identity in relation to 
having a ‘hidden’ disability” and “renegotiating identity following CES”. The other 
qualitative study, interviewed 10 CES patients.
157
 Major themes to emerge from that 
study included: “symptomatic pain”, “impact on life”, “common symptoms with 
varying chronology”, “sense of change/ seriousness”, and “contact with HCPs”. 
Both these studies explored lived experience of patients with CES. In contrast, for 
the current study, the outcomes of importance to participants are discussed generally 
and then they are requested to prioritise key outcomes in the context of evaluating a 
new treatment. 
Although CES is due to dysfunction of the lumbo-sacral nerves coming off the end 
of the spinal cord, it is sometimes classified within the wider spinal cord injury (SCI) 
category. SCI is an event where an individual experiences permanent or temporary 
spinal cord damage resulting in limitations of motor, sensory or autonomic function 
and major physical and sensory disabilities.
159
 SCI occurs most commonly in young 








  The mean age for CES 
patients in a systematic literature review was 45.5.
135
 A retrospective review found 
the annual incidence of CES due to disc herniation as 1.8 per million in Slovenia.
164
 
The annual incidence of SCI in developed countries is shown to vary from 11.5 to 
53.4 per million population.
165 166
 CES is also a different pathology as it involves 
lower motor neurons as opposed to SCI that involves upper motor neurones as well. 
Given CES is sometimes classified with SCI, it is pertinent to also consider what 
qualitative research involving persons with SCI has revealed. However, considering 
the differences in pathology, age affected and incidence it would be sensible to be 
cautious in directly extending SCI evidence to CES.  
A meta synthesis of qualitative studies analysing what factors contribute and detract 
from the experience of a life worth living following SCI identified 7 papers for 
analysis.
167
 Ten main concerns for SCI patients regarding quality of life were 
identified: 1) body problems, 2) injury and loss, 3) relationships, 4) responsibility for 
and control of one’s life, 5) occupation, and ability to contribute, 6) environmental 
context, 7) new values/perspective transformation, 8) good and bad days, 9) self-
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worth, 10) self-continuity. There was an overwhelming sense of loss for those 
patients concerned mainly with bodily dysfunction. Quality of life was deemed less 
when there were problems with impaired body and sense of loss.
167
 
In a quantitative systematic review of health and life priorities for SCI individuals 
four areas of function were identified as the most important: bladder, bowel, sexual 
and motor function (including arm/hand function and walking).
168
 Patients with 
tetraplegia (partial or total loss of use of all four limbs) considered arm and hand 
function to be most important whereas those patients with paraplegia only 
(impairment in motor or sensory function of the lower extremities) prioritised 
mobility as most important. The physical and psychological aspects of health and 
relationships with family and friends were also perceived important.
168
 Fatigue has 
been found to have a negative impact on quality of life for patients with SCI, 
however this health outcome was not included in the questionnaires used by any of 
the studies reviewed.  
A scoping review of secondary health conditions in SCI patients due to the condition 
analysed 92 studies.
169
 Secondary health conditions were not defined in the 
publication but examples were given such as such as pressure ulcers, pain and 
spasms. It found that secondary health conditions occurred at a higher rate in those 
with SCI compared with the normal population. The most common conditions or 
symptoms were pain, bowel and bladder regulation problems, muscle spasms, 
fatigue, oesophageal symptoms and osteoporosis. In relation to frequency and rated 
importance to patients, three health conditions were evident: pain, bladder problems 
and bowel issues.  
The aforementioned paragraphs illustrate that whilst significant qualitative research 
has been completed regarding the life effects of SCI, little CES specific evidence is 
available. A methodological review paper
144
 summarised the experiences of using 
qualitative methods in the pre-Delphi stage for three different core outcome sets. It 
showed that qualitative research can aid identification of outcomes important to 
stakeholders, help with prioritisation of outcomes, determine the scope of outcomes, 
identify the best language for use in Delphi surveys and inform comparisons 
between stakeholder data and other sources such as systematic reviews.  
In line with pragmatist philosophy it is now appreciated that using a qualitative 
approach to inform COS development is a beneficial and justified route.
33
 CES 
patients are known to be dissatisfied with the current care model. Reasons include 
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feeling neglected and disbelieved by the professional network,
158
 and perceived lack 
of clinician knowledge and appropriate communication with regards to 
management.
157
 Therefore qualitative interviews with  CES patients to address the 
objectives identified in section 4.1 – conducted and reported in line the 





4.4 METHODOLOGY  
 
4.4.1 Design 
As noted previously, following the approach described in chapter 1 of Ritchie et 
al,
151
 a pragmatic approach was employed in designing this study. Rather than the 
method being dictated by a certain epistemological position, the most appropriate 
method to address the question of which outcomes are important to CES patients 
who have undergone surgery was chosen, namely. qualitative data collection. 
Qualitative methods vary however, as an established social science technique, the 
interview (unstructured or semi-structured) is one of the main data collection tools in 
qualitative research;
171
 not least because it provides a powerful medium through 
which to enhance understanding of others.  
Participants are here seen as experts in their own experiences and, by providing them 
with a forum within which to tell their own story in their own words, they can 
provide us with an understanding of their thoughts, commitments and feelings about 
the phenomenon of interest. As noted by Jones, 1985: “In order to understand the 
other persons’ constructions of reality we would do well to ask them… and to ask 
them in such a way that they can tell us in their terms… and in a depth which 
addresses the rich context that is the substance of their meanings.” 
172
  
In the context of the current study, qualitative, semi-structured interviews were 
identified as the data collection tool most suited to the objectives given that the topic 
had not been explored to date and so would provide greater insight than could likely 
be gained from questionnaire responses. Arguably, the value of qualitative inquiry to 
underpin this phase of the study lies in its potential to give voice to the individual 
living with CES. Semi structured, face to face interviews enable participants to 
convey, in their own words, the underlying trajectory of their condition, the feelings 
associated with it and outcomes of importance to them. In this way, the opinions, 
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attitudes and beliefs of patients with CES can be brought to the fore; viewed not as 
secondary to medical opinion but as having their own primary importance.  
Individual interviews were considered preferable to conducting focus group 





 In addition, one-to-one interviews were considered to 





4.4.2 Patient recruitment  
 
4.4.2.1 Locating the sample 
The Walton Centre NHS Foundation Trust is a tertiary neurosurgical centre with a 
catchment population of 3.5 million.
173
 The participants for this qualitative study 
were recruited from an existing database of CES patients who had previously 
undergone surgery at the Walton Centre NHS Foundation Trust and had been 
followed up clinically by a member of its healthcare team (be it a consultant, a 
registrar or a nurse specialist).  
 
4.4.2.2 Participant selection criteria 
Since 2006, the Walton Centre has maintained a registry of all adult CES patients 
(≥18 years) who have undergone spinal surgery to remove a compressive lesion.  At 
the time of this study over 200 patients were on this database. For each person, the 
database recorded diagnosis, time since operation, age, sex, severity of presentation 
and contact information. With the help of the local care team, this database was used 
to identify potential participants for the present study. Table 4.1 identifies the 
eligibility criteria used for the study. 
 
Table 4.1 Participant Inclusion and Exclusion criteria 
INCLUSION CRITERIA EXCLUSION CRITERIA 
Adult patients Adults unable to consent for research 
Formal diagnosis of CES (any type) Unable to converse in English 




Less than 10 years since the procedure  
 
It has been recommended that if the main aim of pre-Delphi qualitative research is to 
ensure no outcomes are overlooked for inclusion in the “long list” for use in the first 
round of a Delphi then an explicit sampling strategy is recommended to ensure all 
potentially relevant subgroups from the target population have the opportunity to 
become involved.
144
 For this reason a stratified purposive sampling
174
 approach was 
used for the current study. This is a hybrid approach in which the aim is to select 
groups that display variation in some particular phenomena but each of which is 
fairly homogenous, so the subgroups can be compared. Two characteristics which 
are from a clinical perspective often considered to have relevance to patient outcome 
after CES are the severity of the original CES presentation (Cauda Equina Syndrome 
Incomplete (CESI) and Cauda Equina Syndrome with urinary Retentions (CESR))
8
 
(see Table 4.2 notes) and the time since operation (short (≤2 years) or long term (>2 
years and ≤10 years) (see Table 4.2). These factors informed the sample framework 
used for this study, producing 4 subcategories to populate. All subcategories for the 
sampling frame were deemed a priority and “nesting” of male and female was done 
within them.  
 
It was anticipated that the database would generate 50 patients per category. Due to 
reasons such as some patients no longer being alive, some living long distances from 
the tertiary hospital, and a lack of interest in participating, it was anticipated that up 
to 10 patients may reply from each category. This would have produced up to 40 
patients in total. Considering CES is a relatively rare condition, the eligibility criteria 
was not restrictive to ensure recruitment was feasible and to allow capture of 
relevant outcomes.  
 
Table 4.2 Sampling frame with the suggested quotas 
 CESI (Cauda Equina 
Syndrome Incomplete) 
CESR (Cauda Equina 
Syndrome with 
retention) 
Short term ≤2 years 
since operation 
10 participants 10 participants 
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Long term >2 <10 years 
since operation 
10 participants 10 participants 
Notes. The more severe presentation of CESR describes painless urinary retention 
with overflow incontinence and complete perianal sensory loss. When the patient 
complains of CESI, the symptoms include urinary issues of neurogenic origin 
including loss of desire to void, altered urinary sensation, and hesitancy with partial 
saddle anaesthesia.  
 
The aim was for data collection to continue until data saturation had been achieved. 
Data saturation is reached when increasing the sample size no longer contributes to 
new evidence.
151
 Within the current study a collective decision was to be made by 
the main interviewer (NS) and members of the wider research team as to when data 
saturation had occurred. The decision was supported by having regular debriefs with 
the research team following interviews and developing a preliminary data matrix that 
highlighted what new themes and areas of importance were emerging from the data.  
Prior pre-Delphi qualitative studies have shown that when data saturation occurs 
varies. In the MOMENT study,
175
 for example, which focused on otitis media with 
effusion, data saturation was achieved with 30 participants. In the PARTNERS2 
study, which looked at mental health conditions, study saturation was reached at 14 
interviews with a further 2 conducted to confirm this.
48
 A study investigating fatigue 
in Motor Neurone Disease undertook qualitative interviews and a cross-sectional 
survey.
176 177
 They had reached theoretical saturation at 10 interviews and further 
interviews were conducted to ensure consistency across wide range of disease 
phenotypes. Sticking rigidly to a sample frame can therefore be counter-intuitive as 
one patient can be data rich as opposed to interviewing multiple patients where the 
data is not rich. The aim is to collect data, which is good enough to allow in depth 
analysis.
151
 So, although the sampling frame may serve as a guide it was not used to 
restrict participants especially at the initial stages of doing the qualitative interviews 
until data saturation was achieved. 
 
4.4.2.3 Invitation 
Having identified and selected ostensibly eligible patients for the study, each was 
sent a letter, signed by a member of the patient’s clinical care team, explaining the 
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study and inviting them to participate (Appendix 4.1). A Participant Information 
Sheet (Appendix 4.2) was included in this communication.  
In line with ethical and professional standards, only patients providing signed, 
informed consent took part in the qualitative study. What is slightly novel though is 
that an ‘opt-out’, rather than ‘opt-in’ approach to following up patients who were 
sent invitation letters was used. Specifically, those who did not opt out of further 
contact within 3 weeks were telephoned by the interviewer (NS) to discuss the study, 
and to confirm their eligibility and willingness to participate. The ‘opt-out’ approach 
was chosen with a view to maximising uptake. Within the wider literature, Travena 
et al, 2006 examined this method in the context of a randomized controlled trial.
178
 
They compared the effect of participants having to contact the trial team to take part 
in a trial (opt in) to having to contact the trial team if they did not wish to be 
approached (opt out). Opt-out improved recruitment by around 20%. An additional 
advantage of the approach is it can be more cost-effective.
179
 The opt out approach 
can be justified from an ethical perspective. There is no evidence to suggest it is 
harmful.
180
 It was used to recruit 426 patients within a recent epilepsy trial with no 
evidence being found that patients viewed it as a violation of privacy or loss of 
personal autonomy.
179
 Importantly, the approach also reduces the likelihood that a 
biased sample of participants will be recruited.
178 181
 
Maximising patient uptake was important given CES is relatively rare and so the 
population of potential participants was small. Whilst little qualitative research had 
been conducted on those with CES, it was considered possible that uptake may have 
been low since we were conducting a non-interventional study without obvious 
immediate benefit to patients and because CES is condition for which people may be 
reluctant to talk about due to the potential of sensitive problems such as bowel, 
bladder and sexual dysfunction. 
 
4.4.3 Interviews 
Research Ethics Committee (REC) and Health Research Authority (HRA) approval 
was obtained on December 2016 for the qualitative interviews by South Central- 
Hampshire A Research Ethics Committee (REC reference 16/SC/0587). Individual 
appointments were arranged for those persons agreeing to participate. At these, 
informed signed consent was obtained from the participant and the interview was 
conducted (Appendix 4.3). In obtaining informed consent all patient questions were 
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addressed, with anonymity and confidentiality being emphasised to the participants. 
A copy of the consent form was subsequently sent to the patients GP along with a 
letter informing them that the patient was participating in the study (Appendix 4.4). 
The appointments typically took place in the patient’s home. Interviewing in a 
participant’s own home has the advantages of disempowering the researcher, who 
finds themselves in unfamiliar territory and increases the authority of the participant. 
This is considered important in increasing the likelihood of eliciting depth-data.
138 182
 
Participants were also offered the option of the appointment occurring at their 
workplace, at their hospital or online via Skype in order to increase recruitment. 
Whatever the location or format, the researcher was mindful that the environment for 
the interview needed to be conducive to concentration- private, quiet and physically 
comfortable
151
 and in all instances they followed the topic guide, adapting it 




4.4.3.1 Eliciting Data 
All interviews were supported by a piloted topic guide (Appendix 4.5). Semi-
structured interviews are the most common interview format used in healthcare and 
allow several key questions to be defined but also allow the interview to diverge to 
pursue an idea and response in more detail.
156
 The flexibility offered by this 
approach allowed for exploring information deemed important to patients but that 
may not have been thought relevant to the research team.  
Detailed consideration was given as to how best to engage patients with the topic of 
a core outcome set and to be able to generate data able to address the study 
objectives. The concepts of ‘outcome domains’, ‘outcome measures’ and the details 
of trial design were considered to be unfamiliar to most patients. Rather than 
therefore explicitly engage with patients in a discourse about research and clinical 
trials we decided instead to follow the approach used in the CONSENSUS 
(Squamous Cell CarcinOma of the OropharyNx: Late PhaSE CliNical TrialS; Core 
OUtcomeS) study which sought to develop a COS for oral cancer. Patients were 
asked to give a chronological narrative of their experience of undergoing treatment 
and life after.
183
 Discussion was facilitated by the use of open-ended, non-leading 
questions about the participant’s diagnosis and their management post operatively 
and in the community.
156
 As outcomes of importance may differ depending on how 
long one is post-diagnosis,
183
 this issue was specifically addressed in the topic guide 
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(Appendix 4.5). At the end of the interview, and once the interviewer had been 
assured that participants had been orientated through the interview process to the 
concept of an outcome, they were then each asked to comment on what the most 
important outcomes for them were.  
Interviews were audio recorded and transcribed verbatim. The transcripts were 
reviewed by the interviewer for correction, but these and the results were not sent 
back to the participants for comment. Audio recording of interviews was chosen 
over writing notes since the latter can interfere with the process of interviewing.
156
 It 
was estimated that the interviews would last from 45 minutes to an hour at each 
sitting to prevent the participant feeling pressurised. The same male interviewer 
(NS) was used throughout. All interviewees were informed at the introduction that 
the interviewer was part of the research team. However, at the end of the interview, 
if the patient enquired, it was mentioned that NS was a clinician not involved in their 
on-going care. NS had completed formal courses in qualitative interviewing prior to 
the interviews. The interviewer did not divulge personal information about himself 
and if any of these questions were asked they were addressed at the end of the 
interview session.  
 
4.4.3.2 Pilot Phase 
NS’ qualitative interview technique and topic guide was piloted with 2 patient 
research partners to establish that the interview structure and technique was clear, 
understandable, and capable of answering the research questions. The transcripts 
were reviewed by a supervisor (AN). This highlighted the corrections that needed to 
be made to the interview structure or technique. Data from the two pilot interviews 
were not included in the sample for final analysis. 
Reflexivity is an important concept during qualitative research when striving 
towards objectivity and neutrality
151
 and analysis of the interviews considered if bias 
from the interviewer’s own beliefs may have crept in.  Whyte’s six-point 




Figure 4. 1 Whyte’s six-point directiveness scale 
Making encouraging noises 
Reflecting on remarks made by the informant 
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Probing on the last remark by the informant 
Probing an idea preceding the last remark by the informant 
Probing an idea expressed earlier in the interview 
Introducing a new topic (1=least directive, 6=most directive) 
 
4.4.3.3 Analysis 
Thematic analysis was used to analyse the interview data. Thematic analysis is a 
pattern-based qualitative method like grounded theory
185
 and interpretative 
phenomenological analysis 
186
 but is not intimately linked to a specific theoretical 
framework. Braun and Clarke (2006) define thematic analysis as a “method for 
identifying, analysing and reporting patterns within the data.”
187
 We employed a 
deductive, latent and constructionist way to approach thematic analysis as opposed 
to an inductive approach. This means coding and theme development are directed by 
the content of the data, reporting concepts and assumptions underpinning the data 
and focuses on how a certain reality is created by the data. The key six phases of 
Braun and Clarke 2006 thematic analysis
187
 guided the analytic process as follows: 
 
1. Familiarisation with the data: This phase involved reading and re-reading the 
data, to become familiar with the data. 
2. Coding: This phase involved generating codes that identify interesting features of 
the data that may have been relevant to answering the research question. It involved 
coding the entire dataset in a systematic fashion and after that, collating all the 
codes. 
3. Searching for themes: This phase involved examining the codes and collating 
data to identify significant broader patterns of meaning (potential themes). It then 
involved collating data relevant to each individual theme. 
4. Reviewing themes: This phase involved checking the individual themes against 
the dataset, to determine that they told a convincing story of the data, and one that 
answered the research question. In this phase, themes are often refined, which can 
involve them being split, combined, or even discarded. 
5. Defining and naming themes: This phase involved developing a detailed 
analysis of each theme, working out the scope and focus of each theme, determining 
the ‘story’ of each. It also involved deciding on an informative name for each. 
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6. Producing the report: This final phase involved bringing together the analytic 
narrative and data extracts and contextualising the analysis in relation to existing 
literature to produce a report.  
 
To not delay the Delphi phase of the wider project the initial analysis of the 
qualitative data set focused on the primary objective of identifying outcomes of 
importance to patients for inclusion in the “long-list” and clarifying the language 
patients used to discuss them.  The list of all potential outcomes from the systematic 
review and qualitative interviews were placed into outcome domains by the research 
team to avoid repetition. 
 Transcripts were reviewed to identify which outcomes were important to patients. 
This was undertaken by labelling and tagging the data. Descriptive analysis was used 
to detect, categorise, and classify the transcripts using NVivo qualitative data 
analysis software. Thematic charting allowed the summarisation of the key outcomes 
of each individual transcript whilst retaining the context and language in which it 
was expressed.
151
 Quotations are used to illustrate themes. Some quotes received 
minor editing to preserve anonymity and ensure clarity of meaning. 
When considering the six phases of the Braun and Clarke 2006 analytic guide,
187
 we 
initially completed phases 1 and 2 to complete the task of identifying outcomes of 
importance to patients and language used.  Once the Delphi process was completed, 
phases 1 to 6 were followed to facilitate a more in depth analyses of the data, 
developing themes and to allow the secondary objectives of this current study to be 
addressed. 
As a way of reflecting on the qualitative analytic process the researcher will verify 
interpretations through discussion with others, including the supervisors, fellow 
researchers, and at seminars.  These discussions will prove important in so far as 
they offered fresh insight – personal, professional and cultural – enabling the 
researcher to constructively reflect on their personal biases and assumptions. 
 
4.4.3.4 Data Management and Confidentiality 
Each participant will be allocated participant identification number. All names, 
addresses and contact details will be removed from the data and kept on a 
spreadsheet. A separate spreadsheet will hold the identification numbers linked to 
study data. At all times the researcher will comply with Good Clinical Practice 
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guidelines with regards to data protection. The researcher will conduct interviews in 
strict confidentiality and this will be emphasised in the consent form, information 
leaflet and by the interviewer before conducting the interview.  
All data will be held on password secured computers and encrypted at the University 
of Liverpool offices. All paperwork relating to the project will be stored away in a 
filing cabinet to which only the research manager of the department has access to via 
a code, key and lock. Only the direct care team will have access to the participant's 
personal data. A designated member of the research team will have access to the 
encrypted records and transcripts. No individuals outside this will be allowed to 
access the data. In line with our university's policy, data will be archived at the 
University of Liverpool for of at least 10 years, longer if deemed of historical 
significance. After this period, the data will be destroyed (please see: 
http://www.liv.ac.uk/media/livacuk/computingservices/regulations/researchdataman
agementpolicy.pdf). 
It is not intended for names and addresses to be used except for contact purposes 
until participants exit the study. The results will be published and will use example 
quotes to illustrate some of the themes found. In doing this, care will be taken to 
ensure participants cannot be identified. This will include the removal of any 




Of the 100 patients who were sent invitations to participate 15 refused to participate. 
Most refusals came from participants returning an “opt out” sheet. The majority of 
participants who refused to take part in the study did not provide a reason. Reasons 
that were provided included, not wanting to discuss negative experiences, being 
anxious, not being interested in the research and not having the time.  
 
Ultimately, 22 participants with CES were recruited for the qualitative interviews. 
Using the sampling frame in Table 4.2, the patients were contacted from each 
category, which was in random order to arrange an appointment. Data saturation was 
reached at 22 participants. This comprised 12 females and 10 males. Of the 
participants, 10 had CESI and 12 had CESR. Participants’ average age was 46 years 
(range 31-61, SD 9.21). The average number of operations the participant had was 1 
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(range 1-4, SD 0.8).  The average time since having the operation was 62 months 
(range 4-122, SD 38.1). We do not know the length of time between formal CES 
onset diagnosis and initial operation.  
 
Most interviews took place at the patient’s home or at their workplace (18). The 
remainder took place by phone (1), Skype (1) or in person at the Walton Centre 
hospital (2). For all but 2 interviews it was only the patient present at the interview. 
For the remainder the patient was accompanied by a spouse/partner.  The average 
length of the interviews was 45 minutes (range 27-72, SD 12.3). 
 
A judgement regarding the quality of data arising from the individual interviewees 
was made by the interviewer (NS) based on their subjective sense of how data rich 
the interviews were. It was categorised into “poor”, “medium” and “rich” (how these 
terms were operationalised is described in the Table ‘Notes’) and Table 4.3 provides 
further details.  
 
Table 4. 1 Demographics and clinical details of participants and interview 
details. 










1 M 50 7 years, 5 months 1 CESI poor 48 Home 
2 M 49 6 years, 2 months 1 CESI rich 59 Work 
3 F 35 8 years, 4 months 2 CESI medium 52 Home 
4 F 35 7 years, 6 months 4 CESR rich 51 Home 
5 F 57 2 years, 6 months 1 CESI medium 27 Phone 
6 F 47 1 years, 2 months 1 CESI poor 28 Home 
7 M 38 7 years, 4 months 2 CESI Poor 50 Hospital 
8 F 31 8 years, 4 months 2 CESI medium 48 Home 
9 F 56 0 years, 9 months 1 CESR poor 38 Home 
10 F 40 0 years, 10 months 1 CESI poor 33 Home 
11 F 46 2 years, 6 months 1 CESR rich 64 Home 
12 M 59 5 years, 4 months 1 CESI rich 44 Skype 
13 M 44 7 years, 1 months 1 CESR poor 33 Home 
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14 M 47 0 years, 4 months 1 CESR medium 46 Home 
15 F 58 10 years, 2 months 1 CESR poor 39 Home 
16 M 56 6 years, 4 months 2 CESR rich 43 Hospital 
17 F 46 9 years, 3 months 3 CESR rich 72 Home 
18 M 61 9 years, 1 months 1 CESR medium 54 Home 
19 F 42 7 years, 2 months 1 CESR medium 30 Home 
20 F 36 7 years, 3 months 1 CESR rich 54 Home 
21 M 32 3 years, 11 months 1 CESR medium 27 Home 
22 M 50 1 years, 6 months 1 CESI medium 52 Home 
 
Notes CESI (Cauda Equina Syndrome Incomplete), CESR (Cauda Equina Syndrome with urinary 
Retention). Data is classified into rich, medium or poor depending on the interviewer’s (NS) 
subjective interpretation of how rich the data was. 
 
4.5.1 Initial Analysis Findings: Outcomes of Importance identified by patients 
As noted in the methods above, the transcripts were initially analysed to identify the 
outcomes of important to patients. These, were documented verbatim through steps 1 




In total, across the interviews, 260 verbatim outcome terms were identified by 
patients. These were collected as they were mentioned each time in the transcripts. 
This is evidenced in Table 4.4. These outcomes were combined with the outcomes 
collated in the systematic literature review to produce the “long list.” The 
development of the Delphi survey questions from the long list will be described in 
the next thesis chapter regarding the consensus process.  
 
Table 4. 2 Number of verbatim outcome terms condensed to final outcomes. 
Outcome category Verbatim outcome terms (n) 
Leg Pain 24 









Saddle numbness 9 
Leg Weakness 15 
Return to work 2 
Back/ Leg stiffness 17 
Fatigue 5 
Sleep issues 6 
Sexual problems 3 
Activities of daily living 3 
Wound infection 3 
Total 260 
 
Notes Verbatim outcome term- every outcome copied verbatim from the transcript, Outcomes 
category- the higher order category of similarly themed outcomes.  
 
4.5.2 Detailed Analysis Findings: Themes 
Having identified the outcome domains of importance to patient participants for 
inclusion in the “long list”, the raw data from the transcripts was coded again de 
novo and then placed into domain summaries. Domain summaries were higher order 
groupings that collectively summarise what the similar outcomes were describing. 
Table 4.5 shows the domain summaries and the ideas for provisional themes, which 
led to the development of the 4 final themes. In the results that follows, each of these 
themes is discussed in detail. Each is divided into the domain summaries with 
illustrative quotes being presented and cross-referenced to the individual participant 
from which it came e.g. (M, 59, CESI, 5y4m, participant 12) means male 
participant, 59 years old, with Cauda Equina Syndrome Incomplete, interviewed 5 
years and 4 months after the operation and was the 12
th
 participant interviewed.  
 
Table 4. 3 Domain summaries, Ideas and Themes. 
Domain summaries Ideas Themes 
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Prioritisation, bladder, bowel, 
sexual, musculoskeletal, 
fatigue, postural difficulties, 
stiffness, back and leg pain, 
sensation 
Varying priorities (of 
outcomes)- depending on 
severity 
1. Varying priorities of 
physical health 
Delay in management, follow 
up 
Anger/ discontent over 
disjointed management/ 
feeling fragile/ sudden 
change in circumstances/ lack 
of follow up, services and 
holistic care 
2. A fragmented healthcare 
service 
Returning to work, support, 
recovery 
Process of adjustment- 
support/awareness, reduced 
opportunities, work, recovery 
3. The process of adjustment 
Anxiety, isolation, low mood, 
suicide, reasoning and 
awareness 
Anxiety over future 
prognosis/ outcome, physical 
struggle to improve, 
diminishing importance, 
reasoning for acceptance, 
feeling like a “fraud” “not 
believed.” Isolation, low 
mood 




4.5.2.1 Theme 1: Varying priorities of physical health 
In this section, the physical outcomes of bladder, bowel, sexual and musculoskeletal 
function along with the pain and sensation domain summaries have been described. 
 
4.5.2.1.1 Prioritisation 
Patients had varying levels of prioritisation when it came to their outcomes 
depending on the severity of their condition. Generally, CESI patients prioritised 
bladder and bowel outcomes as the most important, whilst CESR patients prioritised 
mobility issues and pain control. However, there was empathy and agreement 
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between the CESI and CESR groups regarding the different outcomes experienced 
and prioritised by the other group respectively. For example, it was noted by some 
CESI patients how, over time, bowel and bladder symptoms can become accepted as 
the new normal for the patient and understood that it may be more difficult to 
normalise pain if it was not under control. Another example was that CESR patients 
noted, that over time bladder issues were dealt by self-management in their usual 
routine, but appreciated that it is the outcome which takes the longest to adjust to 
and as such, they could understand that CESI patients were more concerned with 
resolution of bladder and bowel outcomes initially.  
 
“The potential impact on the bladder and the bowel function… I think if it had been 
permanent and I was still self-catheterising… that would have been a huge trauma” 
(M, 59, CESI, 5y4m, participant 12) 
 
“My bladder and everything to do with my plumbing would be number one… I 
would still be able to look after myself pretty much and take medication for the leg 
pain, but the thought of losing all that and being dependent on other people that 
would be like a nightmare .... I wouldn’t wish that on my worst enemy” 
(M, 50, CESI, 1y6m, participant 22) 
 
“If you can get the pain under control then you can deal with everything else that 
comes below it. Pain, mobility, bladder and bowel yes, they’re the ones that are the 
most important in that order … I would much rather have a colostomy bag and 
retain the ability to move around, walk, interact socially and work”  
(M, 47, CESR, 4m, participant 14) 
 
4.5.2.1.2 Bladder function 
After the operation, some patients needed to perform intermittent self-catheterisation 
(ISC) due to urinary retention. This involves the patient inserting a catheter into their 
bladder through the urinary tract usually 5-8 times a day to empty the bladder 
contents of urine. CES patients are taught to do this initially with help from a nurse 
or partner but usually become independent performing the procedure. When the 
urinary catheter was inserted on admission, patients were nervous regarding their 
bladder prognosis and sometimes self-conscious. Some CESR patients who regularly 
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catheterised saw it as a normal daily routine but also realised the negative effect it 
had on their intimate relationships. 
 
“I was getting upset having to ask someone to come and empty my bladder for me... 
they eventually taught me how to self-catheterise… I still catheterise now about 5 
times a day”  
(F, 35, CESR, 7y6m, participant 4) 
 
“I had to self-catheterise … it took a few months from when I was going to and from 
hospital and they were measuring the flow… prayed for it to work… scary because 
at that age I was still sort of youngish and wanting to go out and meet boyfriends 
and things like that” 
(F, 42, CESR, 7y2m, participant 19) 
 
Patients with bladder dysfunction reported changes in the frequency with which they 
felt the need to urinate, inability to completely empty the bladder contents of urine 
(urinary retention), bladder so full that it caused incontinence of urine (overflow 
incontinence), and an inability to feel when they passed urine. A tone of frustration 
was often apparent when participants described their experience of these issues and 
they reported concerns regarding the availability of and ready access to toilets when 
they left the house. CES patients whose bladder function had returned to premorbid 
levels reported relief, whilst those who continued experience difficulties reported 
feelings of embarrassment, especially if they were having what they typically 
referred to as “accidents”. They said it often required an extended period of 
adjustment before the management of the issues had become part of their daily 
routine.  
 
“I couldn’t really sense when I’d start to go for a wee and I wasn’t sure when I had 
finished… getting into a mess as a result”  
(F, 31, CESI, 8y4m, participant 8) 
 
“Sometimes I lose control and sometimes I have to sit on the loo and it takes a bit of 
a while to go to the toilet and… I have to really push sometimes to empty the bladder 
as if I'm going, without sounding crude, as if I'm going for number two”  
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(F, 57, CESI, 2y6m, participant 5) 
 
4.5.2.1.3 Bowel function 
Some CESR patients described altered bowel function as a result of their CES and 
required, to varying degrees, the use of medication, irrigation and manual evacuation 
techniques to try to manage the symptoms.  Irrigation is the use of a medical device 
to wash out the contents of the bowel with water, whilst manual evacuation is 
physical use of a hand to remove hard stool from the rectum. 
 
Participants reported issues with bowel function less frequently than issues with 
bladder function. Participants did though however note that the problems with their 
bowel were not as immediately noticeable to them due to the greater frequency with 
which the bladder is usually emptied relative to the bowel. This meant issues that 
had arisen with the bladder post diagnosis of CES were often more obvious.  
 
All CESI patients who had experienced bowel issues said these had resolved within 
3 weeks of the initial operation. In contrast, 3 of the CESR patients continued to 
experience significant bowel dysfunction. Some reported overflow incontinence 
leading them to “soil” themselves and in extreme circumstances having to wear an 
incontinence pad post operatively. Of the 2 CESR who experienced constipation, 
rectal irrigation was used. Whilst it was said to offer temporary symptom alleviation, 
it was time consuming and reported by participants to lead them to sometimes feel as 
they were a burden on their partners from whom their help was often required. One 
patient already had a colostomy due to the bowel issues and another was 
contemplating it. A few CES patients wanted or already had a further operation for 
continuing back and leg pain but when one patient was having bowel issues 
potentially requiring a colostomy they were more hesitant about this decision. 
 
 “The most traumatic thing has been my bowels...I was taught how to use an 
irrigation system... over time that has not been as efficient as it was and I’ve ended 
up having 2 emergency evacuations of my bowel … I’ve had to do manual 
evacuations … it completely limits my day”  
(F, 35, CESR, 7y6m, participant 4) 
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“I couldn't pass water or open my bowel … really bad pain. In the end, I had to keep 
forcing to pass my stool … that’s why I wear the colostomy bag now... I still have 
trouble with my bowels but it’s not as bad”  
(M, 56, CESR, 6y4m, participant 16) 
 
“I’ve no control over my bowels, I didn’t have any life 6 months ago (before being 
taught rectal irrigation) because I was soiling myself, couldn’t go anywhere couldn’t 
do anything” (F, 46, CESR, 9y3m, participant 17) 
 
4.5.2.1.4 Sexual function 
The main sexual issue for male participants was with the inability to achieve or 
maintain an erection. For women, the issue was that due to the numbness in the 
saddle area, they said they could not “feel anything.” Losing the ability for physical 
sexual intimacy was described by a few CES patients as causing an emotional 
distancing between them and their romantic partner over time. 
 
“In the bedroom side of things, it’s not exactly like it was …  you can lose an 
erection” 
(M, 44, CESR, 7y1m, participant 13) 
 
“Things like sexual function and being able to orgasm … it’s like everything is kind 
of dulled you know a little more”  
(F, 36, CESR, 7y3m, participant 20) 
 
“I don’t get anything out of sexual intercourse due to the numbness (in the genital 
region)…  my husband thought that he was going to hurt me (during sexual 
intercourse) and treating me like an invalid”  
(F, 35, CESR, 7y6m, participant 4) 
 
“no sex… how can I put it, self-confidence, can’t feel anything so you can’t feel the 
passion, romance or whatever else… there's just nothing there” 
(F, 46, CESR, 2y6m, participant 11) 
 
4.5.2.1.5 Musculoskeletal function 
 59 
The ability to mobilise was an important outcome for patients. This was reported as 
generally being reduced due to back and leg pain rather than inherent leg weakness. 
For some patients, these had resolved over time, for others they remained and 
culminated in them being unable to get in and out of the bath by themselves, get into 
a car, difficulties with stairs. In some instances, the issue led to frequent falls with 
wheelchairs, mobility scooters and walking sticks being used by many patients as 
aids. 
 
“The pain is unbelievable, I walk the wife says, like a Yeti“ 
(M, 38, CESI, 7y4m, participant 7) 
 
“So, it was a challenge to get up and down the stairs yes, I did use a walking cane 
for a couple of weeks … it just felt really strange... walking on the moon is the best 
way I can describe it, almost as though there was no gravity” 
(M, 47, CESR, 4m, participant 14) 
 
Having a ‘hidden’ condition was a phrase patients sometimes discussed through the 
issues. With regards mobility one patient described the assumptions that can be 
made by onlookers if mobility difficulties were experienced, but a mobility aid was 
not used: 
 
“So, I can often just walk without an aid but I’ve had consultants look at me and 
say, ‘oh you’re doing really well you know’ because they almost make assumptions 
like … there must be no pain or numbness”  
(F, 36, CESR, 7y3m, participant 20) 
 
Weakness in the legs was most noticed in the form of a “foot drop” rather than 
difficulty walking due to reduced power in the legs. In most cases patients could still 
manage walking but noticed “dragging” or “slapping around” of the foot. 
 
4.5.2.1.6 Fatigue 
Fatigue was commonly reported by participants. Participants often reported how the 
“effort” of doing an activity was greater than premorbidly. Even for those who did 
not experience a physical impediment, activities like walking and going back to 
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work were felt to be physically and mentally more exhausting than before the 
operation. To recover from such activities participants reported the needed for 
extended periods of sleeping and rest. For some participants, the fatigue meant they 
required greater or complete assistance from family and friends with household 
duties they themselves had previously performed. Fatigue severity had changed or 
resolved over the course of time for some participants and was present to varying 
extents in different participants. 
 
“Some days I’m really bad with the pain and I end up sleeping round the clock. I 
think it sort of catches up on me … I sort of hit this brick wall where I’m so tired” 
(F, 46, CESR, 9y3m, participant 17) 
 
 “Shattered absolutely shattered.… I would literally just fall, I’d be sat in the chair 
and I’d fall asleep… I was just completely drained and wanted to sleep all the 
time…”  
(F, 31, CESI, 8y4m, participant 8) 
 
4.5.2.1.7 Postural difficulties and stiffness 
Significant back pain and stiffness made it difficult for some patients to sit down, 
bend over, stand up, lift heavy objects and take long flights. It also prevented some 
from doing general duties around the house like hoovering, going up the stairs, 
gardening and limited workplace activities. Difficulty with posture could affect 
walking or ability to get into a comfortable position for sleep. Back and leg stiffness 
were mentioned but it was not as debilitating as the back pain. Patients complained 
of stiffness or spasms in the lower back or the leg(s). There was variability in how 
long it could last, from days to weeks.  
 
“As soon as I stood up… it felt like someone had opened my back and poured lead in 
there because it felt that heavy”  
(M, 44, CESR, 7y1m, participant 13) 
 
“I feel like a like cardboard (regarding her back)… like my spine and my hip and 
everything’s just like a block you know” 
(F, 36, CESR, 7y3m, participant 20) 
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4.5.2.1.8 Back and leg pain 
Back pain was intense for many CES patients and described as “exhausting,” “over-
rode everything,” “suicide pain,” “back was like a rusty hinge,” and like “sticking a 
knife in your back.” Whilst for many it was not as intense as before their operation, it 
could still limit their posture, walking and sleeping.  
 
“So, when I get like the problems with my knees and the bit of arthritis here and 
there it doesn’t really matter because when you’ve been through that pain of Cauda 
Equina… nothing else touches it so you just get on with it” 
(M, 38, CESI, 7y4m, participant 7) 
 
Leg pain was also a common occurrence either present unilaterally or in both legs 
causing difficulty walking and standing.  
 
“I couldn’t move my leg, I couldn’t have any weight on my leg even the weight of the 
duvet on my leg was enough to put me in agony” 
(M, 47, CESR, 4m, participant 14) 
 
The pain was so intense for some participants that analgesia was being used 
reluctantly by some to try and manage it. A common concern amongst patients 
though was that there was an underlying anatomical issue still present which 
warranted attention and that analgesia was “masking” it. 
 
“When you’re having to take drugs all the time and pain killers its saps your energy”  
(M, 47, CESR, 4m, participant 14)  
 
“Taking medication every single day for back pain … it was depressing me a little 
bit… I mean I couldn’t function in my job properly”  
(F, 47, CESI, 1y2m, participant 6) 
 
“I am in absolute agony … I was taking the tablets and falling asleep and then 
waking up taking more tablets and falling asleep”  




Patients experienced abnormal sensations and numbness in their legs, which was 
unpleasant and concerning for them. This was uncomfortable but did not prevent 
daily activities. Leg numbness was common and there was a range from them not 
being noticeable to abnormal sensation to the feeling that the leg did not belong to 
them. 
 
“I always wear flip flops as my foot is always burning … I always feel like my foot is 
wet… I still check if I’ve got a hole in my shoe or something or if it’s raining it’s just 
a horrible feeling”  
(F, 35, CESR, 7y6m, participant 4) 
 
“It’s like somebody has hit the bottom of my feet with a hammer they feel like 
bruised I've got to walk very tensely”  
(M, 50, CESI, 1y6m, participant 22) 
 
“Feels as though you are walking in a bowl of blancmange”  
(M, 61, CESR, 9y1m, participant 18) 
 
“Left thigh … I’ve got used it now but the whole side is numb... if you rub it gently, 
it’s like rubbing sandpaper...you can feel it but its numb...it’s like somebodies put an 
injection in there”  
(M, 44, CESR, 7y1m, participant 13) 
 
The uncomfortable feeling of saddle anaesthesia was described by a few patients. 
The back and leg pain was so intense before the operation many CES patients said 
they did not pay attention to the signs of urinary issues or saddle anaesthesia before 
the operation.  
 
“(describing saddle anaesthesia) It’s like you’re sitting on a ball… it is so bad that 
you really can’t sit down because when you sit down its so bloody weird …. it feels 
so horrendous” 
(M, 49, CESI, 6y2m, participant 2) 
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4.5.2.2 Theme 2: A fragmented healthcare service 
 
4.5.2.2.1 Delay in management 
Many patients in the study had a time delay before obtaining definitive imaging (e.g. 
MRI) that diagnosed CES. Many recalled making multiple trips to care providers, 
including primary care and the hospital emergency departments, before imaging was 
organised and receiving their diagnosis. Patients described how, as a rare syndrome, 
CES was sometimes not considered as a possible diagnosis for them when they were 
initially assessed. They reported being frustrated by this, especially since they have 
come to learn that CES is considered a time critical condition with their clinical 
outcome potentially having been better if they were managed earlier.   
 
“I feel in my case, there were enough red light signs that it should have been 
captured at least 18 months before, no question… you shouldn’t need to have 
intolerable pain before you get an MRI scan”  
(M, 49, CESI, 6y2m, participant 2) 
 
“I did feel a bit bitter that my outcome could have been a lot different… if I had been 
scanned I would have gone to surgery 24 hours earlier… my bladder and bowel 
would be less damaged”  
(F, 35, CESR, 7y6m, participant 4) 
 
“I was very cross about how it was handled in the emergency department…  I knew 
in Cauda Equina that the amount of time that goes by from the symptoms to the 
beginning of the operation is very important… I felt my concerns were being 
dismissed … I would have liked to have been referred and diagnosed at an earlier 
time”  
(F, 56, CESR, 9m, participant 9) 
 
There was a perception amongst participants that there is a lack of knowledge within 
primary care regarding CES. Before diagnosis, most patients were managed with 
analgesia and not being taken seriously until having worrying signs such as bladder 
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issues or foot drop. After treatment, there is uncertainty regarding prognosis which 
patients find frustrating. This is explored further in the “anxiety” section later. 
 
“I don’t know how many people are fully clear about the syndrome itself… I don’t 
know if professionals could do with a bit more knowledge and information around 
that as well you know your GP and physiotherapist… nobody seems to want to 
commit to giving me clear advise as to how to move forward with it, so I’m kind of 
self-regulating” 
(F, 31, CESI, 8y4m, participant 8) 
 
Different avenues for litigation were seen in this study. One was for medical 
management not deemed adequate. Another was against employers for unfair 
dismissal. One patient although not pursuing a claim had sympathised and 
understood why other patients would do this if they had been severely affected 
clinically. The combination of having a bad clinical outcome, feeling unsupported 
and being encouraged by medico legal companies to file a complaint seemed to 
contribute to litigation.  
 
“As soon as I got Cauda Equina I mean I had about 3 years of every day text from 
lawyers saying let’s sue you know… there are an awful lot of points there where it 
(CES) should have been picked up. If I had ended up like some people I would have 
probably taken that route because I do genuinely feel that this syndrome (CES) is 
not taken seriously” 
(M, 49, CESI, 6y2m, participant 2) 
 
In a few instances, patients themselves acknowledged to have a part to play in the 
delay to diagnosis. This is because they had previously experienced back and leg 
pain for another reason and did not present to a care provider when the CES started 
as they ascribed the symptoms to historic health problems. 
 
“When I went for my physio… every week she would just go if you can’t go the toilet 
you need to go to the doctors and I used to think what a stupid thing to say because I 
was going to the toilet, I now know why she said it...”  




4.5.2.2.2 Follow up 
Medical follow up was described as unsatisfactory service for most participants. 
Some were never followed up in clinic or did not receive what they felt were the 
appropriate referrals. Physiotherapy although offered usually comprised of a session 
in hospital before discharge. Patients, described an anxiety over what they could and 
could not do physically which they said a single session of physiotherapy was not 
sufficient to address. Participants called for ongoing physiotherapy to be automatic 
after surgery for CES rather than requiring the patient to have to request this support 
from their GP.  
 
“The physio input was minimal and in hospital… you had the feeling that their job is 
to get you on your feet, able to use crutches and out the door… maybe having 
somebody you know a district nurse call in or having somebody contact you by 
phone periodically just to monitor the process that would have been reassuring”  
(M, 59, CESI, 5y4m, participant 12) 
 
“There wasn’t really much aftercare.... there was a real kind of lack of explanation 
and follow up … over the years I just kind of lived with the residual effects of the 
condition…  almost kind of second guessing what to do… like spinning plates trying 
to manage it all”  
(F, 36, CESR, 7y3m, participant 20) 
 
Bowel and bladder care were also seen as a one-off teaching event by professionals 
and then the patients were left to self-manage. Usually there was a single follow up 
review in clinic or the patient was assessed using a questionnaire through the post at 
3 months to check on their progress and capture ongoing difficulties. This was not 
deemed to be sufficient, as patients felt further follow up was required for 
reassurance and adequate communication regarding long term management. The 
negative implications from the lack of support were noted for patients, as well as 
their family and friends especially in the form of anxiety over future prognosis and 
activities described later.  
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“I was soiling myself but the bowel irrigation team hadn’t been notified (a referral 
had not been made) … I got upset, I was a blubbering mess and I said to him (the 
surgeon) my partner’s gone and I’m soiling myself. The medical team were supposed 
to sort me out and they never did” 
(F, 46, CESR, 9y3m, participant 17) 
  
“There wasn’t a real follow up from the hospital other than the three-month 
questionnaire that I had to fill in… but what I still don’t know is it going to get 
worse, am I doing the right thing by walking ... am I pushing it to the limit, is that 
ok. Should I be resting?... I still don’t know if I am doing the right thing or not”  
(M, 50, CESI, 1y6m, participant 22) 
 
 “My eldest child was very frightened and I didn’t know what was going on, so I 
couldn’t tell him what was going to happen...it would have helped to have had 
someone come out and speak to us as a family about the changes that might happen”  
(F, 35, CESR, 7y6m, participant 4) 
 
To compound matters, some patients described how they could receive conflicting or 
incorrect information about CES and its consequence from other care providers who 
were not specialists.  To varying extents this was described as confusing patients, 
provoking anxiety and frustration. One participant who became pregnant following 
CES was particularly upset by being recommended that she have a caesarean section 
rather than a natural birth due to her previous spinal operation. However, spinal 
surgery is not routinely a contraindication to having a natural birth. Several 
participants felt their disability was “hidden,” not taken serious and that this had 
negative implication for the extent of aftercare they received:  
 
“If we came out of that surgery say and we needed a wheelchair then we’d probably 
be offered a lot more in terms of help and services... but because we come out and 
we’re still hobbling and walking it’s like, you know, you’re going home with a 
leaflet”  
(F, 36, CESR, 7y3m, participant 20) 
 
4.5.2.3 Theme 3: The process of adjustment 
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4.5.2.3.1 Returning to work 
Reduced mobility due to back and leg pain was cited as the most common reason to 
be unable to continue employment. Most employers were said to not be sympathetic 
to the participant’s condition, did not make adaptations for them at work and instead 
often recommended the person to retire citing inability to continue employment due 
to medical reasons. A patient suggested that this could be due to CES being a 
condition not understood by employers and that CES patients get labelled within the 
“back pain” category. Generally, patients were keen to get back to work. This is 
especially relevant when the family is financially dependent on their income or when 
they have their own business. Patients found it difficult going back to work but with 
supportive staff found the value of having a routine. Some patients had returned to 
work with adaptations made for them by being placed in an office environment, 
preventing activities like long travel and no lifting. However, there were also many 
patients where appropriate adaptations were not made, and they were permanently 
signed off for work. In all cases the patients who were unemployed missed their jobs 
as they had derived a significant amount of satisfaction from their roles.  
 
“I was absolutely gutted, that was my job, that’s what I wanted to do and I worked 
so hard for it... up there I could do it in my head but I just couldn’t guarantee that 
my body was up to scratch every single day. So yes, I had to take ill health 
retirement”  
(F, 35, CESR, 7y6m, participant 4) 
 
“Previously I had been very active … so not being able to work and do something 
that you enjoy … that’s what put me in this place of isolation and depression 
because it is suddenly so much activity to nothing at all”  
(F, 57, CESI, 2y6m, participant 5) 
 
“My employer wasn’t particularly sympathetic to any form of absence from staff. So, 
it was a very sort of put up and shut up and try and keep going…there weren’t a 
great deal of adaptions made by my employer and I am currently in discussions with 
the unions about these things”  
(F, 31, CESI, 8y4m, participant 8) 
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“I just end up being careful with it and my job has changed so I’m in an office 
environment and a safer role … I have specialised chairs and I have desks that raise 
and lower … its brilliant work place so I’ve got really every sort of adaption for 
myself” 
(M, 38, CESI, 7y4m, participant 7) 
 
4.5.2.3.2 Support 
Support in living with CES was said to come mainly from family members and 
partners and to a lesser extent from friends and work colleagues. Their informal 
caring support was described as more consistent and reliable than that received from 
the formal health service. Primarily, the patient’s partners played a significant role in 
caring for them in the short term after the operation including roles like wound care 
and mobilisation to longer term care with duties such as the housework and helping 
the patient to do exercise.  
 
There was a lack of experience of support groups amongst CES patients. One CES 
patient was not encouraged reading online groups as she felt it was more “getting it 
off your chest” than support. Other patients found it useful because they realised how 
lucky they were to not have the severe CES symptoms. There is a consensus 
amongst CES patients that other people (e.g. family and friends) would not 
understand the condition as they had not gone through their experience themselves. 
There were some instances where work colleagues and managers were supportive of 
the patient returning to the workplace and where the council had provided support in 
the form of mobilisation aids in the house like a stair lift, railings and wet room for 
the shower. 
 
“It pees me off that I can’t do loads of things and I'm lucky, my husband… does all 
the washing, he does all the cooking, he does all the cleaning, my son helps him and 
I'm just lucky that I've got that… I work in an office where the staff have been very 
supportive” 
(F, 46, CESR, 2y6m, participant 11) 
 
4.5.2.3.3 Time-frame for recovery 
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Generally, participants described that if there was any recovery with their bladder or 
bowel function it had occurred by 2 to 3 months after the operation and patients were 
disappointed when this did not occur as they were expecting. Back and leg pain were 
the most obvious features to patients hence when this is resolved after the operation 
it was a great relief to them. 
 
“When I went in I was in severe leg and lower back pain, I came out feeling like 
somebody had turned the switch to off. No pain… absolutely amazing” 
(M, 47, CESR, 4m, participant 14) 
 
There was interest and determination amongst many patients to pursue exercise but 
they had anxiety over the long-term effects. Those who are reassured try to do core 
building exercises like Pilates, swimming and walking. The activity of running was 
less preferred limited by back pain or anxiety that the disc may “pop out.” Few CESI 
patients had been able to return to their baseline allowing for their previous more 
physically demanding activities such as fell walking and skiing. 
 
4.5.2.4 Theme 4: Anticipatory anxiety and reduced self-worth 
 
4.5.2.4.1 Anxiety 
A substantial proportion of CES patients reported being worried about their 
prognosis, their physical health and their future employment. They attributed this to 
not being clear on the cause of their condition, what to do after the operation, 
including what physical activity was safe. The scale of the change in their life 
circumstances over what was often a short period of time was said by participants to 
make them be particularly cautious about jeopardising their health any further by 
engaging in activities that might be risky for them. Uncertainty over a range of 
activities from simple daily activities like walking, bending over and lifting items to 
exercise like running, swimming and martial arts was described.  
 
“the difficulty is you’re not clear on the steps of progression. What should you be 
lifting, what should you be doing, how much movement, how long should you stay in 
bed for, what should you be getting up and down for… unfortunately you do your 
own reading don’t you, you ‘Google’ it and then you see what’s out there and you 
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think oh my goodness me, you know and you start to worry that’s where you’re 
going to end up”  
(F, 31, CESI, 8y4m, participant 8) 
 
“It just worries me as I get older am I going to end up in a wheelchair because I’m 
in that much pain … and I’m thinking job wise how long have I got left in this job?” 
(F, 42, CESR, 7y2m, participant 19) 
 
“The back will never be 100% and I understand the back and I sort of protect it now 
it’s like a piece of glass and it’s got a few cracks in it so I don’t want to shatter it” 
(M, 38, CESI, 7y4m, participant 7) 
 
“I’m very grateful that I can walk and I have the sensations back but I feel a little bit 
like a time bomb that another part of the disc could go at any point” 
(F, 31, CESI, 8y4m, participant 8) 
 
The process from a definitive investigation like MRI, transfer for an operation to 
discharge is usually very quick within a few days. In this short space of time patients 
do not adjust to these major life events. This change in life circumstances is not 
addressed at follow up and patients sometimes relive the events in a negative 
manner. The deterioration and intervention were so acute, many patients were 
concerned this may happen again, which contributed towards their anxiety. 
 
“As soon as I came out of hospital I started having like night sweats… I’d wake up 
thinking about hospitals like a trauma really… the actual impact of the surgery and 
with Cauda Equina it’s very quick as well you don’t have much time to process it… I 
think your body and mind can experience it like a trauma because it’s all happening 
so quickly… and then I developed intrusive thoughts” 
(F, 36, CESR, 7y3m, participant 20) 
 
4.5.2.4.2 Isolation 
Isolation was described by many CES patients. This was partly attributed to the lack 
of effective and regular support groups mentioned previously. They experience a 
dismissive attitude and lack of follow up from healthcare professionals. Autonomic 
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dysfunction had contributed to the feeling of embarrassment with having “accidents” 
in public places. This has led to agoraphobia in a few CESR patients. Also, the 
physical difficulty of having sex added to the distance in some relationships and 
some ending. CES affects relatively young adults and there is sometimes a feeling of 
embarrassment, for example, one CESR patient was embarrassed with having “aids” 
for mobilisation around the house and going for rectal irrigation as family members 
and friends are aware of her activities.  
 
“I just felt like I didn’t want to go out, I didn’t want to see people, I didn’t want 
people to see me and then before I knew it, agoraphobia was kind of coming on…. I 
would get thoughts like with panic disorder you know like oh God what if I have a 
panic attack, what if I lose control” 
(F, 36, CESR, 7y3m, participant 20) 
 
“I would say from a sort of an emotional level you feel quite lonely because you 
don’t go to see anybody and you don’t have any sort of follow up for quite some 
time… I think if you were providing support for patients, some level of physiotherapy 
advice would be good and possibly access to some counselling would be good … 
where people can talk about where they’re at and what sort of barriers that they’re 
hitting” 
(F, 31, CESI, 8y4m, participant 8) 
 
“I don’t think people should be left alone with the emotional impact… the operation 
is over and then you go home and you're signed off and that’s it, you're just left with 
it” 
(F, 57, CESI, 2y6m, participant 5) 
 
4.5.2.4.3 Low mood and attempted suicide  
Low mood, and to a lesser extent suicidal ideation, was reported by participants. 
They attributed it as being brought about by the symptoms of back and leg pain. 
They said they had struggled to cope at work due to the pain and reduced mobility 
and some had their jobs terminated prematurely. Associated with the loss of a job 
was the lack of having a routine or being occupied. Some patients also described not 
being able to come terms with their situation or the time that their condition required 
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of them to manage. Two participants reported that psychological distress culminated 
in them attempting suicide as they were dealing with the consequences of CES and 
significant personal events at the same time.  
 
“What put me in this place of isolation and depression because it is suddenly so 
much activity to nothing at all and it has just been very difficult to accept”  
(F, 57, CESI, 2y6m, participant 5) 
 
“I was drinking and I just sat on the bed crying because I was in so much pain and 
in the end, I just took all the tablets (attempted suicide)”  
(F, 46, CESR, 9y3m, participant 17) 
 
“I would say, once your continence starts to be impinged and your pain reaches that 
level then I would say it’s probably time to say goodbye and try and get some 
peace… and I think pain does get to a point where you know it’s just too much”  
(M, 49, CESI, 6y2m, participant 2) 
 
4.5.2.4.4 Reasoning and Awareness 
CESI participants are aware of the range of unfavourable outcomes that they may 
have experienced could have been more severe and are grateful they did not. This 
led to some participants minimising their residual neurological symptoms with the 
acknowledgement that other patients have fared worse than them.  
 
“Compared to what some people go through in their lives being stuck in wheelchairs 
and things I really have nothing to complain about so to me, it is what it is.”  
(M, 32, CESR, 3y11m, participant 21) 
 
“The residual nerve damage is always there and the way I look at it it’s a small price 
to pay for what I believe other people have suffered a lot worse than what I have.”  
(M, 50, CESI, 1y6m, participant 22) 
 
Generally, patients who knew they had CES had a good understanding of the 
condition after their acute event but realise there is no public awareness regarding 
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the condition. Conversely, a few CES patients were unaware of their diagnosis until 




4.6.1 Main Findings 
This is the first qualitative study to identify what outcome domains are of 
importance to CES patients and explored their lived experience of the condition 
before and after diagnosis considering the severity of their condition (CESI and 
CESR). There are two CES qualitative studies in the literature that had reported on 
interviews with all CESI patients
158
 or the severity of the condition was not 
categorised.
157
 Our study allowed insight into whether there was a difference in the 
experiences and outcome prioritisation amongst the different severities of CES. 
However, there are some similarities from these other CES qualitative studies that 
support our study findings, which will be mentioned further in the discussion of our 





In total, 260 verbatim outcome terms were identified. There were 43 verbatim 
outcome terms not identified by the systematic literature review. The verbatim 
outcome terms identified by the qualitative interviews related more to life impact 
outcomes rather than physiological outcomes, which has dominated the literature.
135
  
Having identified these domains meant that patient centred outcomes were added to 
the comprehensive long list of outcomes for consideration in the list for the Delphi 
survey.  
 
The study has also offered more insights than just identification of important 
outcomes. By giving a chronology of events regarding the participant’s own 
experience with CES, the difficulties and issues involved in the acute and follow up 
management of these patients and their mental and physical wellbeing were 
recorded. Participant’s experiences of living with CES and its consequences were 
captured by 4 main data themes; 1) Varying priorities of physical health, 2) A 
fragmented healthcare service 3) The process of adjustment, and 4) Anticipatory 
anxiety and diminished sense of self-worth.  
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In the introduction, it was mentioned that there had been significant qualitative 
research regarding the lived experience of SCI. However, having the symptoms of 







 It has been necessary therefore to consider qualitative evidence from 
the conduct of studies for the wider SCI patient category.  The relevance of findings 
from these studies in relation to our own will be explored within the relevant 
themes.
168
 Four areas of function were seen to be the most important amongst SCI 
individuals: bladder, bowel, sexual and motor function (including arm/hand function 
and walking).
168
 A CES qualitative study found difficulty passing urine, frequency 
passing urine, change in stream, loss of sensation passing urine, constipation and leg 
weakness causing difficulty walking were common symptoms.
157
 The issues with 
having a hidden disability was highlighted in The Care Quality Commission’s 
“Invisible Conditions” campaign in the UK.
191
 Below the themes are explored and 
the domain summaries constituting towards the theme are mentioned within the 
paragraphs.  
 
4.6.2 Varying priorities of physical health 
There are several instances in our study where CES patients were concerned with 
their identity especially with regards to autonomic dysfunction (e.g. bladder, bowel, 
sexual issues) or mobility and wanted to remain as normal as possible to the outside 
world, which conflicted with their need for other individuals to understand that they 
had a disability. It seems there were conflicting identities, which has been noticed in 
another qualitative CES study.
158
 
Bladder and bowel dysfunction were stated as the most concerning symptoms of 
CES in a qualitative study
158
 but they did not differentiate patients according to the 
severity of CES. In our study, different severities of CES were sampled and CESI 
patients prioritised bladder and bowel function as the most important but CESR 
patients prioritised pain and mobility. However, there was empathy from each group 
regarding why other outcomes may be important for other patients, which was 
described in the results. What is important also changes over time. For instance, 
initially the pain is agreed, by most patients regardless of severity, as overwhelming 
before the operation with numbness, foot drop, stiffness, and mobility becoming a 
concern after the operation. In our study, patients were keen to have a further 
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operation to manage continuing back and leg pain but a patient was hesitant when 
requiring a colostomy for permanent bowel issues. This supports the thinking that 
bowel and bladder issues are normalised over time whereas achieving normalisation 
of pain remains difficult. Although not overtly mentioned in the medical setting and 
literature
135 192
 it is evident from this study that sexual function is a silent issue 




Following SCI, individuals experience challenges including fatigue, increased 
workload, and prolonged reaction time.
196
 A scoping review of SCI found that 
fatigue was in the top 7 complications and worsened with increasing age.
169
 Fatigue 
had overwhelmed certain CES patients in this study disrupting their daily home or 
work routine, quality of life and social interaction. However, it has not been 
mentioned or reported previously in the CES literature.
135
  
Many negative effects can arise from the experience of pain. It has been seen 











 A CES qualitative study had found that pain was deemed the most important 
theme discussed by all participants using “dominated” and “all consuming” as key 
phrases.
157
 Many studies have found that healthcare practitioners are perceived as 
not taking a patient centred approach to pain control in general and were more 









 In our study, the inability of patients to detect or 
recognise autonomic dysfunction developing due to the pain was also noticed by 
another qualitative CES study.
157
 It suggests that relying on the patient’s history of 
these autonomic findings would be unreliable before the operation to make a 
diagnosis of CES as the back or leg pain would be preventing them from recognising 
this. Also from our study, we have seen how patients experienced little support after 
the diagnosis of CES and underwent a “trial and error” period of learning of how 
best to manage their pain. Pain has the effect of restricting mobility, causing postural 
difficulties, making it difficult to manage at work and leading to low mood and 
suicide in CES patients. This suggests how detrimental and limiting pain can be and 
highlights that it should be managed as a priority in CES. 
 
4.6.3 A fragmented healthcare service 
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Patients in this study felt healthcare professionals in primary care and A&E did not 
take their concerns seriously enough. CES is a known rare condition and may only 
be seen once in the lifetime of a GP.
10
 This could be ascribed to CES being clinically 
difficult to differentiate from the more common lower back pain or leg pain, which 
is due to degenerative pathology that does not require immediate intervention. 
Similarly, low exposure to patients with SCI has been seen to impede health 





Research in other health conditions such as chronic fatigue and pain has revealed 
that when symptoms are not visible or hard to prove they can be disbelieved by 
others leading to patient distress and anger.
205
 In a qualitative study, CES patients 
felt 2 things were particularly important a) clinician’s knowledge of the condition 
and b) communication about it.
157
 There is also a lack of understanding of the red 
flag signs felt amongst CES participants 
157
 and also there was a lack of listening 
from healthcare professionals which was viewed as a barrier to effective 
communication. In addition, the language used was in vague clinical terms like 
“changes in bladder function” as opposed to using more explicit terms like “I weed 
myself.”
157
 In our study, the communication from healthcare professionals was also 
criticised by some as not being clear enough regarding the “red flag” signs of CES. 
In another CES qualitative study 
158
 patients also report the feeling of being 
disbelieved when they were presenting to professionals with worsening symptoms. 
Also, the aftercare was felt to be non-existent. There was a strong sense of injustice 
expressed by the participants, with a nearly half the sample wishing to pursue a 
claim.
158
 This general dis-satisfaction with the management of CES is also seen in 
our study with CES patients having a delayed diagnosis and unsatisfactory aftercare.  
 
A study that analysed 52 CES related websites and found the quality of information 
to be poor and they had a low readability level.
206
 This reinforces that issue that 
patients find these sites not as accessible and useful as they are intended to be, which 
adds to the lack of understandable CES specific information available to them. The 
short follow up and discharge for CES patients in our study explains why patients 
rely on close family and friends network they are comfortable with for support. A 
study investigating services following SCI found that to improve the independence 
and quality of care and life for patients with SCI more responsive and individualised 
care is needed in the hospital, rehabilitation, and community settings.
207
 It is clear 
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from this there needs to be a similar holistic service for CES patients in the 
healthcare system, which focuses on long term care and management rather than the 
current emphasis, which is acute management and discharge.  
 
4.6.4 The process of adjustment 
Patients with traumatic SCI have found that involving themselves in meaningful 
occupations and roles outside the home increases their quality of life.
208
 




 and returning to work can range from 11.5% to 74% internationally.
210
  
Although there is a lack of evidence regarding employment in CES, the impression 
from CES patients in our qualitative study is that when the condition is more severe 
then employment opportunities decrease. Actively contributing as a member of 
society is valued highly for most disabled people 
211
 and there is strong evidence to 






 CES patients in 
our study were satisfied when they returned to work with the necessary adaptations 
being made with their pre-injury employer and this has also been seen in SCI 
patients to be the most successful route back to employment.
215
 The process of 
adjustment to a meaningful routine can be seen to be much longer or unresolved for 
those CES patients who were unable to return to work. The current social care 
system does not reward patients who want to try and go back to work as they could 
potentially lose their entitlement benefit. This system needs to be improved to 
encourage these young working age CES patients back into sustainable employment. 
 
In our study, the interest to pursue exercise for CES patients is tempered by the lack 
of knowledge as to what is acceptable. It should be made clear in the follow up that 
for CES patients moderate exercise is beneficial for their health and a formal 
programme may be beneficial. SCI patients identified that time in rehabilitation and 
physical therapy was critical for their current level of exercise commitment whereas 
several participants that did not exercise mentioned a lack of support/ 
recommendation to exercise post injury.
216
 In a qualitative study of 24 
neurologically disabled patients many acknowledged the importance of setting goals 
for progression with rehabilitation and recognising their own improvements as a 
source of encouragement and hope.
217
 Many patients adopt a recovery model and 




 This can be an issue when the patient achieves a plateau of neurological 
recovery and rehabilitation fails to return the patient to the expected pre-morbid 
status.
219
 This lack of guidance and goal setting is evident in CES where patients 
have expected recovery to normal and become very disappointed when they do not 
reach this. There needs to be realistic goal setting in the aftercare for CES patients 
depending on the severity of their condition.  
 
4.6.5 Anticipatory anxiety and reduced self-worth 
Physical health can be severely affected in CES but it is appreciated in the literature 




 A study 
had shown anxiety and fear developing as CES was progressing initially and the 
realisation it was different to previous episodes of back pain.
157
 Suicidal ideation 
was also evident in a CES qualitative study to deal with their pain and associated 
consequences.
157
 In the other CES qualitative study most patients mentioned feeling 
that CES came as a sudden shock in life and they felt hopeless about the situation to 
the extent they felt suicidal.
158
 
For CESI patients in our study, minimising the importance of their symptoms was a 
coping mechanism to help continue with their daily routine. A few patients were not 
aware they even had CES until the participant invitation letter came through their 
door. There may be a tendency to not mention the word CES amongst healthcare 
professionals and to explain the condition in an indirect manner leaving the patient 
to believe that they were unlucky with a slipped disc without understanding the 
underlying reason. This reflected a lack of communication between the healthcare 
professionals and patients regarding the diagnosis.  
A CES patient in our study was advised against a natural birth as she had spinal 
surgery. This might reflect how other specialists might contribute to the anxiety 
experienced by CES patients with misinformation. The uncertainty of healthcare 
professionals was seen to be related to poor scientific literature and in these 




Feelings of low mood, suicidal ideation, isolation and anxiety have been explored in 
detail in this study. Addressing the contributory factors to this include a lack of 
adequate guidance, follow up, support services and appropriate pain management as 
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well as the use of a psychiatrist could help resolve the mental issues patients 
experience.  
 
In another qualitative CES study there was the general expectation by CES 
participants that the symptoms would be resolved by surgery and a common lack of 
awareness that the condition could be life changing with permanent consequences.
157
 
This is also reflected in SCI where lack of knowledge regarding SCI was the 
underlying reason for confusion, low resilience, psychological distress, sexual 




 Improving the 
perception of health and providing information on health care procedures in SCI 





 In a similar manner, improving knowledge and understanding of CES 
patients and setting realistic goals, as mentioned before, could lead to improved 
outcomes and re-integration with the wider society.  
 
4.6.6 Reflecting on the qualitative approach 
Using the qualitative approach to investigate outcomes of CES patients has been 
beneficial in many ways. Foregrounding participants’ personal perceptions of their 
experiences developed a person-centred understanding of what living a life with 
CES means. Findings from this qualitative study suggests the desired ideal 
management of CES is more than symptom control. It has addressed the support 
needs of CES patients during and after acute management of the condition. 
Exploring the experiences of living with CES has provided evidence to challenge the 
wisdom of managing CES as an acute condition only. It highlights the need for 
health professionals to address long term issues that are present in a holistic 
multidisciplinary manner. Patient-centred outcomes have been identified for 
inclusion in the next phase of the project, which will enable the development of a 
balanced modified Delphi survey. The suggestions enable healthcare professionals 
and patients to work together to create an appropriate CES service provision. 
 
4.6.7 Strengths and weaknesses of the methodology 
A sampling frame was created and used as opposed to convenience or snowball 
sampling. It reduced the likelihood of recruiting only patients with a severe clinical 
picture and poor outcomes who may be more forthcoming and/ or more readily 
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accessible from clinics. Recruitment into this study was from medical records and 
not from survey samples. Sometimes patients do not remember the details of their 
admission, clinical features, and timing to surgery if survey samples were used. 
Being a tertiary neurosurgical centre with a catchment population of 3.5 million was 
deemed to be more representative of the UK population rather than a local 
orthopaedic department in a district general hospital that would also perform such 
procedures. 
The exclusion criteria for the interviews was only patients who were unable to 
consent. Adults with terminal illnesses and psychological disturbance were not 
excluded as to investigate each patient record in depth was not practical. In 
hindsight, if such patients were encountered the interview would not have 
commenced but in this study no patients were encountered with these issues.  
 
4.6.8 Impact of patient involvement in qualitative research 
It was beneficial to involve patient research partners (PRPs) in the study design. 
PRPs had reviewed the initial protocol. Due to their suggestions, we changed the 
scope of the study from just patients who had a one operation for CES to include all 
patients with CES even if they had recurrent operations to ensure patients with a 
more complex history and long term outcomes were involved in the study. In 
addition, the initial plan to conduct the interviews in a clinic at hospital was 
extended to interviewing patients at home, at work and over social media after PRP 
suggestions. Interviews at home were the most common method allowing 
involvement of patients with travel/ mobility restrictions and it was less intimidating 
for patients. The patient information leaflets were revised by them to use simpler 
language and to highlight that we were developing the “core” outcomes to help 
future research.  
Mock qualitative interviews were performed on the PRPs. Due to their suggestions, 
the topic guide was altered in terms of how to ask the question of outcomes without 
using the term “outcome.” Also, the question of impact on patient’s lifestyle, family/ 
friends and how to improve the current service was also added. 
 
4.6.9 Conclusion 
CES has always been managed as an acute condition in the healthcare system to 
minimise risk of permanent neurological injury. Through the qualitative interviews 
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 However, hospital and community services are not equipped to deal with the 
longer term medical and psychological consequences of this condition. Patients tend 
to find their own solution without access to the appropriate services. Not only does 
this confirm the need to develop a core outcome set for CES to aid future research 
but also highlights the need for a more holistic service for CES to appropriately 
manage the longer-term effects. This would involve more constructive structured 
interaction with physiotherapists, psychologists, relevant medical/ surgical 
specialties and other CES patients through support networks. 
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Chapter 5: Cauda equina syndrome core 
outcome set: the consensus process  
 
5.1 INTRODUCTION 
Currently there is no defined core outcome set (COS) for patients who have 
undergone surgery for cauda equina syndrome (CES). It is an emergency spinal 
condition that requires acute intervention.
53
 We intend to develop a COS to identify 
the outcomes for patients who have CES for use in research studies. A COS is “an 
agreed, standardised collection of outcomes that should be measured and reported, as 
a minimum, in all trials for a specific clinical area.”
35
 The development of a COS 
uses consensus methods such as iterative Delphi surveys and consensus meetings 
and involves major stakeholders in the disease process like patients, carers, 
clinicians, and allied healthcare professionals.
33
 This process prioritises the 
outcomes included, which are relevant and agreed by all key stakeholders to finally 
decide a “core” set of outcomes. There may be many studies looking at a particular 
condition but there will only be a few studies who would have measured outcomes 
in common. In some cases, there will only be one or two consistent outcomes across 
studies.
35
 The concept of a COS was developed in order to standardise outcomes 





A clinical outcome describes an event that occurs because of disease or treatment,
228
 
which is related to the patient’s symptoms, the overall mental state or how the 
patient functions. The Outcomes Measures in Rheumatoid Arthritis Clinical Trials 
group (OMERACT) describes an outcome as “any identified result in a (sub)domain 
arising from exposure to a causal factor or a health intervention.”
229
 A primary or 
secondary outcome can be included in the COS. A literature review of the 227 
published core outcome sets in 2013 revealed that 83 (37%) considered the “what” 




 We intend to focus on “what” outcomes should 
be included in the CESCOS. 
 
The benefits of a COS include: 
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1) Patients are included so important outcomes to them are measured.  
2) A consistent approach will make individual studies easier to interpret and put into 
the context of other studies. 
3) Allows synthesis of data into a systematic review or meta-analysis.
47
  
4) Reduces research waste and inefficiency. It is reported that 85% of research 
funding is wasted across the research cycle with key sources related to outcomes; 
important outcomes are not assessed, published research fails to set its position when 





5.1.1 Including patients in core outcome set development  
There are examples where patients may prioritise different outcomes to HCPs, 
35 45 49
 
have identified outcomes important to them
50
 that researchers have previously not 
paid attention to 
231
 or where researchers have seen as being of little importance.
40
. If 
patients do not have their say in the development of a COS it is likely that outcomes 
will be missed that are important to them and then research studies will fail to give 
definitive information about whether treatments benefit patients or not.
61
 INVOLVE 
is the national UK advisory group encouraging public involvement in the NHS and 
involving patients and public in discussions regarding clinical trials as “they are the 




By including patients at the OMERACT 6 meeting in 2002, fatigue emerged as a 
major outcome in rheumatoid arthritis, and it was agreed to be included in the 
COS.
231
 In the Moment study,
233
 hearing was identified as an important outcome. 
The outcomes regarding hearing differed amongst parents to preschool children (0-
4yr olds) concerned about speech and language, parents of primary school children 
(5-7 yr olds) who were concerned about social interaction and parents of older 
primary school children (8-11 yr olds) who were concerned regarding educational 
performance. This highlights the importance of having a range within the sample for 
qualitative studies
68
 when deciding the COS. In the PARTNERS2 study when 
discussing physical health outcomes with bipolar and schizophrenia patients, broad 
areas were identified like weight gain and reduced physical activity but HCPs 
mentioned specific clinical outcomes like diabetes or blood pressure. Another 
example were social outcomes like being able to participate in a work environment, 
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HCPs identified ability to work as important whereas patients chose subtly different 





5.1.2 The background to core outcome set development  
OMERACT is an international collaboration developed in the early 1990s involving 
patients in the development of core outcome sets and has improved consistency of 










 This shows that core 
outcomes sets have the potential to standardise and improve methodology used in 
clinical trials and the evidence base for healthcare decision making. Likewise, the 
Core Outcomes in Women’s Health (CROWN) initiative is an international group 




The Core Outcome Measures in Effectiveness Trials (COMET) initiative advocates 
the involvement of patients and currently holds a database of on-going core outcome 
set developers
32





The coordinating editors of the Cochrane Review Groups (CRGs) were surveyed 
about issues related to the standardisation of outcomes in their CRGs.
227
 Most of the 
editors (45 of 50) replied revealing that 31% had been involved in the development 
of a COS and 36% were aware of other work to develop a COS for conditions 
relevant to their CRG. Core outcome sets are developed in several clinical areas and 
their use is advocated by the National Institute for Health Research (NIHR) Health 
Technology Assessment (HTA), Cochrane Reviews of the effects of Healthcare 
intervention, the European Medicines Agency, and the UK National Institute for 
Health and Care Excellence.
33 35 55 236
 
 
In the guidance notes for completing full proposals the NIHR HTA mentions the 
following ‘Details should include justification of the use of outcome measures where 
a legitimate choice exists between alternatives. Where established core outcomes 
exist, they should be included amongst the list of outcomes unless there is good 
reason to do otherwise. Please see The COMET Initiative website
32
 to identify 
whether core outcomes have been established. The World Health Organisation 
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(WHO) recognises that “choosing the most important outcome is critical to 
producing a useful guideline.” In the SPIRIT (Standard Protocol Items: 
Recommendations for Interventional Trials) guidance regarding the reporting of 
protocols in clinical trials have mentioned that “the development and adoption of a 
common set of key trial outcomes within a specialty can help to deter selective 
reporting of outcomes and to facilitate comparisons and pooling of results across 
trials in a meta-analysis.”
237
 The International Consortium for Health Outcomes 
Measurement 
238
 organises teams of physician leaders, outcomes researchers and 
patient advocates to define core sets of outcomes per medical condition for use in 
routine clinical practice as opposed to clinical trials.   
 
5.1.3 Reaching consensus 
The main approaches used to achieve consensus include 
47










 When there is contradictory information on a topic, a 
consensus-based method such as the Delphi method is appropriate to determine the 
extent to which key stakeholders agree on the topic.  
 
A Delphi survey is the process of delivering a questionnaire iteratively in sequential 
rounds. This allows informed participants to change their responses after reviewing 
their own and the anonymised group responses from previous rounds. A consensus is 
achieved among all participants in an equal and unbiased manner reducing the effect 
of extreme personalities and power differentials between stakeholder groups.
47 61 243-
245
 An updated review in 2018 
246
 showed that 85% of COS projects on the COMET 
database used a Delphi survey.  
 
5.1.4 The CESCOS consensus process 
This is the thesis chapter for the Delphi survey and the consensus meeting that were 
undertaken to achieve consensus regarding what outcomes to include in the 
CESCOS. This chapter is reported in accordance with the Core Outcome Set-
STAndards for Reporting (COS-STAR).
247
 Systematic literature review and 
qualitative interviews have been done to develop a long list of outcomes. These 
outcomes will be prioritised through two rounds of a Delphi process with key 
stakeholders. A consensus meeting will be held to review the outcomes included for 
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the COS. Decisions and explanations regarding the choice of methodology will be 





An overview of the Cauda Equina Syndrome Core Outcome Set (CESCOS) project 
is provided in Figure 5.1  REC and HRA approval was obtained on March 2018 for 
the Delphi process and consensus meeting by North West-Greater Manchester 
Central Research Ethics Committee (REC reference 18/NW/0022). 
 




The COS-STAD (Core Outcome Set STAndards for Development) recommended 
the minimum standards for the development of a COS.
248
 This had international 
input from key stakeholders such as patient representatives, COS developers, journal 
editors, and trialists through a consensus process. The 11 recommendations and how 


























1 The research or practice setting in which the COS is 
to be applied 
Research studies that will inform clinical decision making 
2 The health condition(s) covered by the COS All severities of Cauda Equina Syndrome 
3 The population(s) covered by the COS Human adults aged 18 or above 
4 The intervention(s) covered by the COS Clinical management of CES including surgery 
Stakeholders  
involved 
5 Those who will use the COS in research Clinical trialists in CES are the healthcare professionals who 
manage CES patients. They are included in standard 6. 
6 Healthcare professionals with experience of patients 
with the condition 
This will include clinicians and allied healthcare professionals 
involved in CES management 





8 The initial list of outcomes considered both 
healthcare professionals and patients views 
Systematic literature review 
135
 considered healthcare professional 
views. Qualitative interviews considered patient views. 
9 A scoring process and consensus definition were 
described a priori  
Described in section 5.2.10 and 5.2.11 of this chapter 
10 Criteria for including/dropping/adding outcomes 
were described a priori 
Described in the 5.2.11 section of this chapter 
11 Care was taken to avoid ambiguity of language used 
in the list of outcomes 
Plain language and clinical explanations available. These will be 
pilot tested with patients and healthcare professionals.  
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5.2.2 “Long to short” list of outcomes 
The use of systematic reviews and qualitative studies to inform COS development 
has been used in the development of many other core outcome sets.
41
 
38 42 183 246 249 250
 
Patient participants can meaningfully take part in COS development without needing 
a detailed understanding of what an outcome is or the reasons why a COS is 
needed.
251
 However, qualitative methods for capturing patient outcomes before the 
Delphi survey were beneficial for highlighting the complexity of the patient 
perspective, the language patients used to describe the outcomes and understanding 
the prioritisation of some outcomes.
61 144
 Information sourced from qualitative 





A systematic review 
135
 identified all the verbatim outcome terms documented by 
studies since 1990 involving more than 5 participants who had undergone surgery 
for CES. The verbatim outcome terms from the systematic literature review were 
combined with those identified from the qualitative interviews. This created a “long 
list” of verbatim outcome terms, which were then reduced to a “short list” of 
outcomes to be rated in the Delphi survey.  The plain language and clinical 
explanations of each outcome and the process of “long list” to “short list” was 
reviewed by the study team including patient research partners for face validity, 
understanding and acceptability and modified according to feedback.  
 
During coding of the qualitative interviews, the transcripts were listened to, 
transcribed and the text regarding certain outcomes were tagged using the NVivo   
 90 
software version 10. Then an inductive approach was taken to develop the initial list 
of outcomes from the body of the interview transcripts. A qualitative supervisor 
(AN) analysed 5 transcripts of the qualitative interviews, coding by hand. The 
outcomes were documented in the 5 transcripts separately by the supervisor (AN) 
and the interviewer (NS).  When compared, most outcomes were reflected by the 
initial coding framework of both researchers. The terminology may have been 
slightly different for some of the coding but an agreement was reached between NS 
and AN. As the remaining transcripts were coded, further outcomes were identified. 
These were verified with AN and the clinical supervisors MW, SC and TM who 
agreed on the outcomes and terminology chosen. Concerns had been raised about 




The taxonomy used 
72
 was the same as that used for the systematic literature review. 
This is to ensure consistency with previous work but also allows future comparison 
with other COS developers where the use of this taxonomy is being advocated. This 
is being piloted for use in Cochrane Reviews within the Cochrane Linked Data 
Project. 
 
The language used by patients in the qualitative interviews (REC reference no: 
16/SC/0587) was used to help term the outcomes for the Delphi. Plain language 
summaries by the COMET Patient Participation, Involvement and Engagement 
(PoPPIE) group 
253
 was used to develop the HCP and Patient Delphi information 
sheet (Appendix 5.1 & 5.2). 
 
5.2.3 The Delphi Methods 
A systematic review which investigated different consensus techniques used for 
designing clinical guidelines 
254
 highlighted the different methodological decisions 
to be taken including size and composition of the panel, methodology of the Delphi 
process, and the way in which the results are presented between rounds and at the 
consensus meeting. The best way to develop a COS is not known and there is 
research being undertaken in this area.
33 60
  
Due to the anonymity of participants, the structured flow with feedback, reduced 
chance of a group or individual being overly influential 
47
 and face-to-face 
consensus meeting at the end, it was felt the Delphi process would offer the most 
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transparent and unbiased method to achieve a consensus. Previously, in paediatric 
asthma, consensus work has been undertaken in two different ways. One group 
adopted an expert panel approach,
45
 whereas another group combined results from 
clinicians and interviews with parents and children via a Delphi survey. This 




To achieve a priority list, we used the “modified” Delphi method 
48
 as opposed to 
the “traditional” Delphi method.
255
 The “traditional” Delphi was developed in the 
1950s by the Research and Development (RAND) co-operation to find out the 
impact of technology in warfare.
256
 Traditionally in a Delphi survey, participants are 
asked open questions in the first round of the Delphi to avoid being biased to 
outcomes already mentioned.
255
 Open questions in the first round of the Delphi have 
been asked to prevent participants being guided by facilitators or steering 
committees.
244
 However, if there is a skewed group initially this could enter bias 
when the outcomes are rated. As a result, for the CESCOS study eliciting patient 
outcomes from a sampling frame of CES patients though qualitative interviews was 
believed to introduce less risk of bias. In addition, there was the option to suggest 
additional outcomes in round one if a participant felt these were not covered, which 
was then considered by the research team. The level of anonymity was “fully 
anonymised”
244
 so participants did not know the identities of other individuals in the 
group and they did not know specific answers other individuals had given.  
 
There must be a minimum of two rounds to be considered a Delphi survey as it must 
have at least one round of feedback.
33
 COS studies have undertaken two rounds
40 42 
257 258
 or three rounds 
233 259 260
 in many cases. After the first round an anonymous 
summary of the responses were fed back to the group. In our “modified” Delphi, 
questioning took place in two rounds. The benefits of having another round such as 
more time for participant reflection and gaining a greater consensus was weighed 
against the disadvantages. The disadvantages would be increased time burden for the 
participants and possibly an increased attrition rate.  The rounds would have been 
kept open for longer than 2 to 3 weeks if response rates are low and to minimise the 
potential of attrition bias
33
. The setup and running of the Delphi including the 





5.2.4 Participants and Inclusion Criteria 
Stakeholders can include patients, carers, patient representatives and patient 
advocates as well as HCPs, and decision makers including funders, researchers, 
statisticians, health economists, and pharmaceutical company representatives.
32 55
 
Patients and HCPs are considered the most important participants in the 
development of a COS.
244
 Delphi participants also need to have the required 
expertise to prioritise items. Other methodologists, regulators and industry 
representatives may be more useful during the stage of “how” to measure an 
outcome or implementation of the COS.
262
 When working in vulnerable groups there 
is the concern that carers can “drown” out the perspectives of patients
61
. During the 
qualitative interviews with CES patients they had mentioned it is hard to fully 
understand what a patient experiences in this condition if they are not a patient with 
CES themselves. For this reason, carers, family members and partners were not to be 
considered as a stakeholder group. Participants for the CESCOS study were 
recruited from two key stakeholder groups: patients and healthcare professionals 
(HCPs). All participants were adults over 18 years of age and able to complete an 
online questionnaire in the English language. 
 
Patients- Participants who have a diagnosis of CES. As patients were recruited from 
a variety of sources it is not possible to separate patients into those that had 
presented with different severities of CES (CESI and CESR) as the clinical details 
could not be collected accurately. 
 
Healthcare Professionals- All members of the clinical team involved in directly 
caring for a patient with CES after presentation. For example, this would include 
members of the spinal MDT: Spinal surgeons, Spinal specialist nurses, Neuro-
rehabilitation doctors and Neurologists. 
 
5.2.5 Sampling and Recruitment 
 
5.2.5.1 Patients 
At the main site (The Walton Centre NHS Foundation trust, Liverpool, UK) the 
clinical care team have a pre-existing database of CES patients they have clinically 
managed. The clinical care team sent invitation letters to the home address of these 
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patients. There was no follow up calls or further correspondence. It was the patient’s 
decision if they wish to be involved and the invitation will contain details of the 
website address patients can access if they wish to find out more details regarding 
the study. This offered a convenient route for personalised invitation of patients, 
which may have improved recruitment. However, the population would have been 
limited to the catchment area of the tertiary centre. To widen the population 
recruited, online patient groups for CES were contacted internationally. A named 
contact for each group acted as the liaison member to circulate the participant 
invitation email and poster. This included the patient groups sharing the recruitment 
details on social media (e.g. Twitter, Facebook etc).  
 
5.2.5.2 Healthcare Professionals 
The main study site has spinal MDT (multi-disciplinary team) meetings held weekly. 
The coordinator has a pre-set mailing list that goes to HCPs involved in the meeting. 
This was used to send the participant invitation email. The membership of national 
and international associations were contacted and invited to participate. They include 
different HCPs in their membership categories. Some examples are listed below: 
Society of British Neurological Surgeons  
Canadian Spine Society  
World Federation of Neuro-rehabilitation 
Spinal Injuries Association 
Snowballing sampling 
263
 was used to increase the sample size. Known contacts of 
the CES study group were contacted and invited to participate. This has been done in 





The participant invitation email/ letter was the first contact for HCPs and patients, 
which is a short introduction and summary of the study. If they were further 
interested, the participant could proceed to the registration website for further details 
and obtain a copy of the participant information leaflet. This study website described 
the background for the COS development and the requirements for being included in 
the Delphi (http://bit.ly/cesdelphi). The importance of completing all rounds of the 
Delphi process was stressed at this stage to try and minimise inter-round attrition. 
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The participant’s invitation letter was developed using the help of the plain language 
summaries for patients and carers regarding the COS and Delphi survey, which were 




5.2.6 Sample Size 
There are no strict recommendations for the number of participants required in a 
Delphi study to gain consensus 
244
 and no agreed method to statistically calculate a 





12 has been suggested as the minimum number of participants in each stakeholder 
group for an effect to be noticed.
267 268
 There are also studies that show these factors 
could influence what outcomes are rated as important.
269 270
 In general, having more 




When trying to develop a COS for pediatric asthma only 13 out of 118 (11%) 
responses were received from the patient charity organisation, Asthma UK.
40
 A 
similar number of patients were expected to participate from CES charities with one 
organisation (https://www.ihavecaudaequina.com) having a membership list of 
approximately 600. In developing a core outcome domain for non-specific low back 
pain, 280 key stakeholders were invited to participate in the Delphi and the response 
rates over their three rounds of Delphi were 52, 50 and 45%.
240
 Considering this, a 
50% response rate was expected from the key stakeholders in the CESCOS Delphi. 
 
A pragmatic approach was taken for sample size and all individuals who met the 
inclusion criteria as identified above, were invited. No further participants were 
invited after the first round of the Delphi. Documentation of the number from each 
stakeholder group who participated were recorded. 
 
5.2.7 Consent 
Consent was implicit by the participant registering their name and email address to 
take part in the Delphi process via the website. This is in line with National Research 
Ethics (NRES) guidance page 8: “'Studies with little or no intervention and less than 
minimal risk are likely to need a much shorter information sheet and you will not 
need to complete all sections (for example the explanation of a questionnaire study 
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may be summarised on the front of the questionnaire itself and completion of the 
questionnaire regarded as consent).” 
 
5.2.8 The Delphi survey 
The survey was constructed and delivered in an online format using the 
DelphiManager software developed by the COMET initiative.
261
 Before starting the 
survey, the participant will be asked to clarify which of the two stakeholder groups 
they belong to. For each stakeholder group, specific clinical and demographic 
information was collected to allow transparency of population details required for 
the readers to independently assess the population and geographical scope of the 
Delphi. A list of these are provided on the Table 5.2 These details would allow 




Table 5. 2 Details requested from participants on the registration page of the 
Delphi survey 
Detail Patient Healthcare 
professional 
Name y y 
Age range y y 
Gender y y 
Country of residence y y 
County/ State or province y y 
Years since diagnosis of CES y n 
Surgery for CES y n 
Years since surgery for CES y n 
Employment status y y 
Full job title including grade and speciality n y 
Years of practice n y 
Interest in attending consensus meeting y y 
Interest in summary of findings y y 
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Following registration, participants could access the first round of the Delphi survey. 
Instructions of how to complete the survey were included at the beginning of each 
round.  
In a study to identify the outcomes for low back pain individuals not participating in 
one round were still subsequently invited to complete the following round.
240
 In the 
CESCOS study only participants who responded to the first round of the Delphi 
were invited to participate in the second round taking the assumption that if they had 
not participated in the first round they would be unwilling to participate in the 
second round. Data was collected over a 4-week period for each round of the Delphi 
process. Extension of the round being open was considered if the response rate 
needed to be improved with key stakeholders as mentioned before.  
 
Participants who did not complete the survey were sent reminders via email when 
they had 2 weeks, 1 week and 48 hours remaining for the completion of the survey. 
Participants who did not complete the questionnaire within 4 weeks of the start were 
deemed not to have completed that round of the Delphi. 
 
5.2.9 Cognitive Interviewing 
Pilot or testing work through cognitive or “think aloud” interviews to examine how 
stakeholders interpret the outcomes on the Delphi survey can help refine/ improve 
the outcomes 
271 272
 and focuses how a respondent decides to score an item.
273
 
Technical terms and jargon is advised against in questionnaires and surveys.
274
 
Piloting of Delphi studies for a COS in cancer surgery and otitis media has 




Cognitive interviews can be done in different ways. The main approaches are 
concurrent probing (questions asked during each item response), retrospective 
probing (questions asked after all item responses), and concurrent verbalisation 
(‘think aloud’ during each item response). Concurrent verbalisation was deemed the 
most appropriate for this study to allow the participants to complete the survey 
realistically. Following a method by Ericsson and Simon (1993),
275
 the participant 
was instructed to think aloud and their verbalisations were transcribed as a 
‘protocol’, which is analysed to gain insights into cognitive processes involved in the 
performance of problem-solving tasks. Ericsson and Simon (1993)
275
 said concurrent 
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verbalisation is better because it is less disruptive to the questionnaire completion. 
Concurrent probes may distort the situation and can potentially produce ‘local 
reactivity’ (where probes about an item encourage respondents to identify spurious 
problems with the item) and ‘extended reactivity’ (where probes about one item 
encourage respondents to identify spurious problems with other items; such as being 
over analytical).  
 
The participant was sufficiently instructed so they knew what was required. 
Therefore, as well as setting the context of wanting to test the questionnaire, the 
participant was informed there are no right and wrong answers and that their 
feedback was important.  
 
5.2.10 Scoring 
For an outcome to be included in the COS there must be a majority agreement of the 
critical importance of the outcome and minority agreement that the outcome is not 
important.
276
 This is in par with the GRADE (Grading of Recommendations 
Assessment, Development and Evaluation) Working Group recommendations.
277-279
  
A variety of different scoring systems have been used in COS studies to rate the 





others have used ranking of outcomes 
282 283




In round one of the Delphi study, participants were asked to rate each outcome using 
a 9-point Likert scale. This scoring system was chosen after previous studies and 
expert databases showed it differentiates the most between questionnaire items.
32 244
 
Critical importance is indicated by the values of 7, 8 or 9. Outcomes that are 
important but not critical would be rated 4, 5 or 6. Outcomes of limited importance 
would be rated 1, 2 or 3. An “Unable to score” category was included to allow some 
stakeholder group members who may not have the level of expertise to score certain 
outcomes.
33
 After the first round of the Delphi, subsequent rounds may retain all 
outcomes 
233 284 285
 or some items may be dropped 
42 257
 according to the pre-
specified criteria. The intention in this study is to retain all outcomes for voting in 
the second round with the first-round scores displayed for each item. This is because 
our outcome list for the Delphi was not large so would not be a time burden for 
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participants and this method is more consistent with Delphi methodology as the 
outcomes are considered for feedback at least once.  
 
In round two, the anonymised feedback was presented from all participant 
stakeholder groups and they were asked to rate the outcomes again using the same 9 
point Likert scale.  As recommended by Sinha et al, 2011
244
 the distribution of 
scores for each outcome considered in the final round were documented. After the 
final Delphi round, there was a list of outcomes within the categories of “consensus 
in,” “consensus out” and “no consensus.” These categories are explained in Table 
5.3. All these outcomes were submitted to a face to face consensus meeting of key 
stakeholders to discuss what outcomes should be finally included in the COS.  
 
5.2.11 Analysis 
We intended to use the “70/15” consensus definition, which was used successfully in 
other COS studies 
42 68 233 257 264 286 287
 for inclusion of an outcome in the COS. 
However, it was revised due to study team and other core outcome set developers 
experience that outcomes were rarely voted 1-3 not important and reach criteria for 
exclusion after the Delphi survey.
264
 Hence “consensus out” was more appropriate to 
set as 50% or less of the patient group and 50% or less of the HCP group scoring an 
outcome 7-9 as was done in a recent COS study.
264
 Consensus that an outcome 
should be included in the COS was defined as 70% or more scoring it as 7 to 9 and 
fewer than 15% scoring it as 1 to 3 (Table 5.3). As a result, the final definitions of 
consensus that were decided are in Table 5.3. 
 




IN Consensus that outcome 
should be included in the 
core outcome set 
70% or more participants 
scoring as 7 to 9 AND <15% 
participants scoring as 1 to 3 in 
the patient and HCP group 
OUT Consensus that outcome 
should not be included in the 
<50% of participants scoring as 
7 to 9 in the patient and HCP 
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importance of an outcome 
Anything else 
 
The results of the two rounds of the Delphi process were documented to include 
number of participants completing the section, number partially completing the 
survey and measure of each group response to an outcome leading to a 
comprehensive list of all outcomes that should be included in the CESCOS. As 
recommended, we will report all scores for each outcome between the stakeholder 
groups
244
 as cut off scores used in most studies do not describe how strongly the 






It was expected that some participants will drop out after each round of the Delphi 
survey. Each participant was given a unique participant number when they 
completed the first round of the Delphi, which allowed identification of the attrition 
rates between the rounds. This was through comparing the mean round 1 scores for 
the participants who completed round 1 and round 2 with the mean scores of those 
that dropped out after round 1. The attrition following the first round of the Delphi 
may be dependent upon the timing of the Delphi rounds (e.g. holiday season), the 
length of the Delphi (from knowledge of completing the previous round), and time 
elapsed between rounds (participants may be disinterested) and the method of 
recruitment between participants.
33
 To reduce attrition rates personalised emails to 
participants, personalised emails from distinguished researchers in the field and the 
offer of being acknowledged in the study publication have all been found to be 
helpful strategies to increase the response rate. A response rate of 80% for each 




5.2.13 The Consensus Meeting Methods 
All participants registering for the Delphi survey were asked if they would be happy 
to attend a face to face consensus meeting involving patients and HCPs. This was set 
up as a tick box on the registration page for the online Delphi survey. They needed 
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to complete both rounds of the Delphi survey to be eligible to attend and be selected 
through the sampling frame. If there was an overwhelming response with more than 
40 participants interested in attending the consensus meeting, the study team 
intended to use stratified purposive sampling.  
 
Participants were invited to the consensus meeting, which took place at the Sid 
Watkins building lecture theatre at The Walton Centre NHS Foundation Trust, 
Liverpool, UK. The consensus meeting was chaired by an independent non-clinical 
facilitator who was not part of the study team. It has been shown that for patients, 
the idea of a consensus meeting being facilitated by an expert in facilitation was 
better than an expert in a condition.
61
 A pre-meeting briefing was held for the 
patients in conjunction with the facilitator and patient representative to allow 
patients to meet the facilitator/ chair and ask any questions. 
The sampling frame (Table 5.4) used was to achieve a varied sample of participants 
for the consensus meeting. As a result, for patients whether they had an operation or 
not for CES, the years since their diagnosis, gender and their location were taken 
into consideration when inviting individuals. For HCPs, their speciality, years of 
clinical practice and location of work were taken into consideration.  
 
Table 5. 4 Sampling frame characteristics for selection of consensus meeting 
participants. 
Patients HCPs 
Operation for CES Location of work 
Years since CES diagnosis Years of clinical practice 
Gender Speciality 
Location of residence  
 
In preparation for the meeting all participants were sent an agenda (Appendix 5.3), 
what to expect document (Appendix 5.4), glossary (Appendix 5.5), venue/ hotel 
guide (Appendix 5.6) and summary of their individual Delphi round scores 
produced by the DelphiManager. Throughout the process participants were reminded 




Forty participants were invited to the consensus meeting. This included 20 HCPs and 
20 patients. Out of the 40 participants; 30 would be from the UK and 10 would be 
international. For the patient group 15 delegates would be from the UK and 5 from 
abroad. For the HCP group 15 delegates would be from the UK and 5 from abroad. 
Standard travel expenses and hotel accommodation would be reimbursed or 
provided. The funds for the consensus meeting were sought from charity and 
industry as “educational grants,” which was ethically approved. Ten of the 
participants were invited before the Delphi survey was released to attend the 
consensus meeting but on the premise, that both rounds of the Delphi were 
completed. This is to make sure there was representation at the consensus meeting 
from key stakeholder organisations closely involved with CES patients, research or 
management. Thirty participants at the consensus meeting would be those who have 
completed both Delphi rounds and ticked their interest to attend the consensus 
meeting during registration for the Delphi survey. Consensus meetings for COS 
development have been done separately for patients and HCPs 
42
 but the CESCOS 
study team believed that this was not an appropriate as a consensus should bring 
both stakeholder groups together.  
 
Struggle with the concept of outcomes is not just amongst patients and it has been 
noted amongst HCPs as well, which has been reported by other studies as well.
45 233 
289
 Providing examples of outcomes in a condition is seen to be useful 
33
 and not to 
use an outcome that could bias respondents. In the pre-information pack emailed to 
delegates and in the initial lectures for the consensus meeting, walking distance and 
pain was used as examples of outcomes for the condition of knee arthritis to keep it 
separate to CES.  
 
In the development of a breast reconstruction COS, patients and HCPs were 
recruited in a 2:1 ratio so that patients’ views were represented preferentially as the 
procedure is a patient selected optional intervention.
257
 In the CESCOS study, 
clinical intervention for CES is performed as an emergency so it was deemed 
appropriate by the study team to have a 1:1 ratio of patients and HCPs. This is to 
maximise the number of participants involved to help achieve consensus. In 
addition, the COS should reflect all key stakeholders input equally. On the day of the 
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consensus meeting informed consent was obtained from the patient participants 
(Appendix 5.7).  
 
Outcomes categorised as “consensus in” across both stakeholder groups from the 
Delphi survey (Table 5.3) were included in the final COS. Outcomes categorised as 
“consensus out” across both stakeholder groups from the Delphi survey were 
excluded from the final COS. Results of the Delphi survey were discussed at the 
consensus meeting and the main discussion was regarding the outcomes deemed as 
achieving “no consensus” in the Delphi survey. Participants at the meeting voted on 
these outcomes anonymously using the TurningPoint system and handsets (Turning 
Technologies, Youngstown, OH, USA). Each handset was pre-registered to either 
the patient group or the HCP group and labelled on the handset P for Patients and H 
for HCP to differentiate for the participants.  
 
The “consistency effect” states that items are answered in relation to responses to 
earlier items. The recommendations suggest that general questions should precede 
specific ones 
290
 and questions should be grouped into topics.
291
 It is also suggested 
that if respondents have stronger opinions over some items than others these should 
be placed first.
292
 In the CESCOS consensus meeting, the outcomes which were 
discussed first had at least one stakeholder group who voted >70%. Then outcomes 
where one group had voted > 50% were discussed. The remaining outcomes were 
the ones where <70% of the patient group and <70% of the HCP group in the Delphi 
survey voted as critically important. 
 
The same criteria for “consensus in” used in the Delphi survey (Table 5.3) was used 
at the consensus meeting. All outcomes that reached “consensus in” were included in 
the COS. All outcomes in the “consensus out” or “no consensus” category after 
voting in the consensus meeting were not to be included in the COS. If there was no 
agreed final COS at the end of the first meeting subsequent meetings would have 
been arranged for this to happen. The participants who had completed both rounds of 




Feedback forms were distributed and collected at the end of the consensus meeting 
(Appendix 5.8). End of study information will be provided in plain English and 




5.2.14 Ethical considerations 
We obtained NHS REC approval for this study as previously mentioned in section 
5.2.1 overview. No risk of harm was envisaged for the study. However, questions in 
the Delphi survey and the consensus meeting covered topics such as bladder, bowel 
and sexual function, which some participants may have found sensitive. To reduce 
this, all responses were anonymised and they were not traceable back to the 
respondent except by the immediate research team. Also, the language used in the 
Delphi was piloted by patients and revised if necessary. 
 
It would have taken time to complete each round of the Delphi questionnaire and 
additionally if the participant was involved in the consensus meeting. Although the 
importance of completing all rounds of the Delphi questionnaire were highlighted to 
the participants it was made clear they could withdraw at any time with no 
consequences. The participants who entered their name and email address on the 
registration page were indicating agreement to participate in the Delphi process as 
per NRES guidance 'Information Sheets and Consent Forms Guidance for 
Researchers and Reviewers' page 8 as mentioned previously. 
 
5.2.15 Data Use and Storage 
The main NHS site kept documentation of which individuals were invited to 
participate to prevent repeated approaches of the same participant. No clinical 
information was collected or stored. When registering to take part in the Delphi 
survey, participants were asked to register an email so that reminders about 
completing the survey were sent appropriately. All data were stored on a University 
of Liverpool computer as encrypted files password protected and accessed by chief 
investigator or immediate research team only. Participants could withdraw from the 
study at any time by contacting the research team. From this point no further email 
would have been sent.  
Survey responses were anonymised by allocation of unique participant number to 
each participant. Records linking individual data to the participant number were kept 
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in a password protected document on a secure server at the University of Liverpool 
accessed by immediate research team. All paperwork relating to the project was 
stored away in a filing cabinet to which only the research manager of the department 
has access to via a code, key and lock. Contact details for participants wishing to be 
informed of the results of the study were recorded. End of the study to include 
completion of data analysis was the 31
st
 January 2019. In line with the university's 
policy, data will be archived at the University of Liverpool for at least 10 years, 
longer if deemed of historical significance. After this period, the data will be 




5.3 RESULTS  
 
5.3.1 Overview 
In total, 997 verbatim outcome terms were sourced from the systematic literature 
review (737) and the qualitative interviews (260). This was then prioritised through a 
Delphi survey with 38 outcomes as one outcome was added in round 2. At the end of 
the Delphi survey, 13 outcomes had achieved consensus to be included in the COS 
according to the criteria in the methods. These 13 outcomes were agreed at the 
consensus meeting and after anonymous voting, three extra outcomes were included 
to the COS making a total of 16 outcomes (Figure 5.2).  
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Figure 5. 2 Overview of COS development and the final CESCOS.  
 
 
5.3.2 “Long to short” list of outcomes 
The long list was created from the outcomes listed in the systematic literature review 
(SLR) 
135
 and from the qualitative interviews conducted with 22 CES patients 
described in the previous chapter. Table 5.5 shows the number of verbatim outcome 










Table 5. 5 Verbatim outcome terms per core domain or subdomain in the 
systematic literature review (SLR) and in the interviews. 
Core Area Core Domain Subdomain SLR Interviews Total 
Death   25 0 25 
Physiological/ 
Clinical 
Nervous System General Disorders 44 12 56 
Bladder Function 141 39 180 
Motor function 62 15 77 
Sensation 53 23 76 
General Neurology 31 0 31 
Lower Back Pain 31 22 53 
Leg Pain 32 24 56 
Bowel Function 60 25 85 
Perineal sensation 23 9 32 
PR tone  16 0 16 
Reflexes 7 0 7 




 22 0 22 




Outcomes relating to 
neoplasm 
5 0 5 
Urological and 
Renal 
Urological and Renal 3 0 3 
Cardiac  Cardiac  3 0 3 
Blood and 
lymphatic  
Blood and lymphatic  2 0 2 
Respiratory  Respiratory  4 0 4 
Gastrointestinal Gastrointestinal 1 0 1 
Musculoskeletal Musculoskeletal 0 17 17 
Life Impact Physical 
Functioning 
Sexual Function 46 9 61 
 Walking 28 41 63 




 2 0 2 
Emotional 
Functioning 
 7 19 26 
Global quality of 
Life 
 8 0 8 
Resource Use Hospital  8 0 8 
Need for 
Intervention 
 13 0 13 
Adverse Events   16 0 16 
Total   737 260 997 
 
Appendix 5.9 is a link to an excel document that provides detail as to how the long 
list was formed from the verbatim outcome terms of the SLR and qualitative 
interviews. Each number below represents the number of the corresponding sheet on 
the excel document: 
1- Here the outcomes from each of the 22 qualitative interviews were listed.  
2- The verbatim outcome terms were organised into common groups through an 
inductive approach. There were 260 verbatim outcome terms from the qualitative 
interviews. 
3- All verbatim outcome terms from the SLR. There was a total of 737 terms from 
the SLR.  
4- COMET taxonomy is in red and the verbatim outcome terms from the SLR are in 
black. The qualitative interview verbatim outcome terms highlighted in blue, which 
were re-organised from sheet 2 under the appropriate domains used for the SLR in 
sheet 3.  
5- Shows the initial list of Delphi outcomes in green on the left column A placed 
under the respective taxonomy. Parallel to each question are the outcomes, that were 
felt to contribute to them. Again, the outcomes from the SLR are in black and the 
outcomes from the qualitative interviews are blue.  
Some subdomains have in brackets “Not included.” This is because the outcome was 
considered at a more granular level with the appropriate questions. As a result, it was 
felt more generic outcomes should not constitute a question. For instance, regarding 
bladder function the questions under this subdomain covered 1) Inability to empty 
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the bladder, 2) Altered sensation when passing urine, 3) Incontinence of Urine, 4) 
Difficulty when passing urine, 5) Urinary infections. Therefore, if the key 
stakeholders were rating these items individually then it would seem logical that 
there is no need to duplicate this and rate a higher level categorisation of them such 
as “Bladder function.” 
6- This shows the questions under the appropriate domains of the taxonomy without 
the individual outcomes listed. 
 
The questions/ outcomes for the Delphi survey and their plain language and clinical 
summaries were reviewed multiple times by the study team including the patient 
representative. The list of the final 37 outcomes and agreed terminology with 
explanations is evident in Table 5.6. 
 
Table 5. 6 Outcome List for the Delphi survey and their associated plain 
language and clinical descriptions 
Name Lay Description (Clinical Description) 
Urinary retention The patient cannot completely empty their bladder. This 
includes the patient using a catheter to empty the bladder.  
Sensation of bladder 
fullness 
The ability to sense that the bladder is full, which may be 
reduced in CES 
Incontinence of Urine  The patient has reduced control over when they urinate and 
“wets” themselves. This includes the patient needing to 
wear incontinence pads.  
Urinary urgency A sudden desire to pass urine 
Urinary frequency The number of times the patient passes urine 
Constipation  The patient has difficulty passing stools. This includes the 
patient using rectal irrigation or suppositories.  
Faecal Incontinence  Less control over when a patient starts to pass stool causing 
“soiling” or “messing” oneself 
Abdominal distention  Tummy bloating 
Abdominal pain Tummy pain 
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Anal tone A measure of the strength of the muscle in the back passage 
that prevents stool coming out. 
Physical ability to 
have sexual 
intercourse  
Physical problems with sexual intercourse such as difficulty 
achieving or maintaining an erection, numbness and 
reduced sensation in the genital region during sex or pain 
when having sex. (Clinical description: Erectile 
dysfunction, numbness or reduced genital sensation during 
sex and dyspareunia). 
Leg muscle strength Reduction in the strength of the legs. (Clinical description: 
Reduction in leg muscle power). 
Foot drop Weakness that prevents the patient lifting their foot off the 
floor. (Clinical description: Weak muscles that dorsiflex at 
the ankle). 
Reflexes Automatic muscle reflexes usually checked in the legs 
during a medical exam by a doctor to see if they are present 
or not. (Clinical description: Present or absent lower limb 
reflexes).  
Sensation in leg(s) Reduced feeling or numbness in the leg(s) 
Sensation in genitals Reduced feeling or numbness in the genitals 
Perineal sensation Reduced feeling or numbness around the skin close to the 
anus. (Clinical Description: Reduced or loss of perineal 
sensation and saddle anaesthesia).  
Lower back pain Pain in the lower back  
Pain in leg and/or 
feet 
Pain in one or both legs including “sciatica” 
Back stiffness  Feeling back is ‘stiff’, ‘tight’ or having uncomfortable 
muscle contractions 
Leg stiffness  Feeling legs are ‘stiff’, ‘tight’ or having uncomfortable 
muscle contractions 
Fatigue Feeling tired or energy levels are “low” 
Non-specific pain Pain that is not limited to just one part of the body (such as 
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back or legs) but is instead all over the body 
Global Quality of 
Life 




Impact of CES on the patient’s job or working life 
Social functioning Impact of CES on relationships with partner, family and 
friends including ability to join in with social activities 
Ability to do Daily 
activities (Physical 
functioning) 
Ability to do daily activities like shopping, hoovering, 




Decreased ability to move around. Patients may require 
walking aids e.g. stick, Zimmer frame, wheelchair 
Difficulty with body 
posture (Physical 
functioning) 
Difficulty with bending, lifting, standing and sitting, lying 
flat (difficulty sleeping). Here the difficulty to stand may 




A reduced desire for sexual activity 
Anxiety (Emotional 
functioning) 
Feeling of unease, worry or fear 
Isolation (Emotional 
functioning) 
Feeling of loneliness, not “in touch” with society 




Feeling “low” or feeling “blue”. This may include having 
suicidal ideas/ thoughts 
Hospital resources Length and total cost of the hospital stay for the patient, use 
of medication, investigations, surgical instruments, staff 
time and other medical resources.  
Need for further 
intervention 
The patient needs a repeat or further operation to help 
resolve CES or complications. 
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Death This is a very rare event. For example, death within 30 days 
of an operation for CES either happening in hospital or after 
discharge due to a chest infection or heart attack.  
Complications This would include any complication related to the 
operation for CES or hospital stay excluding death. For 
example; wound infection, pressure sores, clots in the veins 
of the legs and lungs, heart attack, transfusion, chest 
infection and recurrence of a spinal tumour. 
 
5.3.3 Cognitive Interviews 
Five consultant spinal surgeons (3 from the UK, 1 from Latvia and 1 from Brazil), 
two patient research partners (1 male, 1 female), and one spinal specialist nurse had 
piloted the Delphi survey on the DelphiManager software including registration and 
their cognitive interviews were audio-recorded and transcribed. The Delphi survey 
was described as well-structured and short preventing user fatigue and a good 
summary of the CES outcomes. The main suggestions were: 
- To have a screenshot explaining the functions of the Delphi on the study website. 
- To request an age range on the registration page rather than asking the specific age. 
- To place an asterix next to items which are compulsory to complete on the 
registration page. 
- To have “years of practice” for HCPs clarified to start from board certification. 
- To clarify from which perspective the participant is rating the outcomes: e.g. please 
rate how important the outcomes are when considering what to look at in future CES 
research studies. 
- Ask the full title of the HCP to include their grade and speciality. 
- Mention that the outcome of death is rare in CES in the explanation as it is 
worrying to see it from a patient’s perspective. 
- Explanation for urinary incontinence, urinary retention and constipation were 
altered slightly. 
- Place ¼ way, ½ way and nearly finished whilst the participant is doing the survey 




5.3.4 The Delphi survey results 
Table 5.7 shows the HCP and patient organisations who circulated the Delphi 
amongst their membership. 
 
Table 5. 7 Stakeholder organisations that agreed and sent out the Delphi survey 
link to its membership. 
Patient organisations Healthcare professional organisations 
Cauda Equina Syndrome Association 
CESA 
Society of British Neurological Surgeons 
Cauda Equina Syndrome Foundation Eurospine 
Spinal Injuries Association Canadian Spine society 
Brain and Spine Foundation International spinal cord society 
 Spine Society Australia 
 World Federation of Neuro-Rehabilitation 
 British Society of Rehabilitation Medicine 
 
Round 1 of the Delphi survey was open from 19
th
 June to 23
rd
 July 2018 (34 days). 
Round 2 of the Delphi was open 2 weeks after from 6
th
 August to the 11
th
 September 
2018 (36 days).  
Initially, 272 participants completed Round 1. This reduced to 172 participants who 
completed Round 2 who were patients (104) and HCPs (68). The overall response 
rate was 63% and this is shown in Table 5.8 Between the key stakeholders, the 
HCPs (82%) had a better response rate than the patients (55%).  
 








Patient 189 104 55 
HCP 83 68 82 
All 
participants 272 172 63 
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Table 5.9 and Table 5.10 display the patient and HCP demographic details 
respectively. The patient participants were predominantly female (75%), Most 
patients were within the age group brackets of 30-39 (29%) or 40-49 (30%). They 
were less than 2 years (35%) or 2 to 5 years (26%) since their diagnosis of CES. 
More than half of the patients (52%) were not in employment or retired. Most 
patients had an operation for CES (89%). With regards to the HCPs, most were of a 
surgical background (71%) compared to a medical background (19%) or an allied 
HCP (10%). Most HCPs had 10-20 years (35%) or 20 plus years (28%) of clinical 
practice since qualifying. 
 
Table 5. 9 Demographics of patient Delphi participants who completed both 
rounds 
PATIENTS n (%) 
Total 104 
Gender  
Male 26 (25) 
Female 78 (75) 
Age group   
18-29 6 (6) 
30-39 30 (29) 
40-49 31 (30) 
50-59 22 (21) 
60-69 13 (13) 
70+ 2 (2) 
Country of residence  
UK 54 (52) 
USA 40 (38) 
Ireland 2 (2) 
Denmark 2 (2) 
Canada 2 (2) 
Australia 2 (2) 
Brazil 1 (1) 
South Africa 1 (1) 
CES diagnosis  
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<2 36 (35) 
2-5 27 (26) 
5-10 23 (22) 
>10 18 (17) 
Employment status  
Employed full time 30 (29) 
part time 10 (10) 
Self employed 9 (9) 
Unemployed 6 (6) 
Unable to work 29 (28) 
Homemaker 5 (5) 
Retired 14 (13) 
Not answered 1 (1) 
CES Operation  
Yes 89 (86) 
No 15 (14) 
 
Table 5. 10 Demographics of HCP Delphi participants who completed both 
rounds 
HCPs n (%) 
Total 68 
Gender  
Male 60 (88) 
Female 8 (12) 
Occupation  
Neurosurgery 36 (53) 
Orthopaedic 12 (18) 
Neuro-rehabilitation 5 (7) 
Neurologist  4 (6) 
Spinal Cord Injury 4 (6) 
Spinal nurse  3 (4) 
Physiotherapist  2 (3) 
Psychologist  2 (3) 
Years of practice   
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<2 4 (6) 
2-5 6 (9) 
5-10 14 (21) 
10-20 24 (35) 
20+ 19 (28) 
Not stated  1 (1) 
Country of residence  
UK 41 (60) 
Canada 11 (16) 
Portugal 3 (4) 
Ireland 2 (3) 
Germany 2 (3) 
Australia 2 (3) 
India 2 (3) 
Czech Republic 1 (1) 
USA 1 (1) 
Brazil 1 (1) 
New Zealand 1 (1) 
Malaysia 1 (1) 
 
Of the 172 participants who completed the Delphi, 55% were form the UK and 45% 
were from outside the UK with North America being the highest recruitment 
location (31%) (Figure 5.3). Participants from 14 countries were involved in round 









Figure 5. 3 Geographical distribution of Delphi participation.   
 
 
Figure 5.4 and Figure 5.5 shows the average Delphi scores between key 
stakeholders who had completed both rounds compared to the stakeholders who only 
completed one round.  
The mean round 1 scores for patients (mean 7 SD 1.02) and HCPs (mean 6 SD 0.87) 
were not different compared to the participants that completed both rounds for 
patients (mean 7 SD 0.93) and HCPs (mean 6 SD 0.87). 
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Figure 5. 4 Bar chart showing average Delphi scores for patients who completed 
both rounds (blue) Vs patients who only completed the first round (orange). 
 
 
Figure 5. 5 Bar chart showing average Delphi scores for HCPs who completed 
both rounds (blue) Vs HCPs who only completed the first round (orange). 
 
 
Sixty-five additional outcomes were suggested at the end of round 1. Sixty-four of 
the outcomes were deemed not appropriate by the clinical study team (NS, SC, MW, 
TM) to include. This was because 33 (52%) were not an outcome, 30 (47%) were 
covered by other outcomes already on the Delphi survey and 1 (1%) suggestion was 















Patient average scores 














HCP average scores 
Round 1+2 Round 1
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was felt this was neuropathic pain which was then re-worded in plain language to 
“pain from abnormal sensation or non-painful stimulus” for rating in round 2. 
During the entry of this outcome for rating in round 2 another outcome, namely, 
“sensation in genitals” was accidently deleted. This meant although “sensation in 
genitals” should have been in two rounds it was only rated in the first round. Both 
“sensation in genitals” and “pain from abnormal sensation or non-painful stimulus” 
achieved “consensus in” in the one round they were in and it was agreed by the 
study team to include them in the “consensus in” category for the consensus 
meeting.  
 
Table 5.11 shows the percentage of participants who had voted 7 to 9 (critically 
important) for each outcome at the end of round 1 and 2. According to the pre-
specified scoring criteria in the methods; 13 outcomes were included as “consensus 
in,” (green), 6 were “consensus out” (blue) and 19 had “no consensus” at the end of 
both rounds. Three outcomes namely, leg muscle strength, perianal sensation and 
complications had moved from “no consensus” in round 1 to “consensus in” after 
round 2. In these cases, it was due to a higher proportion of HCPs voting the 
outcome critically important in the second round, which allowed the outcomes to go 
above the 70% threshold for inclusion. There were no cases where an outcome was 
voted 7 to 9 by 70% of a key stakeholder group (patients or HCPs), which then 










Table 5. 11 Percentage of patients and HCPs scoring 7-9 for an outcome in 
round 1 and 2. Green were the outcomes that were included and blue were the 
outcomes excluded. 
Outcome Patients HCPs Patients HCPs 
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R1 R1 R2 R2 
Urinary retention 74 93 80 97 
Sensation of bladder fullness 69 61 74 63 
Incontinence of Urine 76 91 84 100 
Urinary urgency 57 30 55 36 
Urinary frequency 48 27 43 31 
Constipation 67 25 66 31 
Faecal Incontinence 80 94 89 99 
Abdominal distention 49 18 42 12 
Abdominal pain 54 23 52 24 
Anal tone 63 57 76 69 
Physical ability to have sexual intercourse 80 81 84 92 
Leg muscle strength 71 67 80 72 
Foot drop 64 60 76 60 
Reflexes 51 11 44 3 
Sensation in leg(s) 66 40 63 32 
Pain from abnormal sensation or non-painful 
stimulus 
X X 85 81 
Genital Sensation 82 72 X X 
Perineal sensation 74 65 75 73 
Lower back pain 83 29 83 35 
Pain in leg and/or feet 82 48 83 53 
Back stiffness 53 10 47 6 
Leg stiffness 48 11 48 7 
Fatigue 56 16 56 15 
Non-specific pain 48 8 36 6 
Global Quality of Life 85 80 90 75 
Occupation/ Role functioning 72 81 85 88 
Social functioning 62 70 66 73 
Ability to do Daily activities (Physical 
functioning) 
81 80 89 90 
Mobility and Walking (Physical 
functioning) 
86 82 91 88 
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Difficulty with body posture (Physical 
functioning) 
60 52 70 50 
Sexual desire (Emotional functioning) 64 64 65 65 
Anxiety (Emotional functioning) 69 51 74 49 
Isolation (Emotional functioning) 72 56 74 59 
Low Mood and Depression (Emotional 
functioning) 
75 58 78 63 
Hospital resources 74 46 83 51 
Need for further intervention 84 51 89 53 
Death 54 59 66 72 
Complications 78 65 82 72 
 
There were 499 score changes in total for round 2. Patients made 326 (65%) score 
changes and HCPs made 173 (34.7%). Table 5.12 clarifies that most patients made 
score change based on personal reflection (70.6%) whereas most HCPs (58.4%) had 
made the score changes based on stakeholder feedback.  
 
Table 5. 12 Reason for score changes in the stakeholder groups. Percentages are 
given in brackets. 
 
Patients HCPs 
Due to stakeholder 
feedback 90 (27.6) 101 (58.4) 
Due to personal 
reflection  230 (70.6) 56 (32.4) 





5.3.5 The Consensus Meeting 
An update of the results was requested by 262 out of 272 participants (96%) who 
had completed round 1 of the Delphi survey. When the article is openly published 
for the core outcome set we will refer them to this. Interest in taking part in the 
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consensus meeting from round 1 was registered by 234 (86%) participants in round 1 
of the Delphi survey. 
 
The consensus meeting was chaired by a non-clinical researcher (STB) independent 
to the study team with expertise in core outcome set methodology. Table 5.13 
illustrates the number of participants interested in attending the consensus meeting in 
round 1. Then those participants who completed round 2 who were eligible to attend 
are displayed. At any one point only 40 invitations were sent out for HCPs and 
Patients using the sampling frame. If there was a participant unable to attend then 
another one was invited in lieu. This was done as there was only sufficient funding 
for 40 participants in total.  
 
Table 5. 13 This shows the number of participants who registered an interest in 
round 1 to attend the consensus meeting, the number who completed round 2 
and were eligible to attend, the number invited using the sampling frame and 
the final numbers in attendance.  
Consensus Meeting Patients (n) Healthcare 
professionals (n) 
Registered Interest 163 71 
Eligible to attend 101 58 
Invited to attend 43 47 
Confirmed to attend 24 25 
In attendance 16 18 
 
The consensus meeting was attended by 34 participants (16 patients and 18 HCPs). 
Twenty-five participants were from the UK and 9 were from outside the UK. The 
demographic details of the HCP delegates who attended the meeting are in Table 
5.14 below. There was representation from members of the Society of British 
Neurosurgery Society, Canadian Spine Society, Spine society of Australia, 
Eurospine, Association of British Neurologists, Spinal Injury Association and 
British Society of Rehabilitation Medicine. The demographics of the patient 
delegates are below in Table 5.15 There was representation from founding members 
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and members of the USA based CES Foundation and UK based CES Association 
charity organisations.  
 








1 M ≥2 <5 Consultant Neurosurgeon Czech Republic  
2 M ≥20 Professor of Neurosurgery Canada 
3 M ≥5 <10 Consultant Neurosurgeon Brazil 





M ≥20 Professor of Neuro-
rehabilitation 
India 
6  M ≥20 Spinal Injury Consultant UK- 
Buckinghamshire  
7 M ≥20 Spinal Injury Consultant UK- Southport 
8 M ≥10 < 20 Consultant Neurologist UK- Sheffield 
9 M ≥10 < 20 Spinal physiotherapist UK- Liverpool 
10 F ≥10 < 20 Clinical psychologist  UK- Stanmore 
11 F ≥5 < 10 Spinal nurse specialist UK- Liverpool 
12 F < 2 Spinal nurse specialist UK- Liverpool 
13 M ≥2 < 5 Consultant Neurosurgeon UK- Brighton 
14 M ≥10 < 20 Consultant Neurosurgeon UK- London 
15 M ≥20 Consultant Neurosurgeon UK- Manchester 
16 M ≥5 < 10 Consultant Neurosurgeon UK- Liverpool 
17  M ≥20 Consultant Neurosurgeon UK- Liverpool 





Table 5. 15 Patient participant demographics at the consensus meeting 








1 F 30-39 ≥2 < 5 Y Unemployed Denmark 
2 F 40-49 ≥ 2 < 5 Y Employed 
full time 
Australia 
3 F 30-39 ≥5 < 10 Y Unable to 
work 
USA 
4 F 40-49 ≥2 <5 Y Unable to 
work 
Canada 
5 F 40-49 ≥5 <10 Y Employed 
part time 
UK- Lancashire 
6 F 60-69 ≥5 <10 Y Retired UK- Wales 
7 F 30-39 < 2 N Employed 
full time 
UK- England 
8 F 50-59 < 2 N Employed 
part time 
UK- Lancashire 









11 M 60-69 < 2 Y Self 
Employed 
UK- Wales 
12 M 40-49 ≥5 < 10 Y Retired UK- Blackpool 
13 M 50-59 ≥5 < 10 Y Employed 
full time 
UK- Liverpool 
14 M 60-69 ≥10 Y Retired UK- Liverpool 
15 M 40-49 < 2 Y Employed 
full time 
UK- Liverpool 





There was no significant difference or participation bias when comparing average 
round two Delphi scores between participants who attended the consensus meeting 
(patients mean 7 SD 1: HCPs mean 7 SD 0.7) compared to those participants who 
did not attend the consensus meeting but who had completed both rounds of the 
Delphi survey (patients mean 7 SD 0.85: HCPs 7 mean SD 1) (Figure 5.6 and 5.7).   
 
Figure 5. 6 Bar chart showing average Delphi scores for patients who attended 
the consensus meeting (orange) compared to patients who did not attend the 
meeting (blue). 
 
Figure 5. 7 Bar chart showing average Delphi scores for HCPs who attended 






















Table 5.16 shows the percentage of participants that voted 1 to 3, 4 to 6 and 7 to 9 
for the “No consensus” outcomes in the consensus meeting. It was decided by the 
facilitator and the study team to stratify the “no consensus” outcomes for discussion 
as described in the methods section. They were grouped together so that when voting 
on the outcomes there was a theme to follow. Clinical outcomes (anal tone, sensation 
of bladder fullness, foot drop) followed by outcomes related to pain (pain in leg or 
feet, back pain) then outcomes related to quality of life (low mood and depression, 
social functioning, isolation, anxiety, difficulty of body posture).  
 
The “No consensus” outcomes, which were voted into the core outcome set (green) 
had 0% voting 1 to 3 in both stakeholder groups. The outcome of hospital resources 
was not voted in by both stakeholder groups (Table 5.16). HCPs had argued that not 
all studies should be required to do economic evaluations as this was impractical and 
researchers should be allowed to do this as a separate study. Also, they felt that 
healthcare resources should not be measured as critical because a patient’s clinical/ 
psychological recovery was more important and relevant for a “core” set. 
The outcome that was re-voted in the consensus meeting was low mood and 
depression. HCPs had not voted this critically important compared to patients in the 
consensus meeting initially. The patients felt there was not appropriate discussion 
regarding this outcome before voting and a re-vote was agreed by the study team 
after an adequate discussion between the stakeholders. The outcome of global 
quality of life was described by the HCPs as including the outcome of low mood and 
depression. However, the facilitator had clarified that this is not always a feature for 
quality of life assessment tools and any outcomes related to quality of life should be 
voted in separately to the global quality of life outcome for them to be considered in 
the assessment. The re-voting resulted in the outcome being included. The outcome 
of death was deemed to be already covered by the outcome of complications and the 
study team agreed to include this in the definition of complications hence it was not 
voted on during the consensus meeting.  
 
The outcomes of foot drop, low back pain and need for further intervention were 
voted as critically important by patients but not by HCPs (blue). The reasons for not 
voting low back pain critically important was that HCPs believe that this pain is not 
due to CES. It is felt that low back pain is most likely due to several different causes 
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294
 and to ascribe it to CES would be incorrect. However, the patients did mention 
that they felt it was higher within the CES population who are younger than the 
general population who experience back pain. Since the outcome of pain due to 
abnormal sensation or non-painful stimulus was the plain language definition of 
neuropathic pain this outcome was believed to encompass leg pain and this is maybe 
a reason why leg pain was not voted critically important by both stakeholder groups. 
With regards to the outcome of foot drop this was not included as HCPs felt the 
outcome of mobility and walking would encompass the effects experienced by 
patients from foot drop. HCPs felt the outcome of need for further intervention was 
included within complications. This would include the need for a repeat procedure to 
relieve the compression causing CES. Need for further intervention was interpreted 
correctly by patients as needing further procedures to manage their clinical sequelae 
from CES. However, HCPs felt this was not relevant to future research studies, as if 
a patient has had many procedures it does not mean they have had a “worse” 
outcome due to CES clinically. In addition, having a repeat operation to resolve CES 
compression was the procedure that HCPs were most concerned about and this was 
already covered by the outcome of complications.  
 
The “no consensus” outcomes which were critically important by <70% of 
participants from both stakeholder groups in the Delphi survey were agreed by the 
consensus meeting participants to not be voted on and to accept the results of the 
Delphi. These outcomes included; sexual desire, constipation, sensation in the legs, 
urinary urgency and abdominal pain. The outcome of fatigue although in this 
category was requested by the patient stakeholder group to be voted on again and the 
facilitator/ study team agreed. Other outcomes already included in the COS were 
seen as contributory to fatigue such as mobility and walking, ability to do daily 
activities and leg muscle strength and this was cited as a reason by a HCP and a 
patient as not choosing it critically important. Fatigue did not reach the criteria for 
inclusion in the COS.   
Wording for the outcomes of need for further intervention and fatigue were changed 
as seen in Table 5.17 Both these outcomes were still not voted into the COS after 
rephrasing. The outcome of complications was adapted to include death as requested 
by the participants. 
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Table 5. 16 Voting on the “no consensus” outcomes for the meeting. 
 
Patient (%) HCP (%) 
Outcome 1-3 4-6 7-9 1-3 4-6 7-9 
Anal tone 19 62 19 29 62 12 
Sensation of bladder fullness 0 12 87 0 23 78 
Foot drop 0 12 88 0 50 50 
Pain in leg or feet 0 44 56 6 61 34 
Back Pain 0 12 88 12 29 62 
Low mood and depression 0 0 100 0 17 83 
Social functioning 0 12 88 0 28 72 
Isolation 0 69 31 0 72 28 
Anxiety 0 31 69 0 50 50 
Difficulty of body posture 0 50 51 0 83 17 
Need for further intervention 0 19 82 0 44 56 
Hospital resources 6 82 13 17 72 11 
Fatigue 0 33 67 0 78 22 
 
Table 5. 17 Outcomes where the definition was changed during the consensus 
meeting. 
Outcomes Delphi  Consensus meeting 
Need for further 
intervention 
The patient needs a repeat or 
further operation to help resolve 
CES or complications 
 
The patient needs a repeat or 
further operation to help manage 
consequences of CES. 
Fatigue Feeling tired or energy levels are 
“low” 
Extreme tiredness or lethargy 
Complications This would include any 
complication related to the 
operation for CES or hospital 
stay excluding death. For 
example; wound infection, 
pressure sores, clots in the veins 
of the legs and lungs, heart 
attack, transfusion, chest 
This would include any 
complication related to the 
operation for CES or hospital stay 
including death. For example; 
wound infection, pressure sores, 
clots in the veins of the legs and 
lungs, heart attack, transfusion, 
chest infection and recurrence of 
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infection and recurrence of a 
spinal tumour 
a spinal tumour 
 
The final COS is listed in Table 5.18 There are 16 outcomes in total categorised 
under autonomic function, non-autonomic function and quality of life.  
 
Table 5. 18 The 16 outcomes that constitute the Cauda Equina Syndrome Core 
Outcome Set. 
CES Core Outcome Set 
Autonomic 
function 
Bladder function Incontinence of Urine 
Urinary retention 
Sensation of bladder fullness 
Bowel function Faecal incontinence 
Sexual function Physical ability to have sexual intercourse 
Sensation Perineal sensation 




Power Leg muscle strength 
Pain Pain due to abnormal sensation or non-painful 
stimulus 
Adverse Events Complications (including death) 
Quality of life Global quality of life 
Occupational role functioning 
Social functioning 
Ability to do daily activities 
Mobility and walking 
Low Mood and depression 
 
The consensus meeting feedback form was completed by 13 out of 16 patient 
participants (81%). From the completed responses, 100% of patient participants 
strongly agreed or agreed with the questions posed on the feedback form for the 
meeting (Table 5.19). The feedback form was completed by 16 out of 17 HCPs 
(94%). For the HCPs, apart from 1 participant who ticked neither for “I was satisfied 
with the process used to agree the core outcome set on the meeting day” all other 
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participants strongly agreed or agreed with the questions on the feedback form 
(Table 5.20). The comments were generally positive as evidenced in Table 5.21. 
Figure 5.8 shows some of the study team with the international participants at the 
end of the CESCOS consensus meeting.  
 
Table 5. 19 Patient feedback for the consensus meeting. Number of participants 
are displayed with percentage in brackets (%). 
Questions  
Strongly 





2. The information that the 
organisers provided me with in 
advance of the meeting was 
helpful 
10 (77) 3 (23) 0 0 0 0 
3. I was satisfied with the 
process used to agree the core 
outcome set on the meeting day 
8 (62) 5 (38) 0 0 0 0 
4. I was satisfied with the way 
the meeting was facilitated 
12 (92) 1 (8) 0 0 0 0 
5. I felt able to contribute to the 
meeting 
8 (67) 4 (33) 0 0 0 1 
6. I felt comfortable in 
communicating my views 
10 (83) 2 (17) 0 0 0 1 
7. The workshop produced a 
fair result 





Table 5. 20 HCP feedback for the consensus meeting. Number of participants 









2. The information that the 
organisers provided me with in 
advance of the meeting was 
helpful 
11 (69) 5 (31) 0 0 0 0 
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3. I was satisfied with the 
process used to agree the core 
outcome set on the meeting day 
10 (63) 5 (31) 1 (6) 0 0 0 
4. I was satisfied with the way 
the meeting was facilitated 
11 (69) 5 (31) 0 0 0 0 
5. I felt able to contribute to the 
meeting 
10 (67) 5 (33) 0 0 0 1 
6. I felt comfortable in 
communicating my views 
10 (67) 5 (33) 0 0 0 1 
7. The workshop produced a 
fair result 
11 (73) 5 (33) 0 0 0 0 
 
Table 5. 21 Comments on the consensus meeting feedback form from Patients 
and HCPs. 
Patients HCPs 
I was very pleased to be asked to 
participate 
Good Result 
The beds in the back were a life saver Well organised and inclusive 
Nish communicated very well before 
and during the meeting 
Good event  
I thought that Sara did an excellent job 
of keeping us all focused and "on track" 
An excellent facilitator with this 
difficult task. 
The workshop produced an excellent 
result 
An excellent venue Very well organised meeting 
Everything was great Very good 
I think everything was run well in a 
relaxed friendly way 
Outstanding organisation skills 
Meeting was facilitated really well 
helping me focus. A day well spent 
Uncomfortable at times but managed 
well 
Really well facilitated Excellent facilitation 
Thank you all Excellent meeting- thank you 
It was great Every domain describes above was 
managed very well and efficiently 
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Needed de-caf tea (only a small 
problem) 
Was very well done right from 
inception till the end 
 Great job 
 Excellent meeting- thank you 
 
 
Figure 5. 8 CESCOS international participants with some of the study team at 





5.4.1 Main findings 
This study is the first in the literature that has determined the core outcomes for 
CES. It has been registered on the COMET database and a transparent process has 
been used involving an international Delphi survey and an international consensus 
meeting to decide the COS. All outcomes included have been scored and agreed as 
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critical by at least 70% of patients and 70% of HCPs. This COS is recommended for 
use in any study assessing outcomes for CES.  
 
5.4.2 “Long to short” list of outcomes 
There have been protocols for COS development and completed COS studies where 
the list of outcomes for rating in the Delphi survey were sourced from the long list 
derived from a systematic literature review and qualitative patient interviews.
41 42 183 
250 264 286
 The short list for the Delphi survey should reflect the outcomes of 
importance by patients and HCPs. 
 
In the current CESCOS study, forty-three verbatim outcome terms were mentioned 
within the 260 from the qualitative interviews that were not seen in the 737 verbatim 
outcome terms from the literature review
135
. These verbatim outcome terms were 
particularly helpful in deciding the plain language summary and terminology of 
some outcomes in the Delphi list. An effort was made to ensure the outcome list for 
the Delphi survey was succinct and there were no duplications as it has been seen 
that a longer list of outcomes is significantly associated with a lower response 
rate.
295
 Pilot testing had helped improve the outcome terminology and confirmed 
that the questionnaire was understandable and not time consuming to complete. The 
outcomes for the CES Delphi were mapped to five domains of clinical outcomes, life 




5.4.3 Delphi survey- number recruited 
There is a variation in the number of participants recruited for Delphi surveys in 
COS development ranging from 12 to 1018 participants. 
42 240 264 285 296 297
 The 
decision of how many individuals to include for a COS is not based on statistical 
power but is a pragmatic choice and it is noted that the numbers can potentially be 
small if the condition is rare or the intervention is not common.
33
 A review of COS 
studies from the COMET database revealed that 22% had recruited patients from 5 
or more countries.
246
The CESCOS study recruited 172 participants (104 patients and 
68 HCPs) for both rounds. The Delphi survey was completed by patients from 8 
countries and HCPs from 12 countries. CES is a rare condition and considering the 
numbers from other COS studies, this was deemed to be a satisfactory response.  
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The reflection from the author (NS) was that recruitment for the Delphi survey of 
HCPs received a better response rate from convenience sampling than through 
professional organisations. For example, the SBNS (Society of British Neurological 
Surgeons) had placed an advert to their membership of 400 consultant members and 
10 members had filled in the survey excluding those who were not contacted through 
the study team. This gives a response rate of 2.5% from this organisation. The bias 
of convenience sampling is that it may have produced results from a local population 
of HCPs known to the research team, which are not generalisable to outside of the 
region if it is the only method of sampling used. However, only 25 (37%) HCPs 
were recruited from convenience sampling and 43 (63%) HCPs were recruited 
through HCP professional organisations. For the patient group, recruitment was most 
successful through social media via the patient charity groups. The intention was to 
set up participation identification centres to recruit patients but this was not seen as 
necessary as the patient response from social media was deemed satisfactory.  
 
5.4.4 Delphi Survey- attrition  
The degree of non-response after the first round is known as attrition.
33
 Attrition bias 
is when participants that do not respond to subsequent rounds have different views 




Attrition rates between rounds for previous COS studies range from 11 to 26%. 
42 262 
264 287
 In the CORMAC study it was noted that patients who were recruited through 
social media had a higher attrition rate compared to those recruited through hospital 
sites (31% Vs 15%).
264
 The assumption was that participants recruited online were 
not as invested as those recruited by personal contact. Previous research suggests 




COS developers are asked to ensure that patients from these organisations have 
relevant recent experience of the condition.
33 233
 To document this, demographics 
were collected from all patient participants in the CESCOS study. In addition, CES 
patients were also recruited from medical records of a single tertiary hospital for this 
study so as not to solely rely on the social media method of recruitment. However, 
there was no significant difference in the mean scoring between patient and HCP 
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participants who had completed both rounds to those who had only finished the first 
round therefore no attrition bias. 
 
5.4.4.1 Attrition rate of patients and healthcare professionals 
The overall response rate of the CESCOS Delphi was 63%. HCPs (82%) had a better 
response rate compared to the patients (55%) in round 2. The attrition rate for patient 
participants was higher in CESCOS study compared to the HCPs and in comparison 
to other recent COS studies.
269 286 287
 There could be a few reasons for this: 
1) Most HCPs were recruited from professional organisations whereas most patients 
were recruited openly from social media. HCPs maybe more familiar completing 
research related prioritisation exercises than patients.  
2) The importance of completing both rounds of the Delphi may have not been 
emphasised enough through social media with the patient group. It was mentioned in 
the information leaflets that two rounds would need to be completed, which may not 
have been read by many participants. In addition, it was not mentioned on the online 
study registration form. 
3) Patient organisations may be open to the public but could be accessed by a narrow 
spectrum of self-selected patients 
61




A few methods could have been used to reduce attrition rates: 
1) The use of a short video explanation by a clinician and a lay person regarding the 
CESCOS study may have been ideal in establishing the reasons for the Delphi 
survey and the importance of completing both rounds.  
2) Setting up participant identification centres and for the local clinical team to 
recruit patients. This may have decreased attrition rates as introduction to the study 
and follow up by the local team would have been more personal but sufficient time 
would be required for each site to be established.  
3) Shortening the time between rounds. There was a month between the rounds 
where patients may have had to refresh their understanding of the study and did not 
have the time or the interest to continue. 
 
5.4.5 Delphi Survey- participants  
Most HCPs taking part in the Delphi were spinal surgeons. This is reflective of 
current CES management as it is managed as an acute condition requiring 
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emergency intervention in most cases.
7-9 17
 In addition, most research in CES is 
performed by surgeons which is reflective of the HCPs involved during the acute 
stage. Sixty-three percent of HCPs had 10-20 years or 20 years plus of clinical 
practice indicating that these were HCPs with significant clinical experience, who 
had contributed to the consensus process.  Patients were in the age group of 30-39 or 
40-49 and 52% of patients were not in employment or retired. This reflects that CES 
affects a working age population with a potential unknown economic burden. 
Eighty-nine percent of patients had an operation for CES and this correlates with the 
aetiology for CES mainly being a compressive pathology that requires surgical 
decompression- most likely due to disc herniation.
7-9
 Sixty-one percent of patients 
were less than 5 years and 39% were more than 5 years from diagnosis of CES 
which allows short and long term outcomes to be prioritised appropriately.  
 
Inclusion of patients from multiple countries is seen to be more difficult than it is for 
HCPs.
33
 In the CESCOS study, 55% of participants were from the UK and 45% 
were from outside the UK. Participants were involved from 14 different countries. 
North America was the most common country from which participants were 
recruited outside the UK. This could be due to the study being conducted in the 
English medium so it was more receptive to Western countries participating. This 
means participants who understood English from non-English speaking countries 
may not be fully representative of the CES population in that country. Of the 227 
COS studies in a systematic review the majority have involved collaborators (79%) 




If the feedback suggests that the participant is in the minority with regards to their 
scoring of importance regarding the outcomes, then they may be more likely to drop 
out leading to an overestimation of the degree of the final consensus.
300
 However, in 
the CESCOS study there was no significant difference in the average Delphi scores 
for patients and HCPs completing both rounds of the Delphi compared to those who 
only completed round 1, which suggests no attrition bias. 
 
5.4.6 Delphi survey- results of the scoring 
In round 1 for a Delphi survey in oesophageal cancer, HCPs rated information 
regarding short term clinical risks higher (anastomotic leakage, in hospital mortality 
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and inoperability) whereas long term outcomes like survival and disease recurrence 




The autonomic related outcomes voted into the CESCOS in round 1 of the Delphi 
are urinary retention, incontinence of urine, faecal incontinence and physical ability 
to have sexual intercourse. A higher proportion of HCPs scored these outcomes as 
critically important compared to patients. Other outcomes scored higher by patients 
in round 1 were genital sensation and quality of life related outcomes such as global 
quality of life, ability to do daily activities and mobility and walking. This reflects 
the literature where HCPs prioritise clinical outcomes compared to those related to 
life impact and quality of life, which patients find important. Role functioning 
although related to quality of life was scored by more HCPs as critically important 
and this maybe because HCPs tend to use it as a proxy for the economic impact of a 
disease. Leg muscle strength, perineal sensation and complications are all clinical 
outcomes but were only included from the second round after more HCPs rated them 
critically important. Reflexes and back stiffness were rated less important by patients 
in round 2, which resulted in these outcomes becoming consensus out. There is 
evidence which suggests that patients tend to rate many or all outcome domains as 
important in prioritisation exercises so HCP views would dominate as the outcome 
domains they do not deem important will not be included in the final COS.
45 155 301
 
This was observed for ten outcomes in the CES Delphi survey where ≥70% of 
patients voted them critical but the HCPs had not therefore excluding them from the 
COS at this stage (Table 5.10). These outcomes were sensation of bladder fullness, 
anal tone, foot drop, low back pain, leg pain, difficulty with body posture, anxiety, 
isolation, low mood and depression and hospital resources. 
 
A randomised control trial was nested within a Delphi survey to determine a COS 
for oesophageal cancer surgery. Question order did not affect the response rates 
amongst patients but fewer HCPs responded when clinical items appeared first. The 
patients rated clinical items quite highly irrespective of the question order more 
patient reported outcomes were rated critical when appearing last rather than first. 
HCPs rated clinical items higher when appearing last.
302
 In the CESCOS study, 
clinical outcomes were placed first and then patient reported outcomes later and this 
may have encouraged patients to rate more patient reported outcomes as critically 
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important and HCPs not to rate the clinical items as highly. However, there were still 
13 outcomes that were consensus in at the end of the Delphi survey of which 9 
outcomes were clinical and 4 outcomes were related to life impact.  
 
In the CORMAC study, it came as a surprise to the study team that colostomy free 
survival which is commonly used in trials in this field was not selected as an 
outcome but colostomy was. This illustrates the issue of using a composite outcome 
that is not of relevance or interest to patients.
264
 In the CESCOS study this was seen 
with the outcome of anal tone, which has been measured in CES research studies 
4 97 
135
 but used as a proxy for faecal incontinence. However, anal tone was not voted 
into the COS but faecal incontinence was, which again highlights the importance of 
not just measuring what clinicians feel is important.   
 
In the CESCOS study, patients were more likely to change their score than HCPs 
when re-scoring in round 2. Out of 499 score changes, 326 (65.3%) were by patients 
and 173 (34.7%) were done by HCPs. This would be expected as there were more 
patient participants in the Delphi compared to HCPs. However, when looking within 
each stakeholder group most patients (70.6%) made score changes based on personal 
experience or reflection whereas most HCPs (58.4%) made score changes based on 
the feedback from the stakeholder groups. In the prostate cancer COS study, 
although the sample size was small, of the HCPs who saw peer only feedback they 
were more likely to change with the influence of other scores (7/10; 70%) than those 
who saw multiple separate (3/7; 42%) or multiple combined feedback (4/7; 57%). 
Conversely, when initial agreement is poor, multiple separate stakeholder feedback 
may be a better strategy to reach consensus.
287
 Randomised controlled trials were 
nested within the development of 3 core sets, each including a Delphi survey with 
two rounds completed by patients and HCPs. Consensus between patients and HCPs 
regarding which items to retain was greater amongst those receiving multiple group 
feedback (65-82% agreement for peer only feedback versus 74-94% for multiple 
feedback). In addition, the differences in round 2 scores were smaller between 
stakeholder groups receiving multiple feedback than between those receiving peer 
group feedback only.
262
 Having multiple feedback in the CESCOS study helped 
decide the 13 outcomes for inclusion in the COS at the end of the second round of 
the Delphi survey.  
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5.4.7 Consensus Meeting- numbers and participants 
When comparing the average Delphi scores between participants who were invited 
to the meeting compared with those participants who did not attend the meeting 
there was no significant difference, which suggests no selection bias. Studies have 
found that researchers who are willing to participate in the consensus panel are 
generally representative of their colleagues.
303
 
Of the 18 HCPs at the consensus meeting, 10 were surgeons involved in acute CES 
management and 8 were doctors and allied HCPs involved in the longer-term care 
and rehabilitation of CES patients. This would reflective of a group of HCPs that 
manage CES patients in the short and long term from diagnosis. In the patient group, 
there was an equal spread of patients in the years since diagnosis of CES (<2: 5, 
≥2<5: 4, ≥5<10: 6 and ≥10: 1), which would have also facilitated prioritisation of 
short and long term outcomes for CES patients.  
 
In the CORMAC study only 6 patients had completed both rounds of the Delphi 
survey. As a result, eligibility for patient participants was expanded to include those 
that had only completed round 1.
264
 In the COS study for prostate cancer, the face to 
face consensus meeting consisted of 13 HCPs and 8 patients. The final COS 
included 19 outcomes.
287
 In the CESCOS study, despite being a rare condition, there 
was a satisfactory response from patients and HCPs who had completed both rounds 
of the Delphi to allow the eligibility criteria of completing both rounds to be 
unchanged for the consensus meeting. This maybe a reflection of it being a rare 
condition so it is not given much “attention” and “resources” medically. As a result, 
patients may have felt this was a unique opportunity to address this imbalance as 
opposed to, for example, patients with cancer who are generally prioritised by HCPs 
regarding management and support.   
 
5.4.8 Consensus meeting- voting 
After both rounds of the Delphi survey, 13 outcomes met the criteria for “consensus 
in” and 6 outcomes achieved the criteria for “consensus out.” There were 19 
outcomes with “no consensus” for discussion at the consensus meeting. All these 19 
outcomes were mentioned at the meeting. The participants agreed with the outcomes 
that were scored consensus in and consensus out during the Delphi survey. 
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The results of the Delphi survey where outcomes were voted <70% by both 
stakeholder groups were to be accepted without having a vote in the consensus 
meeting. However, within this section, the patient group felt strongly about the 
outcome of fatigue, which led to re-voting at the consensus meeting. This still did 
not achieve critical importance from both stakeholder groups at the consensus 
meeting vote. Fatigue has emerged as an important outcome for patients and has 
been subsequently added to the core outcome set in other disease areas,
231 304 305
 
which could be a future possibility for the CESCOS.  
 
Three outcomes were deemed critically important by patients but not by HCPs. 
These included low back pain, foot drop and need for further intervention. Wylde et 
al, 2015
306
 in the development of a COS for post-surgical pain after knee 
replacement also had an additional criteria for an outcome to be “consensus in” if 
90% or more scored an outcome critical from a single stakeholder group. The study 
team did not feel this constituted a consensus, as if there is a majority opinion in one 
group more than 90% and a minority opinion in the other group, the outcome would 
still qualify as consensus in. Even if this criterion was adopted for the CESCOS 
study, these three outcomes would still not have been included as they did not reach 
above 90% 7-9 scoring in a single stakeholder group.  
“Satisfaction with treatment services” was rejected from a low back pain study as 
participants felt it could be highly influenced by factors unrelated to the intervention 
240
 and consequently it would say little regarding the effectiveness of that 
intervention. There was a similar sentiment to the outcome of need for further 
intervention in the CES consensus meeting.  
 
The outcome of death was not voted on as it was felt it should have been included 
within the definition of complications. In the consensus meeting for prostate cancer, 
four outcomes were grouped back into broader domains (urinary function, bowel 
function, sexual function and overall quality of life). This was a pragmatic decision 
by considering the heterogeneity of responses from the Delphi survey and consensus 
meeting with regards to those discrete outcomes.
287
 At the consensus meeting for the 
CORMAC study, different aspects of sexual function were important to different 
participants and hence there was no individual outcome that would have achieved 
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consensus. However, participants agreed that all outcomes related to sexual function 
should be grouped together under the outcome sexual function and this was 
included.
264
 Considering these previous decisions, in the CES consensus meeting, 
death was included in the outcome of complications and explanations were re-done 
according to the request from participants. 
 
The OMERACT filter 2.0 stated that 4 core areas of outcome should be included in 
some manner in every clinical trial: death, life impact, resource use/economic 
impact, and pathophysiological manifestations.
229
 We have covered all these core 
areas except resource use as the outcome of hospital resources was not voted in by 
both stakeholder groups. “Work productivity” was the indirect non-medical costs for 
a lower back pain study and an important outcome for a clinical trial with an 
associated economic evaluation.
307
 However, the domain was believed to be a 
challenge to measure and “out of the scope” for a trial assessing intervention 
efficacy.
240
 These were similar sentiments to the outcome of hospital resources 
hence it was not included in the CESCOS. However, occupational role functioning 
was included in the CESCOS, which is sometimes used as a proxy for the economic 
impact of a disease.  
 
5.4.9 Consensus meeting- the core outcome set 
We have determined 16 outcomes that matter the most to key stakeholders. This 
does not include how they are defined or measured. They can be divided into 
outcomes related to autonomic function (incontinence of urine, urinary retention, 
sensation of bladder fullness, faecal incontinence, physical ability to have sexual 
intercourse, perineal sensation, sensation in genitals), non-autonomic outcomes (leg 
muscle strength, pain due to abnormal sensation of non-painful stimulus, 
complications) and outcomes related to quality of life (global quality of life, 
occupational role functioning, social functioning, ability to do daily activities, 
mobility and walking, low mood and depression). In other core outcome sets, they 
have categorised the outcomes according to intervention.
287
 For the CESCOS, all the 
outcomes could develop regardless of the intervention or not hence they were 
categorised alternatively as in Table 5.17. 
In the medical literature, there is a focus on the autonomic dysfunction and the 
clinical sequelae of CES.
135
 There is little emphasis on the quality of life. This COS 
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has highlighted the importance of occupational role functioning, social functioning, 
ability to do daily activities, mobility and walking, low mood and depression and 
global quality of life to be assessed as a minimum standard. There is also evidence to 




5.4.10 Consensus meeting- feedback 
Feedback from the consensus meeting was positive with 100% of patient participants 
who strongly agreed or agreed with the statements on the consensus meeting 
feedback form. Despite one HCP participant whose answer was neither for “I was 
satisfied with the process used to agree the core outcome set on the meeting day” all 
other responses from HCP participants strongly agreed or agreed with the statements 
on the feedback form. The comments were overwhelmingly positive from both 
patients and HCPs.  
 
5.4.11 Impact of patient involvement in the consensus process 
Two patient research partners (PRPs) were involved in the CESCOS study team and 
patient organisations contributed significantly to the Delphi survey and consensus 
meeting in the following ways:  
1) The short list of outcomes to be rated in the Delphi survey were reviewed by the 
PRPs on the study team. They contributed to the lay language explanations of these 
outcomes.   
2) The design of the website was reviewed by the PRPs through cognitive interviews 
and improvement in the layout and structure of the Delphi survey was performed. 
3) PRPs suggestions were followed to not release the Delphi or hold the consensus 
meeting during a busy time of the year for participants such as school holidays or 
near the Christmas holidays and to have it open for a month to enable participants to 
complete it at a time suitable for them without feeling pressurised.  
4) Patient organisations were integral in recruitment. They had sent the information 
leaflet and online link of the Delphi survey to their international group of patient 
members encouraging them to complete it.  
5) The patient representative of the US based CES charity had practical suggestions 
for the consensus meeting after discussion with her patient members. This included 
the meeting having regular breaks, being able to continue with discussion and voting 
despite participants leaving, having the meeting room near toilet facilities due to 
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mobility issues and using beds at the back of the room so patients can relieve their 
back pain and continue voting. These were all implemented with positive feedback.  
6) PRPs suggested an informal meeting for the patient participants at the hotel the 
evening before the consensus meeting to meet members of the study team and 
facilitator so the patients would feel relaxed on the day of the meeting, which was 
achieved. There was also, as suggested by the CES organisations and PRPs, a 
meeting with patient participants before the start of the consensus meeting to ensure 
they understood the format of the day and to answer any questions before the HCPs 
were involved.  
7) PRPs suggested due to mobility issues taxi to and from the hotel would be 
preferable than multiple train journeys. They co-ordinated groups in taxi to reduce 
the costs incurred on the study budget.  
8) The US based CES charity arranged an online fundraiser and raised over £1000 
from its members to contribute towards the funding of the consensus meeting.  
 
5.4.12 Limitations 
There are some limitations to the consensus process: 
1) The short list of outcomes for the Delphi survey was produced from a systematic 
literature review, which was only performed in the English language and from 1990. 
The qualitative interviews which informed the short list was through a sampling 
frame with patients who had an operation in a single tertiary centre. There may be 
the possibility that further outcomes may have been collected if the systematic 
literature review covered an earlier date and non-English language publications 
and/or the qualitative interviews were done nationally or internationally rather than 
from a regional population. However, the first round of the Delphi survey allowed 
all international participants (272) to suggest additional outcomes, which was 
considered by the study team and patient representatives for inclusion in round 2.  
2) Recruitment for patients was partly through CES charity organisations. Their 
membership may involve CES patients who are more vocal and forthcoming with 
their opinions than the general CES population. There was also recruitment from 
patients who had been treated at a single tertiary centre. Time limitations prevented 
from implementing participation identification centres in other hospitals managing 
CES patients but this method has been seen to produce minimal numbers for patient 
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recruitment in the Delphi survey in another disease area of anal cancer 
(communication with COS developer- Rebecca Fish). 
3) As mentioned before, 37% of HCPs were recruited by convenience sampling and 
may not be generlisable to the population. However, there was representation of 
HCPs from 12 countries for the Delphi survey. HCPs were also recruited from 
professional organisations as well. There maybe be bias here as each professional 
body may encourage its members to follow a certain management protocol for CES.  
4) As mentioned before the attrition rate for the CESCOS Delphi survey was higher 
than other COS studies but this may have been due to recruitment through social 
media.  
5) The Delphi survey and consensus meeting were only conducted in the English 
language due to the limitation of time and budget resources. Even so, participants 
from 14 countries were involved in the Delphi survey.  
6) Clinical details were not asked on the registration page for the Delphi as it could 
not be verified with the clinical notes. As a result, the severity of the patient’s 
presentation with CES (CESI or CESR) was not identified for the Delphi survey. 
There may have been a predominance of CESI or CESR patients who completed the 
Delphi survey that may have biased the results. However, short and long term 
outcomes have been prioritised in the COS suggesting a variety of patient 
participants have been involved. The demographics of age, gender, employment and 
years since diagnosis also support that a range of patients were included in the 
Delphi survey.  
 
5.4.13 Summary and Next steps 
The COS should be reviewed in the future to identify if any outcomes need to be 
added or removed 
33
 and the aim is to do this in 5 years to analyse uptake in CES 
research studies. To ensure consistency in measurement and reporting of these 
outcomes the next stage will involve standardising definitions and recommending 
measurement instruments for each outcome in the COS following the COMET- 
Consensus based Standards for the Selection of Health Measurement Instruments 
(COSMIN) guidelines.
54
 This will be described in further detail in the next chapter 
of overall discussion. 
In the disease area of rheumatoid arthritis, there was an increase in the proportion of 
studies over time using the core outcome sets that were developed, with almost 70% 
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reporting all these outcomes in trials published in 2010. The trialists that did not 
report the COS were unaware of the COS when selecting which outcomes to 
measure.
33
 A question asked in Gargon EA thesis- Was future implementation or 
uptake of the core outcome set considered by your group at any stage?.
299
 Seventy-
six researchers responded and 12 of them that had not considered it (16%). Of the 
rest, this is what they defined as implementation; publication in a journal, 
participating in a meeting, discussing with relevant stakeholder groups, involvement 
of prospective users in the development process who may influence uptake later and 
uptake in guidelines.  
The intention of the CESCOS study team is to publish the results in an open access 
article, present it at international and national meetings, present at CES charity 
events and to disseminate findings through the CES charity groups. This will be 
explained further in section 6.4. 
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Chapter 6: Overall Discussion 
 
6.1 SUMMARY OF MAIN FINDINGS 
This thesis describes the development of a core outcome set (COS) for research 
studies in Cauda Equina Syndrome (CES). It is the first time in the literature a COS 
has been developed for CES. It was created using the methods of a systematic 
literature review, qualitative interviews, a Delphi survey and a consensus meeting, 
with international participation from HCPs and patients.  
 
The systematic literature review
135
 showed that different outcomes were being 
assessed and reported in CES research studies. Most outcomes were not defined and 
an appropriate measurement tool was not used. There was an emphasis on 
physiological/ clinically related outcomes. The systematic literature review 
highlighted the need for a COS to standardise the outcomes reported in CES, and to 
ensure that the priorities of patients were considered.  
 
Qualitative interviews conducted through a sampling frame with CES patients 
revealed more life impact outcomes 
72
 than the literature review but also had 
physiological/ clinical outcomes as well. Patient-reported outcomes were seen in the 
qualitative interviews that have not been identified in the systematic literature 
review. This highlights that the medical literature does not fully report outcomes that 
patients deem important. In addition to the identification of outcomes, thematic 
analysis revealed four main themes; 1) varying priorities of physical health, 2) a 
fragmented healthcare service 3) the process of adjustment and 4) anticipatory 
anxiety and diminished self-worth. These themes have similarities with other chronic 
diseases, which highlights the issue with CES management because it is treated as an 
acute problem with little emphasis on the follow up after initial management. This is 
the largest qualitative set of CES patient interviews to date which stratified patients 
according to the severity of their condition.  
 
The combined “long” list of verbatim outcome terms were discussed with the study 
team including patient representatives to reduce the list of outcomes for the Delphi 
survey. The Delphi survey was distributed internationally to HCP professional 
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bodies, CES patients and charity organisations. A significant number of patient and 
HCP participants from multiple countries completed both rounds of the Delphi 
survey. Most outcomes included in the COS achieved consensus after both rounds of 
the Delphi survey according to pre-specified criteria.  The outcomes with no 
consensus were discussed and anonymously voted on at an international consensus 
meeting attended by patients and HCPs who had completed both rounds of the 
Delphi survey. Extra outcomes were agreed to be included in the COS from the 
consensus meeting. The final COS includes autonomic outcomes (incontinence of 
urine, urinary retention, sensation of bladder fullness, faecal incontinence, physical 
ability to have sexual intercourse, perineal sensation, sensation in genitals), non-
autonomic outcomes (leg muscle strength, pain due to abnormal sensation or non-
painful stimulus, complications) and quality of life outcomes (global quality of life, 
occupational role functioning, social functioning, ability to do daily activities, 
mobility and walking, low mood and depression).  
 
6.2 STRENGTHS 
Methodology was chosen to ensure that key stakeholders were involved and 
represented throughout the process.  
 
The systematic literature review followed PRISMA guidelines and documented all 
outcomes in the literature, if they were defined or not, and what measurement tools 
were used for each outcome domain. This was done not only to aid informing the 
core outcome set but to facilitate the beginning of the next step regarding “how” to 
measure the outcomes.  
 
The qualitative interviews used a sampling frame and successfully obtained a varied 
sample. A topic guide was improved with pilot interviews and then used in the 
interviews for consistency. A sample of the transcripts with qualitative coding done 
by the interviewer (NS) was checked by an experienced qualitative supervisor (AN) 
to ensure similar outcomes and themes were being interpreted from the transcripts. 
 
Outcomes that were deemed important by HCPs were obtained from the systematic 
literature review and outcomes important to patients were obtained from the 
qualitative interviews and used in the modified Delphi survey. This revealed that the 
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outcomes obtained were not fully aligned, between patients and HCPs, which 
supported the use of both stakeholders in the Delphi survey. The Delphi survey was 
completed by 172 participants and 45% of participants were recruited 
internationally, which is significant considering CES is a rare condition and 
managed in a secondary or tertiary healthcare setting by specialists.  
 
The consensus meeting was attended by participants outside the UK, which made up 
26% (9/34) of the group. Patients and HCPs have been separated before in other 
COS studies with the concern that HCPs could dominate the discussion 
42
 however 
in the CES consensus meeting, all stakeholders were kept together. Participants were 
given pre-meeting information regarding their scores and what to expect on the day 
in plain language. The patients had a short briefing with the chair/ facilitator before 
the meeting commenced to provide reassurance and confidence throughout the day 
so they could engage in the meeting.  
 
Equal representation from patients and HCPs was ensured during the Delphi survey 
and the consensus meeting as even though there were a different number of 
individuals in each group the criteria for including an outcome in the COS required 
at least 70% agreement from each stakeholder group. A consensus was achieved and 
a second consensus meeting was not required. Feedback from the consensus meeting 
regarding the pre-meeting information, the process, the facilitation, the ability for 
participants to communicate and contribute and the results were overwhelmingly 
positive and supported the combined patient-HCP interaction. This confirms that the 
process delivered a COS and a fair result agreed by both patients and HCPs. 
 
6.3 LIMITATIONS  
As mentioned before the study was carried out in English only due to time and 
budget resource limitations. Despite this there was still involvement from countries 
where English is not the national language including India, Malaysia, Brazil, 
Denmark, Portugal, Germany and Czech Republic for the Delphi survey. The study 
would have been biased towards individuals who can understand English in non-
English speaking countries. As a result, their views may not be fully representative 
of the general CES population or healthcare professionals in the country. 
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The systematic literature review analysed patients who had an operation for CES. 
The majority of CES cases are due to a compressive lesion that requires an 




The qualitative interviews were also performed with CES patients who had an 
operation for the condition. The qualitative interviews were sourced from a single 
tertiary centre with a catchment population of 3.5 million in the Merseyside region 
of the UK. This was assumed to be reflective of CES patient diversity elsewhere and 
allowed a sampling frame (described in the Chapter 4) to be developed where 
different severities of CES could be captured to identify a range of outcomes from 
patients. However, for the Delphi and consensus meeting the study team decided to 
extend the target population of the COS to include CES patients who were managed 
without surgery. All Delphi participants (including patients from multiple countries 
who did not have an operation) in round one of the Delphi survey could suggest 
further outcomes to be reviewed by the study team in case they were not captured 
from the systematic literature review or the qualitative interviews sourced from CES 
patients who had an operation.  
 
The attrition rate was higher in the Delphi survey (as mentioned in the discussion 
section of the consensus chapter 5) and this was felt due to recruitment through 
social media as seen in another study.
264
 Two months was spent recruiting HCP 
professional bodies and patient charity organisations for distribution of the Delphi 
survey. Eleven organisations were recruited and the recruitment period for the 
Delphi survey could have been kept open for longer but it is believed that this may 
not have had a more beneficial effect than what was achieved.  
 
For the consensus meeting forty participants were invited consisting of twenty 
patients and twenty HCPs. However, thirty-four participants finally showed. There 
was roughly an equal representation of patients (16) and HCPs (18). Having 
different numbers would not have affected the results as percentages of the scoring 
were calculated within each group so it is unlikely that having more patient 
participants would have changed the consensus results. 
 
6.3.1 Participant diversity  
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The systematic literature review
308
 in chapter 2 included studies from the online 
databases of Medline, Embase and CINAHL Plus. This is established literature that 
was mainly performed in North America and Europe. Socio-demographic details 
were not collected here but most papers did not provide details beyond the age and 
gender of the patient cohort. 
The qualitative interviews were performed for CES patients in the Merseyside region 
of the UK. The sampling frame included the severity of the condition (CESI or 
CESR), years since the operation and the age and gender of the patient. These were 
factors felt most pertinent to eliciting the diversity and different outcomes in the 
population. It would have been beneficial to have other socio-demographic factors 
considered but pragmatically this would have been difficult to achieve with the 
resource, time limitations and the small study sample. Ideally, it would have been 
beneficial to conduct a parallel qualitative study in another UK region with a 
different socio-demographic case mix like Birmingham or even in another city of a 
developing country with a different interviewer with the same topic guide and 
training. This would have allowed comparison of outcomes collected and increased 
the diversity of the sample.  
The Delphi survey intended to be as inclusive as possible. Most participants were 
from North America and Europe. It was difficult to involve many CES patients from 
South America, Asia, Africa and Australia as when searching online there were no 
dedicated CES charity organisations identifiable in these locations. Also, trying to 
involve HCPs from these continents was more difficult. With retrospect, it may have 
been beneficial to set up global research partners for the study who would have had 
better understanding and knowledge of local CES patient services and HCPs 
involved in CES care to increase the participant diversity involved. However, this 
would have required ethical approval locally in these countries for the patient 
participants, which would have been challenging considering the time limitations of 
the study.  
The consensus meeting used a sampling frame to select participants from the Delphi 
survey. For the patients, CES severity (CESI, CESR), years since diagnosis and 
geographical location, age and sex were deemed important and for the HCPs 
speciality, years in clinical practice and geographical location were deemed 
important. This created the diversity required to discuss and vote at the meeting. It 
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would have been beneficial to include more international participants but the budget 
restrictions limited this.  
COS studies are encouraged to be international and inclusive as possible with key 
stakeholders in order to facilitate and encourage uptake
33
. To achieve diversity of an 
international selection of participants is better than to incorrectly assume that the 
sample is representative of all CES patients. Our study had diversity for the factors 
deemed important in patient and HCP participants by the study team however it is 
biased in the socio demographic features towards a population of North America and 
Europe. If time and resource limitations were not present then the suggestions above 
may have improved the socio demographic diversity in this study. 
 
6.3.2 Pain outcomes 
Pain due to abnormal sensation or non-painful stimulus was included as an outcome, 
which was the explanation for neuropathic pain. However, low back pain and leg 
pain were not included in the COS as they were not agreed by HCPs as critically 
important. In the literature, leg pain and low back pain are reported
135
 so for it to be 
excluded by HCPs was not expected.  
Another criteria used by a previous COS developer to include outcomes was if more 
than 90% of one stakeholder group votes an outcome critical
306
 but this still would 
not have qualified leg and back pain for our study. There could be participation bias 
as patients with severe leg or back pain without adequate analgesia may not have 
attended a consensus meeting due to difficulty mobilising. To address this, maybe a 
virtual or online consensus meeting could have facilitated such participants being 
involved despite the inherent difficulties with discussions between multiple users on 
an online interface. Another safeguard to the patient’s perspective is to say that if an 
outcome is voted critical by the majority in one stakeholder group then to allow 
further discussion and re-voting at the consensus meeting later in the day. Another 
way would be for participants to submit their reasoning after the meeting, to be 
distributed to all participants involved followed by a re-vote performed remotely a 
week later. This allows participants time to formulate appropriate justifications for 
their voting before a re-vote as sometimes the pressure and structured timetable of a 





Development of an implementation plan have been outlined formally in the COS 
handbook,
33
 which is in italics below. How the CESCOS has addressed it is 
mentioned below the recommendations.  
 
 1. Register the intention to do the COS with the COMET Initiative 
The COS is already registered as study 824 on the COMET website and the final 
COS will be openly available here as well. 
 
 2. Disseminate the COS to researchers in the area of health or social care, through 
publication in an appropriate journal and presentation at relevant conferences 
The COS will be presented at national and international conferences and is being 
authored for publication. The conferences and publications will be targeted towards 
the stakeholders who are involved in CES clinical management and research (e.g. 
Society of British Neurological surgeons, British Association of Spinal Surgeons, 
Eurospine etc). CES charity organisations (e.g. Cauda Equina Syndrome 
Association, Cauda Equina Syndrome Foundation, Spinal Injuries Association etc.) 
will be contacted to allow dissemination and promotion of the COS by patients. The 
publication will also be distributed to contacts of the study advisory board and 
participants of the Delphi who had confirmed they were interested in seeing the 
results of the project. 
 
3. Contact funders of research in the area of health or social care, relevant 
Cochrane Review Groups, guideline producers, regulators and relevant commercial 
organisations to let them know about the COS 
The following healthcare professional organisations will be informed of the COS as 
they would potentially fund studies with CES patients; Eurospine, North American 
Spine Society, Royal College of Surgeons. These research bodies will be contacted 
as potential funders of CES research;
309
 United States National Institute of Health, 
The European Commission, Canadian Institutes of Health Research, Australian 
National Health and Medical Research Council, European Commission, Medical 
Research Council UK, National Institute of Health Research and the Wellcome 
Trust. These commercial organisations will be contacted who could potentially fund 
CES research projects: Medtronic, DePuy Synthes spine, NuVasive, Coloplast. 
 152 
  
4. Inform those responsible for planned and ongoing research identified through 
prospective registries, including trial registries such as those accessible through the 
WHO portal for international clinical trial registries and PROSPERO for systematic 
reviews 
On the WHO portal for international clinical trial registries two studies which are 
currently recruiting include the Understanding CES (UCES) study and the Back or 
Leg Pain and Bladder Symptoms (BLB) Study. The British neurosurgical trainee 
research collaborative (BNTRC) group is conducting the UCES study; a national 
prospective audit collection of CES outcomes (https://www.bntrc.org.uk/current-
projects). NS is on the steering committee for this study and the outcomes of the 
CESCOS is being considered for implementation in the 1 year follow up of the 
recruited patient participants. 
The BLB study aims to see what differences exist between the 'scan positive' and 
'scan negative' groups, help doctors understand more about the outcomes of both 
groups and discover the number of patients with 'scan negative' CES who have 
functional disorders (previously called medically unexplained or conversion 
disorders) or undiagnosed neurological disorders. The study team will be contacted 
in Edinburgh to see if the CESCOS can be implemented in the study.   
On PROSPERO regarding systematic reviews two reviews regarding Incidence of 
Cauda Equina Syndrome and Non-discogenic causes of the cauda equina syndrome 
were being conducted. Corresponding authors will be contacted and informed 
regarding the CESCOS.  
 
5. Contact journals in the area of health or social care to suggest an editorial or 
commentary about the COS 
The highest impact spine journals such as Spine, The Spine Journal and the 
European Spine Journal will be contacted to submit an editorial or commentary 
about the COS. 
 
6.4.1 Patient involvement in uptake 
This CESCOS will be disseminated via charity organisations through their meetings 
and social media, which will encourage patient awareness. Patient organisations will 
be asked to discuss these outcomes at their informal meetings. HCPs can liaise with 
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a representative from these meetings to garner what patients are describing in 
relation to these outcomes and direct them to the appropriate local health services. 
Patients can be encouraged to mention the COS at follow up clinic meetings with 
their local HCPs to use it as a structure as to how their aftercare is being tailored for 
them. Patients can be asked to send copies of the study to their local spine 
department and to circulate it. These strategies will increase awareness 
internationally amongst HCPs and can potentially increase uptake in CES related 
studies. Patient organisations could recommend the COS on their websites and on 
social media, question current and future CES research studies if they used the COS 
mentioning they would advocate it for further studies. This can increase awareness 
amongst clinicians and increase uptake.  
 
6.5 IMPLICATIONS  
Autonomic, non-autonomic and quality of life outcomes were highlighted as 
important for future CES research studies. The autonomic and non-autonomic 
outcomes have been mentioned in the previous CES literature but not all together in 
a single study. The quality of life outcomes has not been collected in CES research 
studies previously but has been identified through interviews and the consensus 
process as being important to patients.  
For researchers in CES, there needs to be a shift from clinician reported 
retrospective data
135
 to using validated assessment tools that measure patient 
reported outcomes especially with regards to quality of life. The CESCOS is not 
restrictive so additional outcomes can be collected with appropriate explanations but 
future CES researchers are recommended to use the CESCOS as a minimum dataset. 
If not, then a reasonable justification needs to be provided as why a CES research 
study would be exempt from using this COS, which has been developed with 
transparent structured methodology by patients and HCPs.   
 
6.6 APPLICATIONS IN OTHER SETTINGS  
The scope of the CESCOS study was for research studies in CES. However, it need 
not be limited to this use. These outcomes are identified by patients and HCPs as 
important and could be implemented for use in a national or international spine 
registry data. There may be outcomes in the CESCOS that are relevant for a core 
information set. These are outcomes important for patients to be informed of in a 
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clinical scenario, for example, informed consent for a surgical procedure.
310
 NHS or 
other healthcare services, charity organisations and support groups could use the 
core outcome set to understand how services can be improved to address the 
outcomes that have been highlighted to be most important in this condition to 
patients and HCPs. Even though there is the potential for the CESCOS to be used in 
these different situations caution must be exercised when doing so as the original 
aim of the COS is for future research studies. There might be some outcomes in the 
COS, which are not suitable for routine data collection or to be mentioned on a 
consent form as an information set. There may also be other outcomes in CES that 
are more suited for these purposes but have not been identified by the COS. It is 
important to be aware of this when potentially applying the CESCOS for other 
purposes.  
 
6.7 FUTURE FURTHER WORK  
Further work is required in understanding why leg pain and low back pain were not 
included in the COS by HCPs when they have been reporting it in the literature. 
Other important areas of further work include “how” the outcomes are to be defined 
and measured, the definition of onset of CES to intervention, and developing a study 
which investigates the relationship between time to intervention and the outcomes of 
the CESCOS to see if there is a significant difference.  
 
6.7.1 Clarification of pain outcomes 
Low back pain and leg pain were not included in the COS as previously mentioned 
under pain outcomes in the implementation section. Further qualitative interviews of 
HCPs to determine the reasons for this difference will be helpful in highlighting in-
depth reasoning for this.  
 
6.7.2 “How” outcomes are measured  
The next stage involves addressing “how” these outcomes are measured. This will 
require the outcomes to have standardised definitions and recommend an appropriate 
measurement instrument for each outcome in the COS following the Consensus-
based Standards for the Selection of Health Measurement Instruments (COSMIN) 
guidelines.
54
 The guidelines state the following criteria to adhere to when defining 




1) conceptual considerations 
2) identifying existing outcome measurement instruments through a systematic 
review or literature search 
3) assessment of the quality and feasibility of the measurement instrument through 
evaluation of measurement properties  
4) generic recommendations on the selection of outcome measurement instruments 
for outcomes included in the COS.  
Boers et al, 1998
311
 had defined outcome measures that should adequately meet the 
criteria of truth (validity; measure what they intend to measure), discrimination 
(reliability and sensitivity to change; discriminate between situations), and feasibility 
(be applied and interpreted easily) to be recommended. 
Although measurement instruments were mentioned in the systematic literature 
review 
135
 it is possible that the included papers did not comprehensively cover the 
measurement instruments available for each outcome. As a result, COSMIN 
recommend that each outcome may require its own systematic literature review if an 
existing review is not available on the COSMIN database. The most important part 
in the assessment of the measurement instrument is content validity before the other 
properties of reliability, responsiveness, internal consistency, structural validity, 
measurement error, hypothesis testing, criterion validity and cross cultural validity 
are analysed.  
Similarly, the definition of the outcomes should be decided through a consensus 
process to ensure it is agreed by key stakeholders. For example, in the CES 
consensus meeting for the outcome of fatigue, the patients requested the explanation 
to be changed and re-voted. Explanation for complications was requested by HCPs 
to include death and the explanation of need for further intervention was requested 
by both patients and HCPs to be changed before voting. Although this is regarding 
explanations of the outcomes, it shows how important it will be to engage key 
stakeholders when deciding the definitions for the outcomes. An expert panel 
discussion to suggest and recommend definitions for the outcomes can initially be 
done. Then international ratification can be sought through a Delphi survey with the 
first round open for suggestions regarding how the definitions can be improved.   
The aim of promoting the CESCOS and selecting the measurement instruments is to: 
- Increase uptake of the COS and reporting of the core outcomes in future CES 
studies. 
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- Increase quality of studies from level 3 retrospective studies to level 1 randomised 
controlled trials. 
- Allow synthesis of data collected to produce a stronger systematic literature 
review/ meta-analysis of CES research studies. 
- Better quality evidence supporting CES clinical guidelines and management. 
- Development of appropriate services for CES patients supported by evidence. 
 
6.7.3 Definition of the time between onset of CES to intervention 
A significant concern in the literature, when talking to patients and medico-legally 
was regarding the timing of surgery and what effect this had on the outcomes for 
CES. However, the time between which patients start having CES symptoms to an 
operation is recorded differently in many studies. This was highlighted in Chapter 
3. This is a significant issue as early surgery is strongly advocated as producing 
better outcomes for CES patients.
14 18 135 312
 There is no agreement regarding at 
which point the clock starts and finishes. This requires the following stages: 
1. The current systematic literature review
135
 (chapter 2) and chapter 3 to be 
extended to the current date with details of the timing analysed. These details would 
include when the timing was started and stopped and how the time was recorded. 
This would create a list of how timing is defined. 
2. The definition of the timing in surgery agreed with key stakeholders through a 
consensus process. 
3. Recommending researchers in CES should use the CESCOS and timing 
recommendations in future research studies to ensure consistency.  
 
6.7.4 Timing of surgery and relation to outcomes 
Once we have decided “how” to measure the outcomes in the COS and defined 
timing to intervention we can design a study to measure the outcomes. There are two 
options for pursuing a research study on CES patients: 
 
1) Prospective cohort study- Run an international study with participating centres 
and have a 1 to 2 year recruitment period to record the duration of symptoms and 
time before surgery. Document all relevant demographics and potential confounding 
factors. Follow up the CES patients long term for 5 years at least measuring all the 
outcomes of the CESCOS. 
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2) Cluster randomised trial- Have centres/regions with an infrastructure set up to 
refer CES patients in a hyper-acute fashion e.g. 24 hour MRI and emergency theatre 
services with expedited blue light transfer facilities. These centres can record the 
time to surgery and then follow up the outcomes of patients’ long term. The other 
centres with standard management and without the infrastructure in place to refer 
CES patients in a hyper-acute manner will have the same follow up of patient 




Through a transparent process, we have created a core outcome set for Cauda Equina 
Syndrome. This has been developed through a systematic literature review, semi 
structured qualitative interviews, a two round Delphi survey and a consensus 
meeting. What has been achieved is the identification at an international standard 
and agreement of outcomes that patients and HCPs believe are the most critical to 
report and measure in any research study for CES as a minimum.  
The systematic literature review 
135
 identified that there was heterogeneity of the 
outcomes reported and measured in CES studies. The qualitative interviews 
highlighted outcomes related to life impact which were not present from the 
literature review and suggests patient outcomes are under-represented in the medical 
literature. Patients and HCPs were brought together successfully for the Delphi 
survey and consensus meeting. The anonymous group results were visible to both 
stakeholder holder groups and there was still appropriate discussion and agreement 
to allow a core outcome set to be made. This shows that both patients and HCPs can 
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Appendix 2.1 Database Search Strategy.  
Ovid Medline 30/9/16 
 
Search # Search term Results 
1 exp Polyradiculopathy/ 2485 
2 (case report or abstract).mp. [mp=title, abstract, original title, name of 
substance word, subject heading word, keyword heading word, protocol 
supplementary concept word, rare disease supplementary concept word, 
unique identifier, synonyms] 
1980773 
 
3 Animals/ 6104266 
4 1 not 2 2119 
5 4 not 3 1996 
6 limit 5 to english language 1253 
7 limit 6 to yr=”1990 -Current” 650 
 
 
Ovid Embase 30/9/16 
 
Search # Search term Results 
1 cauda equina syndrome.af. 2580 
2 (case report or abstract).af. 13016786 
3 animal.af. 5369655 
4  (cauda equina syndrome not (case report or abstract)).af. 1191 
5  (cauda equina syndrome not (case report or abstract) not animal).af. 1116 












Search term Search Options Results 
1 Cauda equina syndrome  330 
2 Cauda equina syndrome NOT (case report 
or abstract) 
 252 
3 Cauda equina syndrome NOT (case report 
or abstract) NOT (animal) 
 246 
4 Cauda equina syndrome NOT (case report 
or abstract) NOT (animal) 
Narrow by Language: - english 241 
5 Cauda equina syndrome NOT (case report 
or abstract) NOT (animal) 
Narrow by Language: - english 









MORTALITY GENERAL	DISORDERS NERVOUS	SYSTEM	OUTCOMESNERVOUS	SYSTEM	OUTCOMESNERVOUS	SYSTEM	OUTCOMESNERVOUS	SYSTEM	OUTCOMESNERVOUS	SYSTEM	OUTCOMESNERVOUS	SYSTEM	OUTCOMESNERVOUS	SYSTEM	OUTCOMESNERVOUS	SYSTEM	OUTCOMESNERVOUS	SYSTEM	OUTCOMESNERVOUS	SYSTEM	OUTCOMESPHYSICAL	FUNCTIONING	ROLE	FUNCTIONING SOCIAL	FUNCTIONING EMOTIONAL	FUNCTIONINGLOBAL	QUALITY	OF	LIFE PHYSICAL	FUNCTIONING	HOSPITAL	USE NEED	FOR	INTERVENTIONADVERSE	EVENTS INFECTION SKIN	AND	SUBCUTANEOUS	TISSUEVASC LAR OUTCOMES	RELATING	TO	NEOPLASMSUR LOGICAL	AND	RENAL CARDIAC BLOOD	AND	LYMPHATIC	RESPIRATORY GASTROINTESTINAL
Outcomes Outcomes Bladder	functionOutcomes Motor Outcomes Sensation Outcomes General	NeurologyOutcomes Lower	back	painOutcomes Leg	pain Outcomes Bowel	functionOutcomes PR	sensationOutcomes PR	tone Outcomes Reflexes Outcomes Sexual	functionOutcomes Outcomes Outcomes Outcomes Outcomes Walking Outcomes Resource	useOutcomes Imaging Outcomes Outcomes Outcomes Outcomes Outcomes Outcomes Outcomes Outcomes Outcomes Outcomes Outcomes
post	operative	deaths 1 satisfactory	outcome 1 bladder	dysfunction 5 motor	weakness 5 sensory	deficit	in	legs 1 nervous	system	(AE) 1 low	back	pain	 9 radiculopathy 2 bowel	dysfunction 3 perianal	sensation 4 rectal	tone 1 lower	limb	reflexes 1 sexual	problems 1 unable	to	work 1 social	function 1 role	emotional 1 quality	of	life 3 walking	ability 2 length	of	stay 3 second	operation	(AE) 1 procedure	related	complication1 post	operative	infection	(AE)1 superficial	wound	infection	(AE)6 peripheral	vascular	(AE) 1 tumour	recurrence 3 urinary	(AE) 1 cardiac	(AE) 2 acute	posthaemorrhagic	anaemia	(AE)1 respir tory	(AE) 1 digestive	system		(AE) 1
In	hospital	mortality 2 poor	outcome 1 urinary	incontinence 12 radicular	paresis 1 subjective	numbness 1 worsening	neurologically2 lumbar	pain 4 sciatica 3 bowel	problems 1 saddle	anaesthesia 3 sphincter	disturbance 1 knee	tendon	reflexes 1 erection-	inability	to	attain1 return	to	work-	excellent1 social 1 mental	health 1 health	related	quality	of	life1 walked	with	a	walking	frame1 	total	charges 1 spinal	instability	(leading	to	dorsal	stabilisation)1 organ	specif c	complications1 infection	(AE) 3 wound	dehiscence	(AE) 1 venous	thrombotic	events	(AE)1 progression	of	tumour 1 prophylaxis	against	pyelonephritis	(AE)1 card ac dysrhythmia 1 intra/	post	operative	transfusions	(AE)1 pneumonia	(AE) 1 TOTAL 1
In	hospital	morbidity 1 total	recovery 2 bladder	incontinence 2 motor	recovery-	complete1 sensory	 3 neurologic	status 2 back	pain-	improvement1 sciatica-	unilateral 1 bowel	recovery 2 perianal	anesthesia-	complete1 anal	sphicnter	dysfunction2 ankle	tendon	reflexes 1 erection-	difficulty 1 return	to	work-	good 1 TOTAL 2 communication 1 quality	of	life-	role 1 ambulatory 2 	routine	discharge	(to	home)1 re-operations 1 total	complication	rate 1 infection	resulting	in	removal	of	implant	(AE)1 pressure	ulcer	(AE) 1 Deep	venous	thrombosis	(AE)7 disease	free	interval 1 renal	(AE) 1 TOTAL 3 TOTAL 2 ARDS	(AE) 1 VARIATION 1
death 10 relief	of	pain-	complete 1 urinary	continence 4 motor	recovery-	full 1 sensory	symptoms 3 neurological	function 2 back	pain-	no	improvement1 sciatica-	bilateral 1 stool	incontinence 1 saddle	hypoaesthesia 2 anal	tone 3 bulbocavernosus	reflex 1 reduced	sensation	during	intercourse1 return	to	work-	mediocre1 VARIATION 2 pyschosocial 1 quality	of	life-	physical 1 able	to	walk	without	aid1 nonroutine	discharge	(not	to	home)1 re-exploration	of	retained	fragment	due	to	significant	pain	(AE)1 complications 4 superficial	infection	(AE)1 wound	breakdown	(AE) 1 Pulmonary	embolism	(AE)3 TOTAL 5 TOTAL 3 VARIATION 2 VARIATION 2 pulmonary	(AE) 1
survival	time 1 relief	of	pain-	partial 1 urinary	retention 8 leg	weakness 2 sensory	deficit 5 neurological	recovery	 3 axial	lumbopelvic	pain 1 sciatic	pain 1 faecal	continence 1 scrotal	sensory	impairment1 perinanal	wink 1 ankle	jerk 1 dyspareunia 1 return	to	work-	poor 1 emotional	distress 1 quality	of	life-	social 1 role	physical 1 hospital	time	 1 herniated	disc	evacuation1 adverse	events 1 postoperative	infection-	instrumentation	related1 wound	healing	(AE) 3 fat	embolism	(AE) 1 VARIATION 3 VARIATION 3 chest	infection 1
mortality 1 near	total	recovery 1 urinary	retention-	complete1 paresis 1 sensory-	complete 1 neurological	deficit 6 low	back	pain-	very	good1 sciatica	improvement 1 flatulence 1 labial	sensory	impairment1 loss	of	sphincter	tone 1 knee	jerk 1 unable	to	attain	orgasm 1 role	function 1 emotions 1 quality	of	life-	personal	limitations1 physical	function 1 mean	hospital	stay 1 evacuation	of	haematoma1 intraoperative	complications1 postoperative	infection-	wound	related	(AE)1 delayed	wound	healing 1 TOTAL 13 TOTAL 4
surgical	morbidity 1 partial	recovery 1 urinary	retention-	partial1 motor	symptoms 1 sensory-	incomplete 1 neurological	status-	excellent1 low	back	pain-	good 1 sciatica	no	improvement1 bowel	incontinence 3 perianal	hyposensibility 1 sphincter	incontinence-	complete1 loss	of	deep	tendon	reflexes1 sexual	relations-	active 1 able	to	perform	daily	occupations	and	activities	without	impairment1 perce tions	of	health 1 TOTAL 8 physically	active	 1 TOTAL 8 local	oedema	and	operative	revision1 postoperative	complications1 discitis	(AE) 2 wound	complication	(AE)1 VARIATION 5 VARIATION 5
survival 2 outcomes-	poor 1 intermittent	self	catheterise8 lower	limb	weakness 1 sensory	loss-	improvement2 neurological	status-	good1 low	back	pain-	fair 1 nerve	root	pain 1 postop	intestinal	symptoms-	incontinence1 ensory	alt ration	in	perineum1 sphincter	incontinence-		incomplete1 TOTAL 7 sexual	relations-	inactive1 no	difficulty	in	normal	life	and	work1 TOTAL 7 VARIATION 6 walking	post	op-	<500	 1 VARIATION 6 evacuation	of	superficial	haematoma	(AE)1 co plication	rate-	in	hospital1 incision	infection	(AE) 1 Pressure	sores	(AE) 1
suicide 2 outcomes-	fair 1 pass	urine	by	straining	abdominal	muscles1 motor	deficit 13 sensory	loss-	no	improvement2 neurological	status-	fair 1 low	back	pain-	poor 1 sciatica-	work	related 1 postop	intestinal	symptoms-	retention1 pe ianal	anaesthesia 1 sphincter	disturbance-	improvement1 VARIATION 7 sexual	intercourse 3 mobility	of	lower	limbs 1 VARIATION 7 walking	post	op-	>500 1 vertebral	compression	fracture	of	upper	adjacent	level-	reoperation1 clinical complications 1 TOTAL 11 skin	pressure	and	pain	(AE)1
survival	rates 1 outcomes-	good 1 failed	TWOC 1 motor-	complete 1 sensory	impairment 4 neurological	status-	poor1 posterior	pelvic	pain 1 leg	pain 12 bowel-	major 1 perianal	sensory	impairment-	dense1 sphincter	disturbance-	no	improvement	1 erection 2 return	to	work 1 walking	post	op-	<200m 1 rod	breakage	-	re-operation1 peri-operative	complications	2 VARIATION 8 wound	related	complications	(AE)1
relative	mortality	risk 1 outcomes-	excellent 1 bladder	recovery 3 motor-	incomplete 1 sensory	recovery-	complete1 neurological	deficit-	satisfactory	outcome1 back	pain 8 intermittent	claudication1 bowel-	minor 1 perianal	sensory	impairment-	moderate1 sphincter	recovery	 1 sexual	dysfunction 2 working	ability 1 weight	bearing 2 secondary	haemorrhage	(AE)1 medical	complication 1 hardware	removal	due	to	screw	prominence	(AE)1
suicide 1 bodily	pain 1 detrusor	weakness	and	dyssynergia2 motor	function 5 sensory	recovery-	partial1 neurological	deficit-	unsatisfactory	outcome1 evere	p st	operative	pain1 radicular	pain 3 bowel	function-	intact 1 perineal	numbness 2 anal	squeeze 1 urinary	continence	during	sexual	intercourse1 r t rn to	work-	never 1 self	care 1 epidural	spinal	haematoma	underwent	fusion	(AE)1 post	operative	c mplications-	neurological1 subcutaneous	wound	infection	(AE)1
alive 1 general	health 2 residual	volumes/	urine 3 lower	extremity	weakness2 sensory	deficit 2 neurological	(AE) 1 persistent	backache 1 radiculopathy 1 bowel	function-	absent 1 sacral	sensation 1 diminished	sphincter	control1 partial	impotence 1 return	to	work-	modified1 mobility	and	locomotion1 seroma	requiring	drainage	(AE)1 TOTAL 16 prominence	of	iliac	hardware	(AE)1
TOTAL 25 energy	 1 urinary	dysfunction 1 motor	loss 1 sensation-	absent 1 neurological-	normal 1 TOTAL 31 chronic	severe	sciatica 1 bowel	sphincter	control	deficit1 saddle	sensory	symptoms1 TOTAL 16 erection	and	ejaculation-	painful1 return	to	work-	normal 1 normal	gait 1 TOTAL 13 VARIATION 12 pseudomeningocele	(AE)1
VARIATIONS 13 chronic	pain 1 average	time	to	voiding	without	a	catheter	following	decompression1 muscle strength-	complete	recovery1 s nsation-	n rmal 2 neurological	recovery-	full1 VARIATION 13 chronic	sciatica 1 postoperative	bowel	function	recovery-	complete1 hypoaesthesia	in	 erianal	region1 VARIATION 13 erection	and	ejaculation-	incomplete1 return	to	work-	full 1 ambulates	independently1 VARIATION 13 subcitaneous	seroma	(AE)1
pain	relief 1 bladder	paralysis 1 muscle	strength-	partial	recovery1 numbness 4 neurological	recovery-	not	full1 radicular	pain	(AE) 1 postoperative	bowel	function	recovery-	partial1 perianal	region-	sensory	deficit1 erection	and	ejaculation-	uncontrolled1 return	to	work-	lighter 1 requires	cane/brace	for	ambulation1 TOTAL 22
overall	results-	excellent1 bladder	symptoms 1 muscle	weakness 1 sensory	improvement 2 spasms 1 TOTAL 32 postoperative	bowel	function	recovery-	incomplete1 TOTAL 23 erection	and	ejaculation-	completely	recovered1 return	to	work-	none 1 requires	wheelchair 1 VARIATION 15
overall	results-	good 1 bladder	function 7 strength 2 sensory	loss 7 neurological	deficit-	partial1 VARIATION 16 full	control	of	defaecation1 VARIATION 16 sexual	function 1 role 1 restriction	of	ordinary	daily	life1
overall	results-	poor 1 neurogenic	bladder 1 radicular	deficit 1 sensory	function 1 nerological	deficit-	full 1 bowel	managament 1 erectile	dysfunction 1 daily	activities 1 assisted	ambulation 1
pain	intensity 1 urinary	frequency 2 foot	drop 1 persistent	burning	type	pain	in	foot1 eurol gical	disorder 1 sphincter	control 2 penilo	cavernous	reflex 1 working	capacity 1 cane	for	walking 1
treatment	outcomes 1 nocturnal	enuresis 1 spasticity 1 sensory	tingling 1 neurologic	symptoms 1 faecal	incontinence 2 ejaculation	dysfunction 1 TOTAL 20 flexibility	of	the	spine-	abitlity	of	patient	to	touch	the	floor1
pain 6 voiding	difficulty 1 plantarflexion	weakness1 hypoaesthesia 2 TOTAL 31 constipation 2 sexual 1 VARIATION 20 able	to	walk	with	or	without	support1
headache 2 UTI 2 muscle	power 1 sensation 1 VARIATION 21 bowel	function 4 vaginal	numbness 1 physical 1 pulmonary	(AE)
recovery	and	outcome-	complete1 	lower	urinary	tract	symptoms-	improved1 residual	weakness	in	lower	limbs1 sensation	recovery 1 bowel	leakage 1 achieve	orgasm 1 sleep 1
recovery	and	outcome-	incomplete1 	lower	urinary	tract	symptoms-	unchanged1 paraplegia 2 sensory	score	in	legs 1 bowel	function-	resolved1 ejaculation 1 energy 1
recovery	and	outcome-	none1 	lower	urinary	tract	symptoms-	deteriorated1 otor 2 sensory	leg	disturbance 2 bowel	function-	improved1 sexually	active 2 TOTAL 28 intra/	post	operative	transfusions	(AE)
recovery 1 mechanical	urinary	problems1 otor	recovery 1 TOTAL 53 bowel	function-	unchanged1 lack	of	intense	pressure 1 VARIATION 25
overall	outcomes 1 bladder-	major 1 motor	improvement 1 VARIATION 26 bowel 2 sexually	inactive 1
outcome	of	CCS	(conus-cauda	equina	syndrome)-	unchanged1 bl dder-	minor 1 permanent	weakness 1 sphincter	function 1 normal	erection 1
outcome	of	CCS	(conus-cauda	equina	syndrome)-	worsened1 Bl dder	function-	excellent1 motor	power	 1 Bowel	function-	normal 1 erection	insufficiency,	but	able	to	achieve	intercourse1
outcome	of	CCS	(conus-cauda	equina	syndrome)-	partly	improved1 bl dder	function-	good 2 muscle	str ngth 2 Bowel	function-	mild	dysfunction1 erection	occurs,	but	unable	to	complete	intercourse1
outcome	of	CCS	(conus-cauda	equina	syndrome)-	fully	improved1 bl dder	function-	fair 1 moto 	w akness	of	lower	extremities1 Bowel	function-	faecal	retention1 unable	to	achieve	erection1
full	recovery 1 bladder	function-	poor 2 motor	score	legs 1 colorectal	evaluation 1 erectile	function 1
recovery-	excellent 1 bladder	function-	resolved1 muscle	strength 1 bowel	frequency 1 orgasmic	function 1
recovery-	fine 1 bladder	function-	improved1 motor	disturbance 1 evacuation	efforts 1 sexual	desire 1
recovery-	OK 1 bladder	function-	unchanged1 severe	paresis 1 anal	pain 1 intercourse	satisfaction 1
TOTAL 44 bladder	function-	normal2 TOTAL 62 incomplete	evacuation	feeling1 sexual	function-	overall	satisfaction1
VARIATIONS 36 bladder	function-	mild	dysfunction1 VARIATIONS 36 rectal	discriminative	ability1 erectile	dysfunction 1
baldder	function-	abnormal1 assistance	with	laxatives.	enemas	or	manual	manoeuvres1 sexual	trouble 1
full	subjective	urinary	capacity1 number	of	spontaneous	defecation1 impotence 1
post	op	urinary	function	recovery-	complete1 abdominal	pain 2 retrograde	ejaculation 1
stress	incontinence 2 abdominal	distension 1 TOTAL 46
catheterise 4 autonomic	neuropathy 1 VARIATION 41
bladder	function-	absent1 associated	gastrointestinal	motility	disturbance1
bladder	function-	intact 1 bowel	deficit 1
bladder	sphincter	control	deficit1 bowel	sphincter	dysfunction1
post	op	urinary	function	outcome-	normal1 bowel	disturbance 1
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Appendix 4.1 Patient invitation letter from clinical care team and response slip 




We are undertaking a novel study to find out what challenges patients who have had an 
operation for Cauda Equina Syndrome face. We have realised that in the medical literature 
there are a lot of issues mentioned relating to Cauda Equina Syndrome but none have been 
verified or prioritised as important by patients. Our records indicate you have had an 
operation for this condition so are in an ideal position to give us first-hand information 
from your own experiences. 
The interview will take about 45 mins and is very informal. No prior experience or 
knowledge of the condition or research is required. We are simply trying to capture what 
challenges you feel are most important that researchers need to concentrate on in Cauda 
Equina Syndrome to try and improve its management. Your personal details and responses 
to the questions will be kept confidential.  
Our research team will send you a participant information leaflet. If you think you are 
suitable and are interested in taking part in the study you do not need to do anything. 
Instead, what will happen is that a member of the clinical care team will telephone you in 
just over 3 weeks to explain the study more and answer any questions you may have. If you 
are still happy to be involved, then they will arrange a time to meet with you at your 
convenience.   
If you ARE NOT interested in taking part in the study or do not think you are suitable then 
we would kindly ask you to return the “Response Slip” in 3 weeks. You can do this using the 
FREEPOST envelope or by email (nishsri@liverpool.ac.uk) or telephone (07935608212). Not 
taking part in the study will not affect your medical care.  
For more information regarding the study you can contact a member of the research team 
at any time on email (nishsri@liverpool.ac.uk) or telephone (07935608212). 
Once again, thank you for your time and we do hope you consider taking part in this novel 
study. 
Kind regards, 
     
Mr Martin Wilby  Mr Simon Clark  Mr Nisaharan Srikandarajah 






     
Please write your name here: …………………………………………………………………  
 
 
I DO NOT want the clinical care team to contact me about this study   
 
To help the research team improve how they do research, please feel free to write 
your reasons for not wanting to be contacted. This will remain confidential and will 

















Appendix 4.2 Patient Information leaflet for qualitative interviews 
  
PARTICIPANT INFORMATION SHEET   
 
Identifying the main challenges for patients who have undergone 
surgery for Cauda Equina Syndrome 
(REC reference no: 16/SC/0587) 
 
You are being asked to take part in a research study. Here is information to 
help you decide if you want to take part or not.  
 
Please read it carefully. If you wish to, you can talk about it with your friends 
and relatives. Ask us if there is anything you do not understand or if you want 
more information. You can take time to decide whether you want to take part. 
 
What is the reason for the study? 
Cauda equina syndrome is a serious neurological condition caused by 
sudden compression of the spinal nerves in the lower back. The majority of 
cases are due to a “slipped disc”, which requires emergency surgery. Severe 
disability can result including leg weakness, pain, bowel, bladder and sexual 
problems. It is the most common emergency spine operation with over 1000 
performed per year in England alone for this condition in the working age 
population.  
Outcomes are health-related issues as a result of the condition (Cauda 
Equina Syndrome). In the medical literature there is significant difference in 
the outcomes mentioned and a clear lack of long term or patient-oriented 
outcomes. We intend to develop a minimum set of outcomes for this 
condition using patients as key participants in the process as they have first-
hand experience of the condition. 
 
Why am I being invited to take part? 
We are looking for people who have had a back operation less than 10 years 
ago due to Cauda Equina Syndrome. We would like to find out what clinical 
issues are related to the condition, impact your life the most and what you 
think researchers in this field should concentrate on. You have been invited, 
as we believe you are a person who fits this description and who would be 
extremely helpful for this research. 
  
Do I have to take part? 
If you do not wish to participate then please appropriately tick and return the 
response slip in the pre-paid envelope to the research team. Alternatively, 
you can call or email them with the details below. If no response is received 
by the research team in 3 weeks they will call you to confirm your decision. If 
you decide to take part, you are free to change your mind at any time and 
you will not need to give a reason. A decision to withdraw will not affect the 
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standard of medical care you receive. No new information would be collected 
on you. However, any information that had already been collected which is 
anonymised would be kept by the study team. 
 
What will happen to me if I take part? 
If you agree to take part, a PhD student (interviewer) will contact you to 
arrange to meet you either at The Walton Centre NHS Foundation Trust or at 
home or via social media (Skype, Facetime) whichever is most convenient 
for you. You will be asked to sign a consent form upon meeting the 
interviewer. We are very flexible and the appointments can be arranged at a 
time convenient for you. Your GP will be informed that you are taking part in 
the project. The PhD student will ask questions on your condition, how it has 
affected you and what the most important challenges you feel are as a 
patient who has undergone surgery for cauda equina syndrome. This may 
involve sensitive questions. It is completely your choice if you want to answer 
them.  It will take 45 minutes to an hour. All interviews will be recorded for 
analysis purposes by the research team only.  
 
Expenses  
We do not expect you will have any expenses from taking part in our study. If 
you decide to take time off work to attend the interview, we will not be able to 
pay you or your employer. As a result, we are very flexible in booking an 
appointment with you. 
 
Are there any benefits in taking part? 
In the short-term you will make an invaluable contribution to developing a set 
important issues that need to be investigated by future research studies and 
trials for Cauda Equina Syndrome. You will be informed of the results of the 
study if you wish for this to happen. 
In the long-term this will improve accuracy of reporting in the medical 
literature leading to strong evidence-based treatment and management 
protocols. It will eventually drive improved NHS services and protocols for 
this condition. 
 
Are there any risks in taking part? 
There are no known risks of taking part. Taking part in the study will not 
change the medical care that you receive so the medical care you receive 
will remain the same before and after the interview. The interview can make 
you think about your condition and feelings. For some people, this can be 
upsetting. You can stop taking part in the interview at any time. You can talk 
to your GP or Cauda Equina support services (www.caudaequinauk.com). 
You can also ask the health professional interviewing you for advice. This 
would not affect the medical care you receive. We would be grateful to hear 
of any issues as a result of completing the study so that we can monitor any 
difficulties participants have and make changes to the study if warranted.    
 
Will my taking part in this study be kept confidential? 
Yes. Anything that we publish or pass on will have your name and address 
and any personal information removed so that you cannot be identified. All 
information will be stored on password-protected computers at the University 
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of Liverpool. Only the research team will be able to analyse the information 
collected on you, which includes the audio recordings. 
 
What if something goes wrong? 
The University of Liverpool has insurance cover just in case you experience 
a problem from taking part in the study. If you are worried about anything to 
do with the study, you can contact us. Our details are at the end of this 
sheet.  
 
What will happen to the results of the study? 
The challenges you mention together with those of other patients will be 
used to make a list of outcomes that will be prioritised in the next part of the 
study, which you will have an opportunity to be involved with. They may also 
be published. You will not be identified in any publication. If you would like to 
have a copy of the published results, you can ask for one by contacting us. 
All information generated by this study, including the transcriptions, will be 
held on password secured computers at the University of Liverpool offices. In 
line with the university's policy, data will be stored at the University of 
Liverpool for of at least 10 years, longer if judged to be of historical 
significance. After this period the data will be destroyed.  
 
Who is funding and organising the study? 
The study is funded by The Royal College of Surgeons England and 
Medtronic Industry but performed independently through the University of 
Liverpool.  The study is being done by The Walton Centre NHS Foundation 
Trust, Lower Lane, Fazakerley. The lead researcher is Mr Nisaharan 
Srikandarajah (PhD student). 
 
Who has reviewed the study? 
This study has been reviewed and approved by National Research Ethics 
Service Committee (Reference: 16/SC/0587).  
 
Contact for further information: 
Should you need further information about the study you can contact the 
research team at any time: 
 
Spinal Research Team 
Mr Nisaharan Srikandarajah 
Room 2:29 
Clinical Sciences Centre 








Thank you for taking the time to read this information and considering taking 
part in this research study. 
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Appendix 4.3 Patient Consent form for qualitative interviews 
    
 
Date…………………………………    
CONSENT FORM 
 
Title of Project: Identifying the main challenges for patients who 
have undergone surgery for Cauda Equina Syndrome 
(REC reference: 16/SC/0587) 
  
Please initial boxes 
1.  I confirm that I have read and understood the participant 
information sheet for the above study and have had the 
opportunity to ask questions.     
 
2. I understand that my participation is voluntary and that I 
am able to withdraw at any time, without giving a reason. 
 
 
3. I understand that the interview will be audio-recorded to 
provide an accurate record of the conversation.  
 
 
4. I agree to take part in the above study.   
 
 
5. I agree to my General Practitioner being informed of my 
participation in the study 
 
Name of Participant……………………………………………………………………………………………….... 
 
 
Date & Signature……………………………………………………………………..………………………………. 
 
 
Name of researcher…………………………………………………………..…………………………………….. 
 
 







Appendix 4.4 GP letter from clinical care team 





We are undertaking a qualitative study called “Informing the development of a core outcome set in 
Surgery for Cauda Equina Syndrome” at The Walton Centre NHS Foundation Trust in partnership 
with The University of Liverpool. For the initial stage we are inviting your patient (name of patient) 
to participate in this. This will involve them undergoing a one-to-one interview that should take 
approximately 45 mins. This will be informal and will seek to find out what challenges s/he faces as a 
patient who has undergone surgery for Cauda Equina Syndrome including sensitive issues. No 
significant clinical risks are envisaged. The study will be fully anonymised and confidential. If you 
would like further information, please do not hesitate to contact us on email nishsri@liverpool.ac.uk 




Mr Martin Wilby   Mr Simon Clark               Mr Nisaharan Srikandarajah 
(Consultant Neurosurgeon) (Consultant Neurosurgeon)             (Neurosurgical registrar) 
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Appendix 4.5 Topic guide for qualitative interviews 
TOPIC GUIDE CES QUALITATIVE INTERVIEWS 
 
Aims and Objectives 
 
-To explore the patient experience of living with Cauda Equina Syndrome (CES) 
-To ascertain what the patient feels are the most important outcomes that they are 
experiencing 
-To ascertain what outcomes the patient feels are the most important to research 
in to improve CES management and aftercare 
-To determine who should be key stakeholders 
-Identify appropriate language to use for patient Delphi iterative process.  
 
 




Explain basic definition of CES 
Explain looking for challenges experienced after the operation for CES 
Explain expected intention, sensitive subjects and duration of interview and 
confidentiality 
Confirm consent to qualitative interview 
 
 





Other medical conditions 
When was your operation for CES? 
 
Interview questions (30 mins) 
 
How has your experience of this condition; Cauda Equina Syndrome been? 
- What was it like before the back operation? 
- What was it like after the back operation? 
 
How do you feel your condition has been managed in hospital and in the 
community? 
 


















Would you be able to prioritise the importance of these for you now? 
 
Was the importance of these different at earlier stages of the condition? (More 
relevant to those in the long term CES category) 
 
Through this process of living with CES who else do you think has a good handle on 
the condition? If anyone? -Gauge other potential key stakeholders 
 
Tell me a bit about the support you had for the condition? 
 
Closing remarks (5 mins) 
 
Considering your hospital, post op and follow up experience what would you have 
liked to change? 
-support services 
-more streamlined service with dedicated clinics 
-research into timing for CES operations 
-follow up as to the effects of long term CES 
 
Offer the opportunity for the participant to comment on their interview transcript 






Appendix 4.6 “Locating Myself” 
“Lens” of the researcher 
 
My view of interviewing patients with Cauda Equina Syndrome (CES) is coloured by 
many factors. I am a surgical trainee who specialises in neurosurgery and a working 
age, middle class, male, adult with a family.   
 
I have been a doctor for 7 years. In that time, I have been a junior doctor and a 
neurosurgical trainee. For these past few years I have been in contact with CES 
patients by reviewing them in clinic and operating on them as a surgical trainee. 
The influence of a person’s professional identity on research313 and the difficulties 
in the maintenance of this balance314 have been explored and documented in the 
literature. I will explore how this is relevant to me personally.  
 
Being a doctor and a researcher 
 
The mentality in hospital regarding patient contact is to be as efficient and 
thorough as possible with every clinical encounter. This means talking to patients in 
a direct manner. We ask open questions to begin with but soon use closed 
questions to try and “hone” in on what the issue is. This is important considering 
that clinic appointments and ward rounds are time limited tasks. The approach to a 
qualitative interview needs to be more open minded. You need to let the patient 
tell their story and then guide them down the path of talking about their outcomes 
after the operation. I am however more used to directing a clinical consultation 
then let the patients direct what I say. More listening was required to draw out 
what CES patients were saying and connecting it to their outcomes after the 
operation.  
 
As a clinician, I am well-rehearsed with the outcomes have been reported in the 
literature. These are usually linked into physiological systems such as bowel 
function, bladder function etc. I did not expect quality of life and psycho-social 
outcomes to prevail during discussions as they did. Since the primary aim was to 
elicit outcomes that patients experience after an operation for CES the scope of the 
interview was mainly limited to this. There was flexibility in the topic guide and the 
interview to discuss other “themes” that emerged. Having been from a medical 
background I initially found these “themes” more difficult to facilitate than eliciting 
outcomes.  
 
I would not divulge the fact that I was a neurosurgical doctor. However, during the 
patient interviews some patients would ask me quite detailed questions regarding 
the condition as they assumed that I was more than just an interviewer and I had 
expert knowledge. Instead of denying this I would mention that I would address 
these questions after the interview. In some interviews, they mentioned outcomes 
they had never experienced as important to them. These patients were medically 
or scientifically trained and they tended to confirm the outcomes the literature was 
reporting. I am not sure if this is what they truly believed or whether they felt this is 





I had never thought of myself being in ill health. As I met young working-age 
patients who were affected more severely by the condition I started contemplating 
about my feelings. There were patients who had serious bowel and bladder 
dysfunction meaning they had to self-catheterise their bladder and use an irrigation 
system for emptying their bowel on a regular basis. Their strength was usually 
found from supportive partners or close family members. This was sometimes 
upsetting to hear but I used the support of my clinical supervisors to discuss and 
resolve such issues with them.  
 
As a surgical trainee, I see CES patients presenting acutely in hospital. We deal with 
their acute management in arranging imaging and performing an operation. Within 
a day or two we usually discharge patients. I can understand why patients 
sometimes felt overwhelmed as within 24 to 48 hours patients could be told they 
are going for an emergency operation and discharged. I have never experienced 
such an acute change in my life over the space of 2 days. I was admitted to hospital 
5 years ago for sepsis and treated where I was in hospital for 2 weeks. I just 
remember that initially I was in denial as everything escalated so fast when I ended 
up from A&E to ITU. From that side, I can sympathise with CES patients as they can 
have a long history of back and leg pain with other more severe symptoms 
developing quite fast. However, I did not like being a patient and wanted to be 
discharged as soon as possible. When patients told me that they would have liked 
to stay in hospital longer to be re-assured and have adequate physiotherapy I 
underestimated that patients are generally not medically trained so they were 
anxious of what they could do and the outcome of their operation.  
 
The experience of interviewing CES patients has taught me that it is hard to 
dissociate from your previous experiences and professional background when 
being an interviewer and analysing the data. Being aware of this throughout the 
process and reflective helps direct the interview and analysis away from bias that 
would otherwise enter. Also, having the supervisory team to check my impartiality 








Appendix 4.7 COREQ guidelines 
 
COREQ (COnsolidated criteria for REporting Qualitative research) Checklist 
 
Topic  Item 
No.  
Guide Questions/Description  Reported on Page No.  
Domain 1: 
Research team 
and reflexivity  
   
Personal 
characteristics     
Interviewer/facili
tator  
1  Which author/s conducted the 
interview or focus group?  
58 NS 
Credentials  2  What were the researcher’s 
credentials? E.g. PhD, MD  
58 MBBS qualification 
Occupation  3  What was their occupation at the time 
of the study?  
58 clinician 
Gender  4  Was the researcher male or female?  58 male 
Experience and 
training  
5  What experience or training did the 
researcher have?  
58 qualitative course 
Relationship with 
participants     
Relationship 
established  
6  Was a relationship established prior to 
study commencement?  
58 open ended questions 
and no personal   
information was given 
Participant 
knowledge of the 
interviewer  
7  What did the participants know about 
the researcher? e.g. personal goals, 
reasons for doing the research  
58 this was not explained 
until after the interview- 
they knew researcher was 
part of the study team 
Interviewer 
characteristics  
8  What characteristics were reported 
about the inter viewer/facilitator? e.g. 
Bias, assumptions, reasons and 
interests in the research topic  
Appendix 4.6 
Domain 2: Study 
design     
Theoretical 




9  What methodological orientation was 
stated to underpin the study? e.g. 
grounded theory, discourse analysis, 
ethnography, phenomenology, 
content analysis  
59 thematic analysis 
Participant 
selection     
Sampling  10  How were participants selected? e.g. 








11  How were participants approached? 
e.g. face-to-face, telephone, mail, 
email  
56 face-to-face 
Sample size  12  How many participants were in the 
study?  




13  How many people refused to 
participate or dropped out? Reasons?  
62 (15 refused to 
participate) 
Setting  
   
Setting of data 
collection  
14  Where was the data collected? e.g. 




15  Was anyone else present besides the 
participants and researchers?  




16  What are the important characteristics 
of the sample? e.g. demographic data, 
date  
63 
Data collection  
   
Interview guide  17  Were questions, prompts, guides 
provided by the authors? Was it pilot 
tested?  




18  Were repeat inter views carried out? If 
yes, how many?  
63 no repeat interviews 
Audio/visual 
recording  
19  Did the research use audio or visual 
recording to collect the data?  
58 audio recorded 
Field notes  20  Were field notes made during and/or 
after the interview or focus group?  
57 field noted made after 
Duration  21  What was the duration of the inter 
views or focus group?  
57 (45 mins) 
Data saturation  22  Was data saturation discussed?  57 
Transcripts 
returned  
23  Were transcripts returned to 
participants for comment 
and/or correction 
62 transcripts were not 







Data Analysis    
Number of data 
coders  
24  How many data coders coded the 
data?  
58 (NS & AN) 
Description of 
the coding tree  
25  Did authors provide a description of 
the coding tree?  
63 Table 4.3 
Derivation of 
themes  
26  Were themes identified in advance or 
derived from the data?  
64 Table 4.4 
Software  27  What software, if applicable, was used 




28  Did participants provide feedback on 
the findings?  
63 No they did not 
Reporting     




presented  presented to illustrate the 
themes/findings? Was each quotation 
identified? e.g. participant number  
Data and findings 
consistent  
30  Was there consistency between the 
data presented and the findings?  
67-93 yes 
Clarity of major 
themes  
31  Were major themes clearly presented 
in the findings?  
67-93 yes 
Clarity of minor 
themes  
32  Is there a description of diverse cases 
or discussion of minor themes?  







Appendix 5.1 HCP Delphi information sheet v1.0 
 
 






What is this about? 
 
We are trying to decide which outcomes are the most important for a patient after 
having an operation for Cauda Equina Syndrome (CES). This would involve filling out 
an online questionnaire and attending an optional meeting.  
 
What are the challenges in measuring outcomes? 
By comparing the outcomes of patients having surgery for Cauda Equina Syndrome 
(CES) we can study what time from symptoms to operation, surgical procedure or 
other management may be best required. This is by combining the information on 
outcomes from a number of different research studies. 
Due to outcome heterogeneity, we are not measuring the same outcomes in CES 
studies and this makes it difficult to synthesise the results to provide definitive 
answers. 
 
What is the solution?  
We want all research studies in Cauda Equina Syndrome to use the same main 
group of outcomes. This would make it a lot easier to study treatment of this 
disabling condition. When a set of main outcomes has been agreed for a health 
condition, it is called a ‘core outcome set’. If all studies measured and reported all 
the main outcomes, we could 
 
 Bring together all study data to get a better understanding of the best 
management for CES. 
 Avoid the problem of some studies only reporting a selection of the outcomes 
that have been measured. For example, ‘cherry-picking’ the best outcomes to 
report and withholding the bad results 
 
What is the purpose of the CES study? 
 
To develop a ‘core outcome set’ for CES patients who have undergone surgery.   
 
How are core outcomes agreed upon?  
Developing a Core Outcome Set for Cauda Equina Syndrome: The 





Deciding which outcomes should be core outcomes requires help from different 
stakeholder groups.  
 
Core outcomes should be relevant to health professionals, but more importantly, 
they must be relevant to patients. Researchers also need to make sure that all 
these experts – patients and healthcare professionals – agree on the core 
outcomes.   
 
The ‘core outcome set’ will be decided upon in the CES study using a Delphi Survey 
and consensus meeting. This is a type of anonymous survey with patients and 
healthcare professionals.   
 
What happens if I take part? 
 
Delphi Survey 
Taking part involves completing a survey on two occasions. Your email address, 
demographic, professional details and location of work will be requested. 
Completing the survey can take up to 30 mins on each occasion. You will see a list 
of different outcomes and be asked to rate how important it is for researchers to 
measure each of these in their studies.  
 
The outcomes were identified by a systematic literature review of completed CES 
research studies to see what they measured, and from qualitative interviews with 
patients to see what they thought should be measured. You can add any additional 
outcomes that you think are missing from the list, which will be considered for 
inclusion by the research team. Once you have completed the survey the results 
will be analysed by the CES study team. No one else will see your ratings.  
 
Once the results have been analysed you will be invited to take part in a second 
survey. This will show how you rated the different outcomes compared with the 
ratings of others who took part.  
 
It is expected that people will naturally differ in how they rate different outcomes; 
there are no right or wrong answers! Using this information, we will ask you to 
reflect on your own view and on the view of the other people who took part.  We 
will then ask you to re-score each item, either sticking with your original score or 
changing it. 
 
It is very important that you complete both surveys – your opinion really matters 
and cannot be counted if you only complete the first survey. Having said that, you 
are free to pull out at any time. 
 
Consensus meeting 
This is optional. You are invited to take part in a consensus meeting when 
registering for the Delphi and your contact details will be requested. If you have 




meeting if you wish to attend. If there is an overwhelming response from 
participants then not everyone will be invited to the meeting and we will select 
participants to obtain a varied sample. If you attend it will be a full day event, which 
takes place in Liverpool, UK attended by participants (patients and healthcare 
professionals) where the outcomes from the Delphi will be finally decided for 
inclusion into the core outcome set by online voting. There is also the chance to 
discuss your views with other key stakeholders and a facilitator.  
 
Advantages/ Disadvantages of participation  
The advantage is that you will be able to contribute to this novel research about 
your experience with managing CES patients through completing the Delphi Survey 
and attending the consensus meeting. Apart from the time taken to complete the 
Delphi Survey and possibly attending the consensus meeting there are no other 
disadvantages seen to participating.   
 
How to raise a complaint 
If you are not satisfied with the content or conduct of this research then please 
contact Mr Michael Jenkinson at Michael.jenkinson@liverpool.ac.uk. He is a 
consultant neurosurgeon who is not involved in the research. He will acknowledge 
your concern, inform the research team and feedback to you the response.  
 
What are the total numbers expected to take part in this study? 
 
We are taking a “pragmatic” approach to this study. This means the more 
participants we have involved for the Delphi process the better the agreement will 
be. We would estimate 250 participants in the Delphi and 30 to 40 participants to 
attend the consensus meeting. 
 
Are there any risks in taking part? 
 
For the Delphi, all participant responses are anonymous to other participants. You 
are not asked about your personal experience but you are asked which outcomes 
you feel are important in this condition. The research team would also be grateful 
to hear of any issues experienced when completing the Delphi and Consensus 
meeting so that we can monitor any difficulties participants have and make any 
changes which are warranted to the study.  
 
Who is conducting the research?  
Nisaharan Srikandarajah is a clinical research fellow at The University of Liverpool 
and a neurosurgical trainee.  
He is conducting the CES study with Martin Wilby, Consultant Neurosurgeon; 
Simon Clark, Consultant Neurosurgeon; Tony Marson, Professor of Neurology; 
Paula Williamson, Professor of Biostatistics; Adam Noble, Psychological Sciences 
lecturer at The University of Liverpool.   
 




When you register, your personal information will be stored securely and not 
shared with anyone outside the CES study team. Only the study team will have 
access to your ratings. All data collected for this study will be kept safely and 
securely on computer. Any identifiable information will be destroyed at the end of 
the study.  
Your ratings will be stored at the University of Liverpool for up to 10 years in case 
queries arise and it is necessary to check that the study has been carried out 
properly. This data may also be used for future research. If you do not wish the 
record of your ratings to be stored they will be destroyed at the end of the study. 
Please email Nish Srikandarajah if this is the case. Professor Tony Marson is the 
primary supervisor for this study and will be responsible for all study data.  
 
Contact for further details: 
 
Email: nishsri@liv.ac.uk OR 
 
Number: 01515295945 OR 
 
Address: Nisaharan Srikandarajah, Room 2:29, Clinical Sciences Centre, University 





Appendix 5.2 Patient Delphi information sheet v1.4 
 




TO PARTICIPATE IN THE DELPHI SURVEY, PLEASE GO TO http://bit.ly/cesdelphi 
 
 
What is this about? 
 
We are trying to decide which outcomes are the most important for patients with Cauda 
Equina Syndrome (CES). This would involve filling out an online questionnaire and 
attending an optional meeting.  
 
What is an outcome? 
 
An outcome is the result of a medical condition that directly affects the length or quality of 
a patient’s life. The effect of a significant medical condition upon a patient can lead to 
many different outcomes, all of which can be assessed.  The outcomes experienced 
can be different from one person to the next and may not be experienced by 
everybody. 
 
Doctors and researchers must assess these issues in a research study.  
For example, in a study looking at patients with Cauda Equina Syndrome (CES) researchers 





But there may be many more outcomes that matter to patients and healthcare 
professionals… 
 
What are the challenges in measuring outcomes? 
 
By comparing the outcomes of CES patients we can study what time from 
symptoms to operation, surgical procedure and other treatments may be best 
required. This is by combining the information on outcomes from a number of 
different research studies. 
If the same outcomes are measured in all research studies, this is easy to do. But if 
different outcomes are measured in different research studies this causes problems 
as we are not comparing like with like. Unfortunately, this is common.  
 
What is the solution?  
 
Identifying the Main Outcomes for Cauda Equina Syndrome: The 





We want all research studies in Cauda Equina Syndrome to use the same main group of 
outcomes. This would make it a lot easier to study treatment of this disabling condition. 
When a set of main outcomes has been agreed for a health condition, it is called a ‘core 
outcome set’. If all studies measured and reported all the main outcomes, we could 
 
 Bring together all the studies to get a better understanding of the best management 
for CES. 
 Avoid the problem of some studies only reporting a selection of the outcomes that 
have been measured. For example, ‘cherry-picking’ the best outcomes to report and 
withholding the bad results 
 
What is the purpose of the CES study? 
 
To develop the main outcomes important to CES patients for future research studies to 
use.   
 
How are the most important outcomes agreed upon?  
 
Deciding which outcomes should be the main outcomes requires help from 
different groups of people.  
 
These outcomes have to be relevant to health professionals, but more importantly, 
they have to be relevant to patients. Researchers also need to make sure that all 
these experts – patients and healthcare professionals – agree on the main 
outcomes, also called the “core outcome set.” 
 
The ‘core outcome set’ will be decided upon in the CES study using a Delphi Survey 
and consensus meeting. This is a type of anonymous survey with patients and 
healthcare professionals.   
 
What happens if I take part? 
 
Delphi Survey 
Taking part involves completing a survey on two occasions. Your email address, 
demographic details, date of surgery and your residing location will be requested. 
Completing the survey can take up to 30 mins on each occasion. You will see a list 
of different outcomes and be asked to rate how important it is for researchers to 
measure each of these in their studies.  
 
The outcomes were identified by looking at completed research studies to see what 
they measured, and from interviews with CES patients to see what they thought 
should be measured. You can add any additional outcomes that you think are 
missing from the list, which will be considered for inclusion by the research team. 
Once you have completed the survey the results will be analysed by the CES study 






Once the results have been analysed you will be invited to take part in a second 
survey. This will show how you rated the different outcomes compared with the 
ratings of others who took part.  
 
It is expected that people will naturally differ in how they rate different outcomes; 
there are no right or wrong answers! Using this information, we will ask you to 
reflect on your own view and on the view of the other people who took part.  We 
will then ask you to re-score each item, either sticking with your original score or 
changing it. 
 
It is very important that you complete both surveys – your opinion really matters 
and cannot be counted if you only complete the first survey. Having said that, you 




This is optional. You are invited to take part in a consensus meeting when 
registering for the Delphi. If you have completed all the rounds of the Delphi you 
will be sent the details of the consensus meeting if you wish to attend and your 
contact details will be requested. If there is an overwhelming response from 
participants then not everyone will be invited to the meeting and we will select 
participants to obtain a varied sample. If you attend it will be a full day event, which 
takes place in Liverpool, UK attended by participants (patients and healthcare 
professionals) where the outcomes from the Delphi will be finally decided for 
inclusion into the core outcome set by online voting. There is also the chance to 
discuss your views with other key stakeholders and a facilitator.  
 
Advantages/ Disadvantages of participation  
The advantage is that you will be able to contribute to this novel research about 
CES through completing the Delphi Survey and attending the consensus meeting. 
Apart from the time taken to complete the Delphi Survey and possibly attending 
the consensus meeting there are no other disadvantages seen to participating.   
 
What are the total numbers expected to take part in this study? 
 
We are taking a “pragmatic” approach to this study. This means the more 
participants we have involved for the Delphi process the better the agreement will 
be. We would estimate 250 participants in the Delphi and 30 to 40 participants to 
attend the consensus meeting.  
 
Are there any risks in taking part? 
 
For the Delphi, all participant responses are anonymous to other participants. You 
are not asked about your personal experience but you are asked which outcomes 
you feel are important in this condition. Some outcomes may be sensitive in nature. 





any time and withdraw from the study. You will not need to provide a reason for 
doing this and it will not influence your ongoing medical care.  
If you are concerned about the feelings you are left with after completing the 
questionnaire please discuss this with CES support groups (details provided below). 
The research team would also be grateful to hear of this so that we can monitor 
any difficulties participants have and make any changes which are warranted to the 
study.  
 
During or after the consensus meeting, if you have any concerns you can speak to 
the clinicians (Tony Marson, Martin Wilby and Simon Clark) who are part of the 
research study team and who can advise you appropriately. For example, if a 
question regarding a body function makes you reflect on your own negative 
personal experience and you wish to talk about it or you have concerns about how 
the day is running. 
How to make a complaint 
If you are unhappy, or if there is a problem, please let us know by contacting 
research team (details below) and we will try to help. If you feel you cannot come 
to us with then you should contact our university’s Research Governance Officer 
(Tel: 0151 794 8290; ethics@liverpool.ac.uk). 
 
Who is conducting the research?  
 
Nisaharan Srikandarajah is a clinical research fellow at The University of Liverpool 
and a neurosurgical trainee.  
He is conducting the CES study with Martin Wilby, Consultant Neurosurgeon; 
Simon Clark, Consultant Neurosurgeon; Tony Marson, Professor of Neurology; 
Paula Williamson, Professor of Biostatistics; Adam Noble, Psychological Sciences 
lecturer at The University of Liverpool.   
 
Confidentiality and data protection 
 
When you register, your personal information will be stored securely and not 
shared with anyone outside the CES study team. Only the study team will have 
access to your ratings. All data collected for this study will be kept safely and 
securely on computer. Any identifiable information will be destroyed at the end of 
the study.  
Your ratings will be stored at the University of Liverpool for up to 10 years in case 
queries arise and it is necessary to check that the study has been carried out 
properly. This data may also be used for future research. If you do not wish the 
record of your ratings to be stored they will be destroyed at the end of the study. 
Please email Nish Srikandarajah if this is the case. Professor Tony Marson is the 
primary supervisor for this study and will be responsible for all study data.  
 
Contact for further details: 
 






Number: 01515295463 OR 
 
Address: Nisaharan Srikandarajah, Room 2:29, Clinical Sciences Centre, University 
of Liverpool, Lower Lane, Liverpool, L9 7LJ 
 
If you are upset or concerned following completion of the questionnaire please 
contact these organisations for further support: 
 
CESA (Cauda Equina Syndrome Association) 
Web address: http://www.ihavecaudaequina.com 
Email: support@ihavecaudaequina.com 
Telephone: 0333 577 7113 
  
Cauda Equina UK 
Web address: https://caudaequinauk.org.uk 
Email:  info@caudaequinauk.org.uk 
Telephone: 0845 602 1993 
  
Cauda Equina Foundation  
Web address: https://www.caudaequinafoundation.org 
 
Spinal Injuries Association 
Web address: https://www.spinal.co.uk 
Email: sia@spinal.co.uk 








Appendix 5.3 Agenda for the consensus meeting 
 
International CES consensus meeting Agenda 
 
09:00  Pre-meeting patient briefing 
 Registration 
 
09:30 Introduction and welcome 
 Background to the project 
 Summary of the Delphi results 
 Goals of the day 
 
10:15 Introduction from the chair- Housekeeping, format for discussion and 
voting, the ground rules for discussion 
 
10:30  Session 1 
 Consensus “IN” and consensus “OUT” items from the Delphi 
 
10:45 Coffee/ Tea 
 
11:00 Session 2 





13:15 Session 3 
Discussion and voting on outcomes on which there is disagreement 
between stakeholder group  
 
15:00 Coffee/ Tea 
 
15:15 Session 4 
Discussion and voting on outcomes on which there is disagreement 
between stakeholder group  
 
16:00 Session 5 


















Nish Srikandarajah Convenor 
Sara Brookes Chair 
Claire Taylor Administrator 
Tony Marson Support 
Simon Clark Support 
Martin Wilby Support 
Adam Noble Support 









Including if name to be included on 
publication 
(sign registration log, hand out delegate 
pack and direct to patient briefing coffee) 
Claire, Kirsty 
Patient briefing and patient consent forms Nish 
Chairing discussions Sara 
Photographing results slides as a backup Simon 
Calculating % 7-9 and recording  Tony, Martin 
Handing out of microphone to delegates 
during discussion 
Claire, Kirsty 
Noting key points of discussion/ minutes Nish 
Rolling flipchart of outcomes agreed Kirsty 
Emergency handout of paper and pens in 
case voting failure  
Claire, Kirsty 
Receiving caterers/ tea coffee into room @ Claire, Kirsty 
Collecting feedback forms & expense claim 







Appendix 5.4 What to expect document for the consensus meeting 
Introduction 
 
Thank you for agreeing to take part in the International Cauda Equina Syndrome 
(CES) consensus meeting. This booklet will help explain what the consensus 
meeting will involve. We hope this is useful to you. 
 
You will have access to a “Participant Information sheet” via the study website 
(bit.ly/cesdelphi) which has details of why you were asked to take part in the study, 
the funding and the oversight of the study and what to do if you have a complaint 
that needs attention. 
 
What is the purpose of the CES study? 
 
CES is a serious neurological condition where in most cases there is compression of 
the nerves coming off the end of your spinal cord called “the cauda equina.” If this 
is not addressed or managed appropriately it can lead to significant adverse effects 
on a patient like leg weakness/ paralysis, bladder, bowel and sexual dysfunction to 
name a few. 
 
The management of CES is assessed through research studies. However, these tend 
to be of a low quality and they do not look at similar outcomes. “Outcomes” are the 
effects of the condition on the patient.  
 
The purpose of this study was to determine what the “core set” of outcomes would 
be that patients and healthcare professionals need to agree on to be used in all 
future research studies for CES. The “core set” are the essential things that all 
researchers should measure and report in their studies. Having a “core outcome 
set” will ensure that outcomes relevant to both patients and healthcare 
professionals are included in future research studies and can improve the quality of 
evidence available to help make safe and effective management decisions.  
 
What are “core outcome sets” and why do we need them? 
 
How healthcare treatments are developed 
 
To help patients, doctors and other healthcare professionals make decisions about 
treatments, we need evidence (proof) about what works best. Treatments are 
developed and tested by researchers to make sure they work and are safe. To do 
this, researchers need to look at the effects those treatments have on patients. 
Researchers do this by measuring an “outcome.” 
For example, in a study of how well an operation for arthritis of the knee works 
“outcomes” might include: 
 
- quality of life 





- knee pain 
- return to work 
 
 
What are the challenges of measuring outcomes? 
 
Different studies looking at different treatments for the same condition often 
measure different outcomes. For example, look at two studies of how to treat 
obesity: 
 
Study A- researchers measure weight loss at the end of an exercise regime 
 
Study B- researchers measure calorie intake per day whilst on a diet 
 
When these two studies are finished, we cannot compare or combine their results 
because they have measured two different things. A like for like comparison cannot 
be made. 
 
How can we solve this issue? 
 
If all studies in a health condition used the same outcomes, the results could be 
compared and combined. This would reduce waste by making best use of all the 
research.  
 
When a set of main outcomes has been agreed for a healthcare condition it is 
called a “core outcome set.” If all studies in a condition like obesity measured and 
reported these outcomes we could pool all the data together to get a better 
understanding of the best management. 
 
What makes an outcome “core”? 
 
There are many different outcomes that can be used to measure how well a 
treatment works. Different outcomes may mean more to certain people. For 
example, one person maybe very interested to know how a knee operation for 
arthritis may improve walking and another may want to know how much the pain is 
reduced. Patients and healthcare professionals may have different priorities.  
 
However, for an outcome to be considered “core” it needs to be relevant to 
patients and healthcare professionals. A “core outcome set” is a list of all the 
essential things that researchers should measure when investigating the impact of 
treatments for a condition. All these essential or “core” outcomes should be 
included in all research studies in that health area. Core outcomes are not the only 
outcomes that can be included in research studies- they may include additional 
outcomes if it is relevant to the research question being asked.  
 






Deciding which outcomes should be core requires a lot of discussion. Core 
outcomes should be relevant to patients and healthcare professionals. Researchers 
working on core outcome sets need to make sure that there is representation from 
patients and healthcare professionals to agree on the core outcomes. To deliver 




What are consensus methods? 
 
Consensus methods can include surveys, meetings and discussions where the 
opinions of the relevant experts are considered.  
 
Why is it important to involve patients? 
 
Core outcome sets need to include outcomes that are relevant to patients and 
healthcare professionals. There has been previous work, which showed examples 
of patients identifying outcomes that would have been overlooked if healthcare 
professionals had decided on their own.  
 
What have we done so far? 
 
Initially, we reviewed the medical literature to record what outcomes were being 
described for CES. Then we performed one to one interviews with patients who had 
CES. The outcomes we collected from them were then combined with the 
outcomes we received from the review of the literature. Similar termed outcomes 
were then condensed into a list to be used for the two rounds of the online 
International Delphi survey which you would have completed.  
 
So far, we asked you to complete two surveys: 
 
1. Round 1 asked you to rate the importance of CES outcomes based on your 
own opinion. 
 
2. Round 2 asked you to rate the importance of CES outcomes again, whilst 
considering how other participants in both groups (patients and healthcare 
professionals) rated the outcomes in round 1. 
 
Whilst this may seem a complicated process, the aim of asking you to complete 
both surveys was to consider both your views and experiences, as well as the views 
and experiences of the other group. By doing this, we aimed for participants to 
reach consensus (or agreement) on the most important and meaningful outcomes 
for CES. 
 






Do I need to prepare for the meeting? 
 
You do not need to prepare anything for this meeting. You will be provided a 
summary of how you rated each outcome in the Delphi survey. This is provided to 




Who will be at the consensus meeting? 
 
There will be roughly just over 50 people at the meeting. This will be: 
 20 patients 
 20 healthcare professionals 
 1 chair person 
 4 people from the research team 
 3-4 administrative staff 
 3-4 observers who are interested in doing similar research in different disease 
areas 
All participants will have taken part in the two rounds of the Delphi survey.  
 
What will happen at the consensus meeting? 
 
The day will start with an informal introduction for the patient participants. You will 
be able to ask questions and meet the research team and the chairperson Sara 
Brookes. We will ask you to sign a written consent form confirming that you agree 
to take part in the meeting. 
 
The meeting will start with a description of the background of the project and we 
will show the results from the Delphi process. Then there will be a series of 
discussions facilitated by an independent facilitator. The aim of this is to allow 
people to express their opinions and to hear the opinions of others regarding the 
outcomes discussed. The facilitator will ensure everyone who wants to speak can 
speak.  
 
After each discussion, you will be anonymously voting using keypads on whether 
the outcome should be included in the core outcome set. The final part of the day 
will be to review and agree the outcomes that were voted into the core outcome 
set. The research team may make confidential notes during the meeting to help 
with what has been said.  
 
How will the voting take place? 
 
Every participant at the meeting will be given their own voting handset. At the 
beginning of the meeting we will ask you to choose on the handset if you are a 





separately. This will help us to make sure that both group views are considered 
equally even if there are more people in one group than the other.  
After each discussion, we will ask you to vote on how important it is that the 
outcome is included in the core outcome set. As used in the Delphi survey the 
voting will be on a scale from 1 (not particularly important) to 9 (critically 
important). Once everyone has voted we will show the final results.  
 
How will you decide what is included in the core outcome set? 
 
We will include an outcome in the core outcome set if 70% or more people in both 
groups rate the outcome either 7, 8 or 9 
 
The core outcome set is the minimum set of outcomes so if an outcome is not 
included in the core outcome set it can still be used in research studies if it is 
relevant to the research question. 
 
How long will the meeting last? 
 
The meeting will start at 9AM and finish at 5PM. There will be regular breaks and 
refreshments and lunch will be provided. There are toilet facilities near the meeting 
room.  
 
What will happen to the results of the meeting? 
 
We will use the information gathered during the meeting to recommend a “core set 
of outcomes” that should be measured and reported in all future research studies 
evaluating CES patients. The results will be presented at professional conferences 
and published in medical journals. We will also send a summary of the results to 




If you have any questions or need any further information before the meeting 
please contact: 
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Appendix 5.5 Glossary of terms for the consensus meeting 




Abstract: A summary of the main features and results of a research study.  
 
Analysis: Data analysis involves looking at and making sense of research data so 
that the questions the study is asking can be addressed. For some types of research 
this will involve looking at numbers and statistics to identify patterns. For other 
types of research, it will involve examining words of what people have said in 
interviews and identifying the main themes. Analysis is often done with specialist 
computer software.  
 
Anonymised data: This is data where the participants cannot be identified. Details 
such as name, address, telephone number must be removed along with any other 
data where if it was combined with other data available to researchers, could 




Baseline measure: It is the patient symptom or characteristic that is measured at 
the beginning of the research study (e.g. pain, weight) before any treatment starts. 
 
Bias: Bias is when a specific research design or analysis would favour a specific 
outcome thereby making the results unreliable. It is important to avoid bias in 
healthcare research so that it can influence the results and lead to unsafe or 





Care Pathways: A care pathway is a care plan within an agreed time frame, written 
and agreed by a team including, doctors, nurses and physiotherapists.  
 
Cauda Equina: A group of nerves that come off the end of the spinal cord and 
supply the legs, perineum and pelvic organs such as the bladder and bowel.  
 
Cauda Equina Syndrome: when there is dysfunction or damage of the cauda equina 
nerves it can lead to a syndrome with multiple signs. Some of these signs include 
numbness in perineum, leg weakness and pain, bladder and bowel dysfunction.  
 
Core outcome set: This is an agreed, standardised set of outcomes which can be 






Cancer: A disease where the body cells grow and divide uncontrollably. They can 
spread to nearby tissues, and may spread to other parts of the body through the 
bloodstream or lymphatic system. Cancerous tumours are called malignant.  
 
Categorisation: Grouping similar characteristics or objects into categories so they 
can be compared and understood.  
 
Characteristic: A certain trait or feature. 
 
Chief investigator: A senior researcher who has overall responsibility for the 
design, conduct and reporting of a study. 
 
Chronic Conditions: A chronic condition is a human health condition or disease that 
is persistent or otherwise long-lasting in its effects. Also, known as a long-term 
condition.  
 
Clinical Trials: Research studies involving patients, which compare a new treatment 
with another treatment or the best treatment currently available. They study 
determines if the new treatment is safe or better than the one that already exists. 
Regardless of how the treatment is in laboratory testing it must go through clinical 
trials to find out the benefits and risks to patients before formally releasing.  
 
Clinical Engagement: This means working with clinicians on aspects of the study. 
So, it might mean talking to general practitioners, physiotherapists or nurses about 
the methods to be used, or inviting people to be on a research study team.  
 
Clinical Indicators: These are measures of the process, structure and/or outcomes 
of patient care.  
 
Coded Thematically: Thematic analysis in its simplest form is a categorising 
qualitative data. Researchers review their data, make notes and begin to sort it into 
categories. It helps researchers move their analysis from a broad reading of the 
data towards discovering patterns and developing themes. (See Qualitative)  
 
Cohort: A group of people identified for study and clearly defined by certain factors 
such as the area they live in. Can also be used to describe a study type.  
 
Cohort Study: An observational study in which a defined group of people (a cohort) 
is followed over time and outcomes are compared in subsets of the cohort who 
were exposed.  
 
Collaboration (in the context of user involvement): Active, on-going partnership 
with members of the public in the research process. Members of the public might 
take part in an advisory group for a research study, or collaborate with researchers 






Comorbidity: it is the presence of one or more additional conditions to the main 
disease under investigation.  
 
Complication: an unanticipated problem that develops following and because of a 
procedure, treatment or illness.  
 
Consensus: A general agreement amongst members of a group. 
 
Consensus Meeting: A consensus conference is a type of meeting where people are 
brought together to discuss and agree on a particular issue, for example priorities 
for research.  
 
Contraindications: Having a condition with which a treatment or procedure cannot 
be given. Contraindications highlight the balance of risk versus benefit of a 
procedure or treatment.  
 
Colostomy: opening of the bowel onto the surface of the abdomen (tummy). A bag 
is worn over the opening to collect the human waste produced from digestion.  
 




Data: Information collected during research. It can be in the form of numbers (for 
what is called quantitative research) or words (for qualitative research).  
 
Delphi Study: This is a type of consensus study that uses several rounds of voting 
on topics to reach agreement on the most highly rated and important items. (See 
Consensus study)  
 
Demographic Factors: Description of a group within a society, age, gender, 
location, etc.  
 
Design: The specific way a research study is done (e.g. a randomised controlled trial 
or a postal survey)  
 
Dissemination: Communicating the findings of a research study to a wide range of 
people who might find it interesting. This can be done through producing reports, 
publishing articles in journals, issuing press releases, giving talks and presenting 
scientific posters at conferences.  
 




Efficacy: The ability of a treatment or therapy to work as intended, under ideal and 





effectiveness, which is the ability of a treatment or therapy to work under ‘real 
world’ conditions).  
 
Emergency surgery: It is a medical emergency which requires immediate surgical 
intervention as the only way to help resolve the issue. 
 
Epidemiology: The study of how often health care problems occur in different 
groups of people and why.  
 
Ethics: These are a set of principles that guide researchers who are carrying out 
research with people. Ethical principles are designed to protect the safety, dignity, 
human rights, and wellbeing of the people taking part. They include the 
requirement to ask each individual to give their informed consent to take part in a 
research study.  
 
Ethics Committee: The job of an ethics committee is to make sure that research 
carried out respects the safety, dignity, human rights, and wellbeing of the people 
who take part. Ethics committee approval is needed for health and social care 
research. Ethics committee members include researchers, health care professionals 
as well as lay people/members of the public.  
 
Evidence Based Guidelines: Evidence-based guidelines are designed to summarise 
the evidence available to address a specific question regarding a medical condition.  
 
Evidence Based Health Care: The practice of medicine in which the physician uses 
methods of diagnosis and treatment based on the best available current research, 
their clinical expertise, and the needs and preferences of the patient.  
 
Expert: A person with a high degree of skill in or knowledge of a certain subject.  
 
Expert Meeting: An expert meeting is a meeting that brings together people who 
have knowledge of the topic under discussion. Experts can be health care 




Facilitators: People who give assistance to help make people do tasks or take part 
in activities.  
 




Generalisability of Results: How much the results or findings can be transferred to 






Generalisable: When the results of a study are generalisable it means that they are 
relevant to groups of people or patients other than the particular group that the 
study was carried out in. A study carried out in one region of the UK might be 
generalisable to the whole UK population.  
 
Grant: A grant is money given to researchers by funding organisations (i.e. 
governments, health organisations, charities) to enable them to carry out a piece of 
research. In order to get research studies funded, researchers have to write a 
research proposal and receive positive peer review (i.e. feedback from other 




Health Economics: Health economics is a type of research method that allows 
researchers to study the cost of treatments and benefits of treatments to the NHS 
and patients.  
 
Health Policy: Health policy can be defined as the decisions, plans, and actions that 
are undertaken to achieve specific health care goals within a society.  
 
Health Care Professional: A person who is qualified to work in health settings (e.g. 
physiotherapist or occupational therapist).  
 
Heterogeneous: Having widely different or diverse characteristics. For example, the 
research study included two groups, a heterogeneous group of healthy patients 
under 50 years old and a homogeneous group of male patients all with arthritis, 
aged between 50 and 60 years old. (See Homogeneous)  
 
Homogeneous: Things of the same type/similar or of same nature.  
 
Hypothesis: A statement created by researchers when they speculate upon the 
outcome of a research project or experiment. A hypothesis should govern the 




Impact on Practice: Research can have an impact on practice, if the way that 
practice is managed changes because of the results of the research.  
 
Implementation: If the results of research are taken up in health care settings they 
have been implemented in practice.  
 
Informed Consent: The process of agreeing to take part in a study based on access 
to all relevant and easily understood information about what participation means, 







Intervention: Something that aims to make a change and is tested through 
research. For example, giving a drug, providing a service or giving people 
information and training are all described as interventions.  
 
Involvement: Involvement in research refers to active involvement between people 
who use services, carers and researchers, rather than the use of people as 
participants in research (or as research subjects). Many people describe 
involvement as doing research with or by people who use services rather than to, 




Journal: A journal is a regular publication in which researchers formally report the 
results of their research to people who share a similar interest or experience. Each 
journal usually specialises in one particular topic area. Examples are The British 




Lay Person: The term ‘lay’ means non-professional. In research, it refers to the 
people who are neither employed academic researchers nor employed health or 
social care professionals.  
 
Likert Scale: A series of multiple-choice answers arranged in an ordered line used 
to respond to a question. They are often used in questionnaires to ask someone 
how strongly they agree or feel about something. For example, strongly agree; 
agree; undecided; disagree, strongly disagree.  
 
Longitudinal: A scientific study conducted over a long period of time with data 
collected from participants at more than one point in time during the study.  
 
Long-term Condition: A state of health, disease or physical condition that a patient 




Mean: The mean is the average of a set of numbers. To calculate, (1) add up all the 
numbers, (2) then divide by how many numbers there are. Example, (1) 2 + 7 + 9 = 
18. (2) Divide by how many numbers (i.e. we added 3 numbers). Answer = 6 (Also 
known as a mean score)  
 
Methods: These are the ways researchers collect and analyse information. These 
include interviews, questionnaires, diaries, clinical trials, experiments and watching 










Observational Data: Data collected through observation.  
 
Observational Study: Studies which attempt to understand the cause and effect of 
relationships. The researcher does not influence the population in any way or 
attempt to intervene in the study but observes the situation e.g. patient 
appointment within a consultant’s clinic.  
 
Outcome: A planned measurement described in the protocol that is used to 





Participant: Someone who takes part in a research study. Can also be referred to as 
a research subject.  
 
Pathology: The scientific study of the nature of disease and its causes, processes, 
development and consequences.  
 
Patient Reported Outcomes: A patient reported outcome measure is a 
questionnaire that asks the person to report how they feel on a particular topic. It 
may ask for example how much pain a person has felt in the last 24 hours and ask 
them to rate it from none, mild, moderate, severe or extreme.  
 
Population: This term can refer to the participants in a healthcare study; or it can 
also refer to a general population of people.  
 
Post-operative: This means the period after the operation.  
 
Prevalence: The number of cases of a specific disease present in each population at 
a certain time.  
 
Prognosis: Factors that are identified in an individual with a particular disease that 
helps to understand what might happen to that person in the future.  
 
Prognostic Factors: A situation or condition, or a characteristic of a patient, that 
can be used to estimate the chance of recovery from a disease or the chance of the 
disease recurring (coming back).  
 
Prospective Observational Cohort: A study which follows over time a group of 
similar individuals (cohorts) who differ with respect to certain characteristics under 
study. These studies find out how characteristics of individuals affect rates of a 






Protocol: A protocol describes in great detail what the researchers will do during 
the research. A protocol will be submitted to the ethics committee for approval.  
 
Purposive Sampling: This is often used in qualitative research where a group of 
people are invited to be interviewed on the basis of their characteristics. For 





Qualitative: Qualitative research is used to explore and understand people’s 
beliefs, experiences, attitudes or behaviours. It asks questions about how and why. 
Qualitative research might ask questions about why people self-manage for knee 
pain. It won’t ask how many people self-manage their knee pain. It does not collect 
data in the form of numbers. Qualitative researchers use methods like focus groups 
and interviews (telephone and face to face interviews).  
 
Quantitative: In quantitative research, researchers collect data in the form of 
numbers. So, they measure things or count things. Quantitative research might ask 
a question like how many people visit their GP each year, or whether a new drug 
gives more effective pain relief than the drugs that are usually used. Quantitative 
researchers use methods like surveys and clinical trials.  
 
Questionnaires: A series of questions and other prompts for the purpose of 




Randomisation: Assigning participants in a research study to different groups 
without taking any similarities or differences between them into account. For 
example, participants in a study could have their names randomly picked out of a 
hat to see which group they will be in. Randomisation minimises the differences 
among groups by equally sharing people with particular characteristics among all of 
the groups.  
 
Red Flags: Red flags are signs of possible serious underlying conditions requiring 
further medical intervention.  
 
Rehabilitation: Rehabilitation is a treatment or treatments designed to facilitate 
the process of recovery from injury, illness, or disease to as normal a condition as 
possible.  
 
Repeat Surgery: Surgery in the same anatomical location for the same or different 
indication.  
 
Research: The term research means different things to different people, but it is 





treatments policies or care. The definition given by the Department of Health is 
“the attempt to derive generalisable new knowledge by addressing clearly defined 
questions with systematic and rigorous methods.”  
 
Research Governance: This is a process aimed at ensuring that the research is of 
high quality, safe and ethical. The Department of Health has a Research 
Governance Framework for Health and Social Care, which everyone involved in 
research within the NHS or Social Services must follow.  
 
Research Methods or Techniques: The ways in which researchers conduct 
research. This includes how researchers collect data (i.e. Interviews, 
questionnaires, clinical tests) and analyse data (statistics, modelling).  
 
Researchers: These are the people who do the research. They may do research for 
a living and be based in a university or hospital. Researchers may also be service 




Secondary Outcome Measure: The outcome measures in a clinical trial that provide 
information on therapeutic effects of secondary importance, side effects or 
tolerability. Data on secondary outcomes are used to evaluate additional effects of 
the intervention not included in the primary outcome measure.  
 
Self-Management: Self-management has different meanings to different people 
(for example the Department of Health, doctors and patients). For patients, 
generally it means the activities and skills they use to take care of themselves. For 
example, people who have osteoarthritis have developed sophisticated ways of 
managing their joint problems without needing to visit their general practitioner.  
 
Service User: This is someone who uses or who has used health and/or social care 
services because of illness or disability.  
 
SF-36: The Short Form 36 (SF-36) is a general health related quality of life 
questionnaire which can be used for a range of health conditions. It gives a score 
based on the patient’s mental and physical health. The SF-36 can be used to 
calculate the cost-effectiveness of a health treatment. The SF-12 and SF 6D are 
shorter versions of the questionnaire.  
 
Social Factors: Description of a group of people within a society – their 
employment, skills, education and social class.  
 
Subgroups/sets: When participants of a study are further divided according to 
factors e.g. age, sex, severity of the disease, or physical condition.  
 
Survey: A survey is a way of gathering information from a sample of people who 





undertaken by postal questionnaire, or undertaken face to face (e.g. in research 
clinics), or can be undertaken using medical records.  
 
Systematic(ally): Carried on by using step-by-step procedures in an efficient and 
methodical way.  
 
Systematic Reviews: Systematic Reviews aim to bring together the results of all 
studies addressing a particular research question that has been carried out 
worldwide. They are used to bring the results of a number of similar trials together, 
to piece together and assess the quality of all the evidence. Combining the results 




Techniques: A way or method of doing something.  
 
Themes: The main ideas or recurrent topics repeated throughout the study.  
 






Variable: Any factor that can be controlled, changed, or measured in a research 
study.  
 
Verbatim: Using exactly the same words as were used originally to create a precise 
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Appendix 5.6 Venue/ hotel guide for the consensus meeting 




Thank you for attending the consensus meeting on Friday November 9th 2018. We 
are funding this meeting through charitable donations so politely request where 
possible to keep transport costs to a minimum. The following document will outline 
the options for public transport. We realise this is not always possible and will be 
able to reimburse any reasonable costs as stipulated in the guidance document 
with receipts. If you do take the taxi please can you ring the suggested firms below 
and pre-book.  




The CES consensus team.  
 
The Richmond Apart Hotel 
 
Address: 24 Hatton Garden, Liverpool L3 2AA 
Telephone: 0151 236 1220 
Closest station: Moorfields Station 
Website: https://www.bestwestern.co.uk/hotels/the-richmond-bw-premier-
collection-84201 
Car Parking: Please pre-book with the hotel at the Q Car Park Moorfields for a 
discounted rate of £8.50 day 
 
Meeting Venue: Sid Watkins building (on the Aintree hospital/ The Walton Centre 
hospital site) 
 
Address: Sid Watkins Building, The Walton Centre, Lower Lane, Fazakerley, 
Liverpool, L97BB 
Telephone: 0151 525 3611 
Closest station: Fazakerley Station 
How to find us: https://www.thewaltoncentre.nhs.uk/50/how-to-find-us.html 
Car Parking: https://www.thewaltoncentre.nhs.uk/52/parking.html This will be 
anywhere on the Aintree hospital site and the multi-storey car parking at a cost of 
£5.50 all day 
 
If you are unsure of how to find your way, please contact the Patient Experience 
Team on 0151 529 5530/6100. 
 
Taxi Firms suggestions 
 






Delta Taxi: 0151 922 7373 
 
Uber: via smartphone app 
From the hotel to the meeting venue 
 
The train will be from Moorfields to Fazakerley station. Both stations have disability 
access.  
Train fare anytime day return: £3.90 



































Liverpool Lime Street is the main station for Liverpool. It is a 10-minute walk to the 










a) Take a taxi from station to meeting venue £12-£15 one way (Recommended) 
b) Train or short walk from Liverpool Lime Street to Liverpool Central and change to 
































1) There is a direct train from Manchester Airport to Liverpool Lime Street that 
takes less than 1hr 15mins and departs every 30 mins. It should cost £18.20 for a 
return ticket. Liverpool Lime Street is the main station for Liverpool. It is a 10-
minute walk to the hotel.  











There are two options from Liverpool Airport to the hotel: 
1) There are buses that go to Liverpool City Centre or Liverpool South Parkway 
(station): https://www.merseytravel.gov.uk/getting-around/key-
destinations/Pages/Travelling-from-Liverpool-John-Lennon-Airport.aspx 
There is a direct train from Liverpool South Parkway to Moorfields Station. The 
hotel is a short walk from Moorfields Station. 






Appendix 5.7 Informed consent for the consensus meeting 
    
 
Date…………………………………    
CONSENT FORM 
 
Title of Project: Developing Core Outcome Set for Cauda Equina 
Syndrome Consensus Meeting (REC reference: 
18/NW/0022) 
 
Please initial boxes 
1.  I confirm that I have read and understood the participant 
information sheet for the above study and have had the 
opportunity to ask questions. 
 
2. I understand that my participation is voluntary and that I 
can withdraw at any time, without giving a reason. 
 
 
3.  I understand that data collected during the consensus meeting, 
may be looked at by individuals from the research team, where 
it is relevant to my taking part in this research. I give permission 
for the research team to have access to this data. 
 
4. I understand that anonymous quotations and data from the 




5. I agree to take part in the above study.   
 
 
Name of Participant……………………………………………………………………………………….... 
 
 
Date & Signature…………………………………………………………………………………………………. 
 
 
Name of researcher……………………………………………………………………………………………….. 
 
 










Appendix 5.8 Evaluation form for consensus meeting 




1.Please choose the option which describes you best: 
☐Health care professional  ☐  Patient 
 
2. The information that the organisers provided me with in advance of 
the meeting was helpful. 





3. I was satisfied with the process used to agree the core outcomes set 
on the meeting day. 





4. I was satisfied with the way the meeting was facilitated. 





5. I felt able to contribute to the meeting.  





Thank you very much for attending the CES consensus meeting on 9TH 
November 2018.  
We would value your feedback about the consensus meeting, to help 
improve future core outcome set work. If you could take a few moments to 





6. I felt comfortable in communicating my views. 





6. The workshop produced a fair result. 





7. Do you have any comments about the practical arrangements for 
the workshop (e.g. venue, timing of the meeting, catering, number of 









(This example evaluation form is based on a form developed with the COMPACTERS 
COS Study team (Steven Maclennan, Thomas Lam, Linda Pennet, Paula Williamson) 
and Heather Bagley (COMET) and was adapted from a previous evaluation used by 
the James Lind Alliance Mesothelioma Priority Setting Partnership Workshop) The 
form was further developed with the input of Bridget Young and Rosemary 




















1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22
Leg	pain Back	pain Back	pain	(priority) Leg	pain Unable	to	move	legs	24	hrsSevere	lower	back	painRight	leg	pain Low	back	pain Lower	back	painLeft	bum	cheek	numbnessSciatica Inability	to	pee	quite	suddenlyLeft	leg ciatica-	cramp	in	your	legSciatic	pain	 Back	pain-	“suicide	pain”Low r	back	pain-	like	sticking	a	knife	in	your	backBack	pain-	“like	somebody	stab ed	me”L g	pain	 Low 	pain-	like	“knife	in	the	back	with	throbbing”Intermittent ca terisationLeft	sci tic leg	painSeve e	sc atica
Back	pain I	went	to	pee	and	was	numb/	I	just	couldn’t	pee-	urinary	numbnessLeg	p in Legs	giving	way Unable	to	feel	anything	for	24	hrsNumbness	right	leg/	calfNormal	bowelsSciatica Trickling	urine“Dodgy”	back-	muscle	spasm	in	back/	stiffLower	back	painI mobile-	mobilisationSt ffness	in	the	lower	backLower	back	painLeg	pain Bilateral	leg	painWet	myself Back	pain	like	a	“rusty	hinge”Legs	shaking	secondary	to	the	painL g	 umbnessBack	pain Stiff	back/	Back	spasms/	cant	bend	over
Difficulty	walking Saddle	anaesthesia/	saddle	numbness/	upper	thigh	numbnessExcruciating pain Leg	weakness Problems	with	bladder Numbness	backsideElectric	shocks	in	legs	12-15	months	afterNumbness	in	leg-	graduating	up	the	legUrinary	retentiondifficulty	sleeping-	sleeps	in	recovery	position-	sleeping	issues	6	months	into	itWet	th 	bed Severe	diffuse	back pain“Lump of	lead” feeling	in	the	backPin 	and needl s	left	footL ft Leg	numbnessPin 	and	needles	in	leg	stumpSoiled my elf	for	a	weekLeg numbnessDropped	foot-	draggingBack/	leg	painNot	going	to	the	toiletCouldn’t	feel	legs/	feet
Not	emptying	bladder-	catheterised	after	a	whilePassing	s ool	not	happeningDrop	foot Catheterising	5	times	a	dayLower	back	pain-	terrible	awful	pain-	quite	severe-	worse	than	leg	pain-	feels	as	if	back	is	broken-	back	jars	and	grates-	ends	up	having	spasmsDifficulty	walking condary	to	the	painSle p	issues B ck	was	“seizing” up	–	“freezing”	upCo ld not	stand	with	the	paincan’t run with the dog- feels	lik 	bones are	banging	against	each	otherCannot	feel	h r	legsFoot	dr p Pro lems	with	urinationSt ff ess	i footUnable	to	drive	6	weeksTroubl 	passing	water	No	cont ol	over	the	bowel-	used	Peristeen	methodsNo 	passing	water	and	using	catheterRight	leg numbDiarr oea/	stomach	issues/	feeling	impacted/	not	emptying/	bowel	urgencyPassed very	littl 	urine	“Plumbing”	is	fine/ bladder
Erection-	“not	working	at	all”	Bowel	function	due	to	immobilityNo	action	in	my	foot Emergency	evacuations Right	foot	numbness-	leg	becomes	numbConstipation-	couldn’t	go	to	the	toiletDifficulty	bending	overLeg	feels	heavy,	limping,	dragging	foot,	difficulty	walkingWas	using	crutches	to	walk/	hobbling	around/	difficult	to	walk	more	than	a	feet/	less	stamina	to	walknumbness	improved	over	2	to	3	weeks	Right leg	p s	and	ne dles.	Altered	sensation	in	right	leg/	footSelf cath t risationLeft thigh	numb	p tchLeft	leg pain Difficulty	walkingF rcing	to	pass	stoolUnable	to	workDrop	foot Self-catheteriseCannot	orgasm/	everything	broken	downStruggling	to	empty	bladderPain	in calves-	getting	tighter	and	tighter
Pain	was	the	worseResidual	anaesthesia	in	buttocksRect l sensa ion Manual	evacuations Can’t	walk	very	far-	difficult	to	walk-	uses	wheelchair	for	distancesBladder	was	fine	aft r	t e	ope ationWeakn ss	in	legs	limited	by	painBowel-	I	couldn’t	feel	it	properly	on	the	way	outW t	myself N 	feeling	in	saddle	area	all	the	way	down	the	legsPatches	of	sensory	loss-	not	noticeableErection- sometim s	he	loses	his	erection	but	does	not	bother	himNo	sens tion	to go	and	have a	weeUnaw re	bl dder	 as	full	until	m dical	staff	saw	herNot emptyi g	bladd -	intermittent catheterisation-	unable	to	do	then	suprapubic	catheterWa king	d fficultieUrine/ at 	inf ctionsWas	g ing	n mb	with tingling	in	the	bottomLow	mo Numbness	in	legs	(b lly	button	to	hips)LBP	=	sciatica	in	in ensity
Numbness	legs “slapped”	foot/	dropped	footShuffling	ar und	on	sticksLow	mood Never	goes	shopping-	ADLs	limitedright	leg	pain Stress-	multiple	factorsBladder-	I	do	go	an	awful	lot	now.	I	don’t	feel	like	I	have	all	that	sensation	back.	Unable	to	hold	itButtock/ thigh	pain Mobility	bad-	10/11	st ps.	Ca not	walk	up	and d wn	stairs.	Has	a	chair	lift.	Falls	over	quite	easily	so	has	2	walking	sticks.	Constipation Difficulty	walking/	standi g	upDidn’t	fee 	the need	to	go and	have	a	movementC n’t	have an	er ctionLost	con rol	of	egsUs 	walking	stick	Bladder-	not	working-	felt	scared	at	the	prospect	that	this	might	not	improveFlexibility	and	mobility	reduced/	moving and bendi g	is	difficultLeft	drop footCom le ely	numb-	cat eter
Low	mood/	uninterested/	depressionleft	big	toe	not	working1	to	6	months	for	everything	to	improveSleep issues	(du 	to	pain) Sexual	issues-	I’m	nil	completely	(emotionally)Left	leg	not	“as	strong”Impacted	bowel-	manual	evacuation	by	district	nursesFeels	 nfit I	have	no	energy-	spends	3	days	at	work	then	2	days	off	and	is	knackeredProblems	with	getting	and mai taining an erection-	not	as	often	as	it	wasLeft	foot crampBl dder	issues Doe n’t	feel	like	e ting	sometimes	due	to	the	painLeft	leg	pain-	worse	than	backCannot	 ve	 n	erectionCannot	sleepUses	walking	stick	Balance	is	not	greatNo	PR	sensation
Sensation	less	down	back	passagebowel movement	(80%	recovered)Anxious r garding	physical	activityLeg numbness Back	pain	is	the	worst	>	more	than	the	bladderback	pain	is	the	worstFeels	lonely Bending	over	sets	of	the	back	pain-	is	conscious	of	this	all	the	time/	lifting	&	bendingCant	feel	anything	related	to	bladder	so	has	a	catheter.	Self-catheterisation.	Res d al	volumes w r 	improvi with	bladderFoot	 akn ssC theteris d-	real y	uncomfortableS me	nights	couldn’t	sleep	due	to	the	back	and	leg	pain-	watching	telly	to	try	and	ease	the	painLost	control	of	bladder Walking	with	a	stick-	does not	like thisNight	sweat /	ps chological tr uma/	agoraphobiaDiffi ulty	w lkingLeft	foot	drop
constipation Cramps Saddle	numbness Really	has	to	push	to	empty	bladder	and	for	number	2Self	 otivation	to	avoid	depressionSkin	infection Pain	is	the	most	important	and	fear	Bowels-	cannot	feel	the	need	to	go	to	the	toilet.	DiarrhoeaAbility	to	walk/ mobilityNeed	to go	to	th 	toilet	and	cannot	hold	itWalki g	limited-	uses	a	wheelchair/	scooterLost	all	sensation	from wais 	down	and	in	saddle	area“stiff”	mornings-	referring	to	her	backSpine	+	hip	+ everything	is	one	block-	feels	stiffStiffness	in back/ posture	relatedLeg weakn ss
don’t	walk	wellFatigue	and	weakness Left	foot	and	heel	burning Bladder	urgency	 Reduced	feeling	in	toesLeg	stiffness Absolutely	knackered	after	workUnable	to	run-	brings	on	back	and	leg	painChallenge	to	get up	and down	the	stairsBad	wound	infection	(from	surgical	site	that	needed	antibiotics)Ba k	pain	after	sex depression Fluidity	of	spine	less Mobility	is	very	important
mentally	took	a	long	time	to	get	over	itB adder	weakn ss Falls Accidents	now	and	again-	wet	herself	2	to	3	times	a	week Urinary	frequency	increasedLow	mood Depression/	fed	up	about	itReally	noticed	leg	pain	resolved	post	op	and	could	stand	upLower	back	tiff ns	up/ seizi g upTried	to	commit suicide	(but	multiple	factors	in	play-	not	just	CES	back	pain)Post	op	wound infection	 Tired	after	work-	in	he	afternoon	has	to	have	a	lie	down,	which	was	not	the	case	before	conditionRestless	legs Painful	to	walk	on	t e	feet/	heels/	and	front
erectile	functionTension	in	upper	back No	feeling	down	there-	sexagoraphobic Sensation	came	back	gradually Most	important	outcome	is	to	be	able	to	walk	properly	and	mobilityBowel issues trouble	opening	my	bowelsFaecal overflow Whole	body	vibrating/	burning/	abnormal	sensationsStruggling	to	sleep	due	to	the	leg	pain
back	to	work	in	6	weeks Patches	of	numbness/	numbness	in	buttock	region Sitting	in	an	office	chair Sleep	disturbance	secondary	to	the	painSaddle	area	numbness








Leg	pain Back	pain Difficulty	walking Not	emptying	bladder-	catheterised	after	a	whileErection- “not work ng	at	all”	Numbness	legs Low	mood/	uninterested/	depressionSensation	less	down	back	passageI	 e t	to ee	 nd	was	numb/	I	just	couldn’t	pee-	urinary	numbnessGeneric Saddle	anaesthesia/	saddle	numbness/	upper	thigh	numbnessPassing	stool	not	happeninglef big	toe	not	workinback	to	work	in	6	weeksCramp Fatigue	and	weaknessSleep	i ues	(due	to	pain)No	feeling	down	there-	sexNever	goe 	shopping-	ADLs	limitedElectric	shocks	n	legs	12-15	months	afterSkin	infection
Leg	pain Back	pain don’t	walk	well bowel	and	bladder	prioritieserectile	function Leg	numbness mentally	took	a	long	time	to	get	over	itRectal	sensation Pain	was	the	worseResidual	anaesthesia	in	buttocksBowel	fu ction	due	to	immobilityDrop	fo t Unable	to	workTension	in	upper	backAbsolutely	shattered-	feeling	tired-	exhaustedSle p	issu s Sexual	issues-	I’m	nil	completely	(emotionally)Sit ing	in	an	office	chairWhole	body	vibrating/	burning/	abnormal	sensationsBad	wound	infection	(fro 	surgic l	site	that	needed	antibiotics)
Leg	pain Back	pain	(priority)immobile	in	a	wheelchair	(maybe	a	higher	order	of	priority	if	one	had	this)Bladder	weakness Problems	with getting	and	maintaining	an	erection-	not	as	often	as	it	wasRight	foot	numbness-	leg	becomes	numbAnxious	r garding	physical	activityNumbness b ckside Excruciating	painSaddle	numbnessbowel	movement	(80%	recovered)No	action in	my	foot Difficulty	bending	overI	have	no	energy-	spends	3	days	at	work	then	2	days	off	and	is	knackereddifficulty	sleeping- sleeps	in	r covery	positio - sleeping	issues	6	months	into	itCannot	orgasm/	everything	broken downUnabl to drive 6	w eks Post	op	wound	infecti n	
Left	foot	and	heel	burningLower	back	pain-	terrible	awful	pain-	quite	severe-	worse	than	leg	pain-	feels	as	if	back	is	broken-	back	jars	and	grates-	ends	up	having	spasmsShuffling	around	on	sticksCatheterising	5	times	 	dayErection-	sometimes	he	loses	his	erection	but does	not	bother	himNumbness	right leg/ calfLow	mood Bowel-	I	couldn’t	feel	it	properly	on	the	way	out1	to	6 months f r	everything	to	improvePatches	of	numbness/	numbness	in	buttock	regionconstipati n Leg	weakness Back	was	“seizing”	up	–	“freezing”	upAbsol tely	knackered	after	workSleep	disturbance	secondary	to	the	pain
right	leg	pain Back	pain	is	the	worst	>	more	than	the	bladderLegs	giving	way Problems	with	bladder Can’t	have	an	erection Numbness	in	leg-	graduating	up	the	legagoraphobic Bowels-	cannot	feel	the	need	to	go	to	the	toilet.	DiarrhoeaUnable	to	feel	anyth ng	for	24	hrsLeft	bum	c e k	numbnessEmergency	evacuationsUnable	to	move	legs	24	hrsAnkle	seizes	upTired	after	work-	in	the	afternoon	has	to	have	a	lie	down,	which	was	not	the	case	before	conditionCanno 	sleep
Right	leg	pain Severe	lower	back	painFalls Really	has	to	push	to	empty	bladder	and	for	number	2Cannot	have	an	erection Reduced	feeling	in	toesS ress-	multiple	factorsNo	PR	ensation Sensation	came	back	graduallyNo	feeling	in	s ddle	area	all	the	way	down	the	legsManual	ev cuationsWeakness	in	legs	limited	by	pain“Dodgy”	back-	muscle	spasm	in	back/	stiffStruggling	to	sleep	due	to	the	leg	pain
Sciatica back	pain	is	the	worstCan’t	walk	very	far-	difficult	to	walk-	uses	wheelchair	for	distances Pins	and	needles	in	anklesSelf	motivation	to	avoid	depression Could	not	stand	with	the	painLost	all	sensation	from	waist	down	and	in	saddle	areaC stipation-	couldn’t	go to the	toiletLeft	eg	not	“as strong” Stiffness	in	the	lower	back
Buttock/	thigh	pain Low	back	pain Difficulty	walking	secondary	to	the	painReally	has	to	push	to	empty	bladder	and	for	number	2numbness	improved	over	2	to	3	weeks	Feels	lonely Feels	unfit Was	going	numb	with	tingling	in	the	bottomNormal	bowelsFoot	drop “Lump	of	lead”	feeling	in	the	back
Leg	stiffness Lower	back	painLeg	feels	heavy,	limping,	dragging	foot,	difficulty	walkingBladder	urgency	 Cannot	feel	her	legsEmotionally	and	psychologically	it	has	affected	me Saddle	area	numbnessImpacted	bowel-	manual	evacuation	by	district	nursesFoot	weakness Lef 	foot	c amp
Sciatica Bending	over	sets	of	the	back	pain-	is	conscious	of	this	all	the	time/	lifting	&	bendingFalls Accidents	now	and again-	wet	herself 2	to	3	times	a	weekRight	leg	pins	and	needles.	Altered	sensation	in	right	leg/	footConfidence	reduced Constipation Lost	control	of	legs Stiffness	in	foot
Left	leg	sciatica-	cramp	in	your	legLower	back	painLevel	of	physical	activity	and	numbness	most	importantBladder	was	fine	after	the	operation Patches	of	sensory	loss-	not	noticeablePain	is	the most	important	and	fear	 Didn’t	feel	the	need	to	go	and	have	a	movementDrop	fo t Lower	back	stiffens	up/	seizing	up
Sciatic	pain	 Severe	diffuse	back	painWas usi g	crutches	to	walk/	hobbling	around/	difficult	to	walk	more	than	a	feet/	less	stamina	to	walkBladder-	I	do	go	an	awful	lot	now. I	don’t	fe l	like	I	hav 	all	that	sensation	b ck.	Unable	to	hold	itL f thig nu b	patchL w	mood Bowel	issues Dropped	foot-	dragging “stiff”	mornings-	referring	to	her	back
Left	leg	pain Lower	back	paincan’t	run	with	the	dog-	feels	like	bones	are	banging	against	each	otherUrinary	frequ ncy	increased Pins	and	needles	left	footDepression/	fed	up	about	it Forcing	to	pass	stoolLef 	drop	foot Spine	+	hip	+	everything	is	one	block-	feels	stiff
Leg	pain Back	pain-	“suicide	pain”Mobility	bad-	10/11	steps.	Cannot	walk	up	and	down	stairs.	Has	a	chair	lift.	Falls	over	quite	easily	so	has	2	walking	sticks.	Trickli g	urine Left	Leg	numbn ssDoe n’t	feel like	eating	sometimes	due	to	the	pain trouble	opening	my	bowelsLeft	foot	drop Restless	legs
Bilateral	leg	pain Lower	back	pain-	like	sticking	a	knife	in	your	backMost	important outcome	is	to	be	able	to	walk	properly	and	mobilityUr nary	r tention Pins	and	needles	in	leg	stumpTri d to	commit	suicide	(but	multiple	factors	in	play-	not	just	CES	back	pain)Soiled	myself	for	a	weekLeg weakness Stiffness	in	back/	posture	related
Some	nights	couldn’t	sleep	due	to	the	back	and	leg	pain-	watching	telly	to	try	and	ease	the	painBack	pain-	“like	somebody	stabbed	me”Im obile-	mobilis tionWet	myself Leg	numbness	(in	thigh	and	shin)Memory	loss No	control	over	the	bowel-	used	Peristeen	methodsStiff	back/	Back	spasms/	cant	bend	over
Left	leg	pain-	worse	than	backBack pain	after	sexDifficulty	walking/	standing	upWet the	bed Leg	numbness depression Faecal	overflow
Leg	pain	 Back	pain	like	a	“rusty	hinge”Ability	to	walk/	mobilityCant	feel	anything	related	to	bladder	so	has	a	catheter.	Self-catheterisation.	Right	eg	numb Low	mood Diarrhoea/	stomach	issues/	feeling	impacted/	not	emptying/	bowel	urgency
Legs	shaking	secondary	to	the	painLow	back	pain-	like	“knife	in	the	back	with	throbbing”Unable	to	run-	brings	on	back	and	le 	painInability	to pee	quite	suddenly Leg	numbness Night	sweats/	psychological	trauma/	agoraphobia Not	going	to	the	toilet
Back/	leg	pain Back/	leg	pain Really	noticed	leg	pain	resolved	post	op	and	could	stand	upSelf	catheterisatio Numbness	in	legs	(belly	button	to	hips)Anxiety
Left	sciatic	leg	pain Back	pain Challenge	to	get	up	and	down	the	stairsResidual	volumes	were	improving	with	bladder Couldn’t	feel	legs/	feet
Severe	sciatica LBP	=	sciatica	in	intensityD fficulty	walking Problems	with	urination
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